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INTRODUCTION 
HISTORY 
In 1787 Aloysio Luigi Galvani (1737-1798), 
at that time Professor of Anatomy at the 
University of Bologna, demonstrated that 
the muscles of the hind limbs of a frog 
manifested "electromotive phenomena." A 
partly dissected frog's leg with a metal 
scalpel accidentally left in contact with an 
exposed nerve showed muscle conh'ac-
tions whenever a nearby electrostatic 
apparatus was rotated. Ensuing experi-
ments led him to describe a method for 
stimulating tissues electrically by simply 
touching a muscle or nerve with tvvo rods 
of clissimilar metals bound together, belie-
ving that it was due to electricity gene-
rated within the tissues. Allesandro Volta 
(1745-1827), Professor of Physics at the 
University of Pavia, challenged Galvani's 
interpretation by denying the existence of 
animal electricity, believing that the stimu-
lation was due to electricity generated at 
the points of contact of the two metals. 
Thus arose a famous scientific controversy. 
To meet Volta's objection Galvani develo 
ped an experiment in which muscle con-
traction was induced using living tissue 
Figure 1 
instead of metal rods. He showed that if a 
nerve was made to touch another tissue a 
two points, one injured and the other 
uninjured, the muscle supplied by the 
nerve would contract. This was the first 
unequivocal demonstration of the existen-
ce of electricity in living tissue and also the 
first description of the current of injury.! 
Since then many researchers were "gal-
vanized" by all kinds of electrical pheno-
mena in various animal models, some of 
these related to the heart. With the deve-
lopment of more sensitive instruments 
more data became available, leading to a 
better understanding of the underlying 
physiology. In 1887 the London physio-
logist Augustus Desire Waller (1856-1922) 
was the first person to record electrical 
activity of the human heart from the intact 
chest wall with the capillary electrometer.' 
Dissatisfied with the quality of the recor-
clings obtained with this insensitive instru-
ment, the Dutch physician and professor 
of physiology at the University of Leiden 
Willem Einthoven (1860-1927) developed 
a more sensitive string galvanometer/,4 
enabling very sensitive and highly repro-
ducible recordings of the electrical activi-
o,JSec. 
~ 
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The serial repetitious deflections or waves denoted as P, Q, H, 5, and T by Willem Einthoven. 
Reproduced from Einthoven U7.: Die galvanometrische Registrirtmg des menschlichen Elektrok4rdiogramms, 
zugleic/} eine Beurtheilung der Anwendtmg des Capillar.Elektrometers in det Pilysiologie. Archiv fiir die 
gesammte Pbysiologie der Menschen tmd der Thiere 1903; 472·80. 
ties of the heart. He introduced the term 
electrocardiogram (EKG or ECG), and 
labeled the serial repetitious deflections or 
waves as P, Q, R, 5, and T. He was able to 
relate variations in the electrocardio-
graphic pattern with conditions such as 
premature contractions of the heart, blocks 
in the heart's conduction system, and heart 
enlargement due to valve dysfunction. 
Noting that the shapes of the deflections 
varied widely with the lead placement he 
proposed a standard lead system known 
as leads I, II, and III. For his discovery of 
the mechanism of tile electrocardiogram 
he was awarded the Nobel prize for phy-
siology and medicine in 1924.5 
It was Fred H. Smith who in 1918 as a 
resident at the Columbia University in 
New York first demonstrated ST-segment 
elevation as a sign of coronary occlusion 
using coronary artery ligation in dogs as a 
mode1.6 He was advised to do so by James 
B. Herrick of Chicago who would later 
publish the first electrocardiogram ob-
tained during the clinical manifestations of 
myocarcUal infarction.1,7 It is now general-
ly believed that ST-segment elevation is 
the reflection of reversible transmural 
ischemia, reflecting the differences in 
resting potentials and depolarization 
pattern between the ischemic and the 
healthy myocardium. 
PHYSIOLOGY 
Figure 1 denotes the different deflections 
of an electrocardiogram during one car-
diac cycle. The P wave reflects the electri-
cal activation of the atria. TIle QRS com-
plex represents the electrical activation of 
the ventricles. The segment between the 
QRS offset and the end of the T-wave is a 
reflection of the plateau phase of the action 
potentials of the ventricular myocardium 
and return to the electrical resting state, 
known as repolarization. The ST segment 
11 
is the segment between the end of the QRS 
complex (known as J-point) and the begin-
ning of the T-wave. 
Two electrocardiophysiologic pheno-
mena have been suggested to explain ST 
elevation during transmural ischemia (lack 
of oxygen) resulting from total coronary 
artery occlusion as conunonly seen during 
acute myocardial infarction. During the 
resling phase of the cardiac cycle (diastole) 
healthy myocardial cells maintain a resting 
membrane potential of approximately -80 
microvolts, while this resting potential is 
less for the ischemic cell. Thus, during 
ischemia a current ("current of injury") 
flows from the ischemic to the healthy 
myocardium during diastole, leading to a 
depression of the T -Q interval. TIlese cur-
rents disappear during the Q-T segment in 
the electrocardiogram, when all ventricu-
lar tissue is depolarized. TIlis is represen-
ted as ST-segment elevation relative to the 
T-P and P-Q intervals in the ECG.8•9 Fur-
thermore, during the activation phase of 
the myocardium (systole) ischemic cells do 
not depolarize as much as healthy cells 
and their repolarization occurs earlier. 
This results in a current from the healthy 
to the ischemic myocardium during systo-
le, which is also reflected as ST elevation 
on the electrocardiogram.9 
Approximately 75% of acute myocardial 
infarction patients have ST -changes sug-
gesting transnnual infarction at presentation 
(presmnably new ST elevation or depres-
sion :2: 1-2 nun), while this percentage mat; 
increase whith serial ECG assessments.9- 2 
Patients without ST deviation generally 
have smaller infarcts and often have less 
benefit of reperfusion therapy. 12·1' Without 
reperfusion of the infarct rela ted artery the 
ST deviation gradually lessens over the 
next hours to days due to necrosis of the 
myocytes and thereblloss of myocardial 
mass ("hum Dutil). 11,1 -22 After repel' fusion 
a more rapid normalization of the ST-
12 
segment occurs. This phenomenon has 
been demonsh'ated clearly during intra-
coronary administration of thrombolytic 
drugs to dissolve the thrombus occluding 
the infarct related artery.2~22 Figure 2 
demonstrates the differences in ST-seg-
ment behavior over time during continu-
OllS coronary occlusion and after reperfusi-
on through the infarct related coronary 
artery. 
ST-SEGMENT MONITORING 
The observation of rapid ST recovery at 
Figure 2 
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the moment of angiographically docu-
mented reperfusion led to several studies 
correlating quantitative ST recovery to 
infarct related artery patency. Several 
methods comparing ST-segment deviation 
between a post treahnent ECG and a fixed 
pre-treahnent reference ECG have been 
reported.23-29 These methods measure the 
ST deviation in one or few post-treatment 
ECGs at intervals typically 60 to 180 minu-
tes after onset of thrombolytic treatment. 
If the ST-segment has recovered below a 
threshold expressed as a percentage of 
the pre-treatment reference ECG ST level, 
o 1 2 3 " :s 6 7 8 9 10 11 12 13 14 15 16 17 18 U 20 21 22 23 
TIME Ihrl 
Holter ST -segment trends in 2 patients with complete occlusion of the infarct related artery. Top, 
successful reperfusion after intra-coronary thrombolysis is characterized by the sudden decline of ST-
segment elevation. Bottom, W1successful reperhlsion with a slow I gradual achievement of ST steady 
state. Reproduced witll permission from: Krucoff MW, Green CE, SatIer LF, Miller KM, Del Negro AA, 
Pearle DL, Fletcher RD, Rackley CE: NOr/invasive detection of coronary artery patency IIsillg COlltitlllOI(S 
ST-segmeflt motlitoritlg. Am J Cardio! 1986; 57: 916-22. Copyright 1986, All rights reserved. 
reperfusion is considered to have occur-
red. If the ST-segment did not recover 
below this threshold reperfusion is con-
sidered to have failed. 
Continuous ST-segment monitoring 
using Holter recorders was developed to 
better document the timing of reperfusion. 
Recordings were analyzed retrospectively 
and allowed to distinguish patients with 
reperfused infarct related arteries from 
those in whom the infarct related artery 
failed to reperfuse after treatment." How-
ever, Holter recordings are limited in the 
number of leads to be used and cannot be 
used at the bedside for guidance of clinical 
care since they require off-line analysis. 
Therefore dedicated continuous multi-lead 
computerized electrocardiographs have 
been developed by several groups wich 
can measure, compare, and display the ST-
segment in real time so that the recorded 
information can be used to guide clinical 
care.30-35 The major application of these 
devices is the display of ST-segment re-
covery and of new ST-segment abnormali-
ties as a reflection of ischemia in various 
unstable coronary syndromes such as 
acute myocardial infarction, unstable 
angina pectoris, and post coronary angio-
plasty. Accordingly they have been called 
"ST monitors" or "ischemia monitors." 
THIS THESIS 
The Ischemia Monitoring LaboratDlY at 
the Duke University Medical Center in 
Durham, USA, in cooperation with Morta-
ra Instrument, Milwaukee, developed a 
real-time oriented digital 12-lead electro-
cardiograph. Essentials of this ST monitor 
(STIOO) have been published previously.'" 
35 TIle manuscripts gathered in this thesis 
are a reflection of investigations as a re-
search fellow in cardiovascular medicine 
at the Duke University Medical Center, 
focussing on the development and testing 
13 
of hardware and software as well as the 
clinical application of ST monitoring. 
Chapter 2 describes tile initial experien-
ce of non-invasive patency assessment 
using continuously updated 12-lead ST-
segment recovery analysis.36 In a series of 
22 acute myocardial infarction patients 
sensitivity for an occluded infarct related 
artery was 90% and specificity was 92%. In 
view of these prDlnising results and the 
results of a larger 144 patient series/7 an 
inter- and intra- observer variability ana-
lysis of this patency assesment technique 
was performed, as presented in Chapter 
3." The evolution and salient principles of 
an automated ST-segment analysis pro-
gram for real-time non-invasive patency 
assessment is described in Chapter 4 and 
the results of the testing of this program 
during PTCA are presented in Chapter 5.'" 
40 In Chapter 6 patterns of ST deviation as 
seen on the 12-lead ECG during occlusion 
of the infarct related artery are correlated 
with the angiographically determined 
infarct related artery." The possibility and 
limitations of a restricted lead set for ST 
monitoring for infarct related artery paten-
cy assessment are discussed. The prospects 
of ST-segment recovery as an endpoint in 
acute myocardial infarction trials are ad-
dressed in Chapter 7.42 Chapter 8 charac-
terizes the impact of coronary angioplasty 
Perfusion Balloon Catheters (PBC) as 
compared to standard angioplasty bal-
loons on quantitative electrocardiographic 
parameters of ischemia severity, extent, 
and "burden." 43 A comparison of conti-
nuous ST-segment recovery analysis with 
methods using static electrocardiograms 
for noninvasive patency assessment du-
ring acute myocardial infarction is presen-
ted in Chapter 9." Chapter 10 reviews ST 
monitoring applications during acute 
myocardial infarctions and compares it 
with other noninvasive patency assess-
ment techniques. Other applications of the 
14 
ST monitor are discussed and areas for 
future research are outlined. Finally, the 
results presented in this thesis are sum-
marized. 
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Continuously Updated 12·Lead S1·Segment 
Recovery Analysis for Myocardial Infarct 
Artery Patency Assessment and Its 
Correlation with Multiple Simultaneous 
Early Angiographic Observations 
Mitchell W. Krucoff, MD, Martha A. Croll, RN, James E. Pope, MD, Karen S. Pieper, MS, 
Prapti M. Kanani, MD, Christopher B. Granger, MD, Rolf F. Veldkamp, MD, 
Beverly L. Wagner, RN, Sharon T. Sawchak, RN, and Robert M. Califf, MD 
Early angiography may not adequately subgroup 
patients with myocardial infarction if cyclic 
changes in coronary flow occur frequently. From 
a pilot experience using a new 12-1ead ST-seg. 
mont monitor, a continuously updated, selkefer-
oncOO ST-f&COvery analysis method was davef.. 
oped to quantify both in&"iamanoous recovery, 8S 
a noninvasive marker of patency, and cumulativo 
Sf recovery over time, as a marner of the speed, 
stability and duration of reperfusion. In 22 
patients with acute infarction in whom 44 obser-
vations of unique angiograp.hic patency were 
noted within 6 hours of presentation, serial 
paieooy assessments simultaneous with all 
angiogntphic observations predicted coronary 
occlusion with 90% sensitivity and 92% specifici-
ty. Of tho 22 patients, 11 (50%) had muHiple S1 
trend transitions suggesting cyclic changes in 
coronary flow beforo catheterization, Speoo, sta. 
bility and duration of S1-scgnwmt recovery wero 
defiood by tho tima to first 50% Sf recovery, 
total number of ST-trend transitions and patent 
physiology index (percentage of monitoring peri~ 
od showing Sf recovery), respectively. Sub-
grouped ang'iogJ'aphically, the median (interquar-
tilo rango) for cumulative S1 parameters with 
patent (n ;; 8) versus occluded (n ::;; 14) arteries 
wero, respectively - time to 50% recovery, 1.57 
(1.16,1.70) versus 0.17 (..().47, 0.32) hoursi num-
ber of r-eolovation/rooovery events, 1.5 (1, 3) 
versus 3 (1, 3)i and patent physiology index, 62 
(47,59) versus 50 (6, 73). Thus, continuous ST· 
segment recovery analysis appears to predict 
simultaneous angiographic patency over serial 
assessmems, whereas cumulativo parameters 
appear to contain independent infonn/rtioo, prob-
ably because of patency changos beforo or after 
angiography. (Am J CardioI1993j71:14S--161) 
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AngiOgraPhkallY defined patcncy provides only a brief anatomic visualizalion of the infarct artcry during the course of ongoing infarction. More 
prolonged angiography has shown that cyclic or "unsta· 
ble" infarct artcry patency is conmlOn and consistently 
related to dynamic ST-segmcnt changes.1.2 Quantifica-
tion of the ST-segment recovery process may provide 
both an instantaneous method for ~erial patency assess-
ments and a cumulative measure of the speed and sta-
bility of reperfusion. Analytic methods for ST analysis 
in patients presenting with abnonnal ST levels subject 
to sudden marked changes arc limited.3--7 To address this 
need, we developed a method of self·referenced, con-
tinuously updaled ST-segmcnt recovery analysis paired 
with a new 12-lead digilul S1' monitor and examined its 
perfonnance in patients who underwent acute angiogra-
phy during myocardial infarction. The goal of this ret-
rospective analysis was to examine. in a preliminary 
fashion, the relation of ST-recovery analysis to simulta-
neous infarct rutery patency and the relation of cumula-
tive ST recovery reflecting speed, stability and duration 
of reperfusion to acute angiographic patency. 
METHODS 
Patient selection: All plltienls presented with chest 
pain within 6 hours and ST-segment elevation not re-
versed with lJ.i.trates, as previously detailed.8 All patients 
had myocardial inf<u"Ction by enzyme elevtltion and all 
underwent cardiac catheterization within 6 hours of ad-
mission. Choice of therapy and liming of c,ltheterization 
were detennined either through physician judgment or 
tluough the 'l1uombolysis ruld Angioplasty in Myocar-
dial Infarction (TAMI) 5 pro!ocol,9 ST-segment moni-
toring data were not accessible to the bedside caretak-
ers in any case, 
Angiographic analysis: For this ;:malysis the infarct 
artery was dcfuled as patent with TIlrombolysis in Myo-
c:udiallnfm·ction (1TMl) uial 2 (0 3 flow, or as occlud-
ed with TTh1I trial 0 to I flow. Unique <lIlgiographic 
observations were included for e\'ery patient in whom 
patency change (from patent to ofduded or vice versa) 
occurred during catheterization, either spontaneously or 
as a result of further therapy. TIMI flow was detemlined 
by experienced angiographers (non-TA1v1I patients) o[ 
by the TAMI AngiograplJ.i.c Core Laboratory al the Uni-
versity of Michigan (TAM1 5 patients). In all fases 
angiographic interpretation was made with no knowl-
edge of ST -recovery data. 
ST-sGgmem monitoring: The Mortara ST Monitor-
ing System (Mortara Instrument, Milwaukee) has been 
described in detail previollsly,:.\4,8 In brief, the device 
meets American Heart Association criteria for frequen-
cy response and sampling rate in standard electrocardio-
graphic cartS.1O A 12-lead electrocardiogranl is auto-
matically acquired every 17 seconds, digitized and im-
mediately compared with the patient's own baseline 
electrocardiogram for ST -segment changes over time in 
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any Icad(s). All measmcments derive from median beats 
at J+6O ms, For the pilot experience, aU clinical alrums 
were disabled, In all patients ST monitoring was initiat-
ed with impedance-monitored skin preparation (Quit. 
Prep, Quinton Medical, Seattle, Washington) using radi-
olucent lead wires and electrodes, A total of 10 elec-
trodes were placed over the standard 6 precordial posi-
tions, with the 4 limb leads placed 011 the bony clavicles 
and iliac crests ("monitoring position ") 10 stabilize 
baseline. Lead positions remained fixed throughout the 
monitoring period, Monitoring was initiated before or as 
B) fAl + PTCA 
~, 
(11r,Wn) 
60' 
-----,------~." 
n .. 
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90' 
FIGURE 1.. 'lhre<H:limoosionaJ ~C di&pl'ay of digital 12-1ead ST-oogment data trended M 5T level (Y-axIs) over each of tho 
12 standard &I~c leads (X-axIs), OVOf tinw (z.axJ9), shown in 3 &patid rotati(lf1$ (10~, 60", 900 f1'om top to 
wHom) tOf' eadl of 2 patients.. A, during elective ~s transJurllinai coronary sngiopls8ty (PlCA) of the right coro-
nary pattems from 7 balloon Inflations croote 7 episodes of 5T (r&}elevation in Id&rrtical precordial ''fingerprint'' pattern fol-
lowed by 5T recovery with each bruloon deflation. Tho "peak and troo&1l" pattom of transitions OV61 time is the paradigm 
tot r&f*fusion/r&OUfusioo. B, same graphi(: display ill a patient with Inferior infBfclion tNated with primary angioptasty. 
Multiple ST transitions 111 matched fingerprint pattern occur spontooooudy for OV61 2 hours b&furo initial oogiogrftphy (A), 
whlch revealOO ran occluded right coronary, reperfused by &nleilteney balloon inflations (B). MI c my~aJ Infarction. 
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SOOI1 after the onset of therapy as possible. Exclusions 
from our retrospective <Ulalysis induded hoohlp of the 
ST monitor >60 minutes after onset of the-wpy or inter-
I1lplion of the ST infonuation by persistent noise, bun-
dle branch block, ventricular rhytlml or ventricular pace-
maker. All patients were kept at bed rest. 
ST>fGCovery scanning and analysis technique:* 
All stored electrocardiograpltic data were downloaded to 
a personal computer and analyzed wilh custom-written 
scanning software which we have previously desclibed.3 
All studies were analyzed over the first 6 how-s, includ-
ing the lime of angiography. Patterns of ST nxovery and 
feelevation associated with cyclic flow changes were 
derived from previous experience with angioplasty bal-
loon inflation and deOation.4•11- U Similarities are graph-
ically illustrated in Figure I. TIle absence of a prede-
fined "baseline" in the myocardial infarction presenta-
tions, howe\'Cl~ mandated modifications for quantitative 
measurements. 
The 3-dimensional graphic display in the SCaIuling 
.softwarc ilIustnlted in Figmc I was used to dcfine e<tch 
patient's S1' measurement matrix. TIle measurement 
matrix was taken as the single most abnonnal lead in 
the most abnOl1l1al eiectJocardio!:,Tnml unless the lead ID-
eation dumged over the course of monitoring or mu1ti-
tSee Appendix for ~ummM)' of definitions. 
FIGURE 2. TwlHfil'OOflstoonl 
Sf-matrix trend from 
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pic precordial wne-s (where anterior zolle::: V1-V4; low 
lateral zolle = V5-V6; high lateral wne = I, aVL; and 
inferior zone::: II, ill and aVF) showed ST elevation 
simull<meously. With either of these exceptions, the 
measurement matrix wa<; taken as the sununated abso-
lute deviation over lhe entire 12 leads, Graphic display 
was also used to identify each patient's nmltilead pat-
tem of ST activity, or ST "fingerprinl."ll Episodes of 
recurrent S1' deviation were taken as evidence of infarct 
artery reocclusion only when the fillgerprint pattern re~ 
curred,13 
Quality control of the 51' matrix mid gmphic displays 
was aflorded by full disdoswe 12-lead superimposition 
SCaIllJing within the analysis software. Every slmldrud 
12-lead electrocardiogmm was directly visualized in the 
Duke Ischemia Monitoring Core Laboratory for all stud-
ies. 
Analysis of ST Iecovery centered on definition of 
"troughs" and "peaks" in the trend of Ule ST-matrix 
level over time (Figure 2). Troughs ruld peaks repre-
sented point'> of tmnsition from ST recovery to WOf!'ieO-
ing or from worsening to recovery, respectively. A tnUl-
sition peak was defined us the most abnoffilal ST level 
directly preceding any single period of ST -segment re-
covery. ST-segmenl recovery was defined as lewlution 
within a 3-hour period consisting of either (I) GSO% 
recovery from the immediately preceding peak ST level 
• 
liME (hQurs) patien1 in Figure lB. Time 
from onset of monitoring to 
first Sf recovery is shown 
as tho interval R. Troosition 
points (11 to T13) associ-
ated with peaks W1d 
troughs I.IlO Kkmtifiml sa 
changos from Sf l'OCovery 
to reolevation or vice VGNIa. 
Patent physiology ii'l'OOx 
equals tho sum of tho dUfa-
tion of the sJmd.tHJ reoovCf)' 
intervals t1ividOO by Ole 
entire monitoring VOOod. All 
trend points ropresoot etJ:mo 
dald 12.food elactro-
CMdiogaphic infOfmation, 
8S illustrated below tho 
trend, which is oonfilTilOO 
\Jaing supromposition scan-
ning. 
111111 IIIIII 
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Of (2) 35 to 49% recove!), relative to the immediately 
preceding transition peak; and ;;::50% recovery relative to 
the most abnonnal peak documented at any time in the 
study before the cunent electrocardiogram, The cunent 
eieClf<K:;u-diognll11 was defined as the eiectrocardiob'f<Ull 
corresponding to each moment an ST-recovery analysis 
was perfonlled, 
A transition trough \Va" defined iL" the most !lomlal-
ized ST level preceding any single period of ST-segment 
reelevation, ST-segment reeJevalion was defined as re-
elevation in a matched precordial "fingerprinl,"13 evolv-
ing over '5:60 minutes and lasting for ;::60 seconds. Min-
imal amplitude of reclevation was required 10 be ~50 
!--tV in any 2 leads or ;;::200 /-tV in a single lead or to a 
level equal to or !,'fCaler than the level of the mosl recent 
twnsition peak. 
Recovery intervals weiC defined as beginning al the 
moment of 50% ST lecovery :md ending at the onset of 
reelevation, TIle time to tirst 50% ST recovery was de-
fined as the time from the onset of thewpy to the onset 
of the tirst recovery interval up to a n1<Lximum of 6 hours 
if no :mch recovery oCl'uned within the monitoring peri-
od, TIle patent physiology index Wil<; taken as the per-
centage of the monitoring period showing ST recovel y, 
defined as the ~ull1mated duration of all recovery inter-
vals divided by the lotalmonitoring dumtion X 100. TIle 
total nUJllber of pc-aks iUld troughs from the ollSet of 
monitoring to the lirsl contra<;t injection was taken as the 
"number of transitions," 
Patency 8sse-ssmem at too l'OOmem of angiog-
raphy: Periods of ST recovery were interpreted as the 
fe,sult of reperfusion and periods of persistent (or re-)ele-
valion were interpreted as the result of (re-)occlusion. 
Periods of incomplete ST transition were interpreted as 
indetCnllinate patency, In all patients, ,m ST-recovery 
analysis patency prediction was logged simuitmleOllsly 
10 
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with the first contrast injection of the infarct artery. In 
all palienls with subsequent unique angiographie obser-
vations (as previously defined), additional ST-recovery 
predictions were logged at each of those times. 
Statistical methods: All categorical data afe repolt-
ed as £I (%). Because many of the continuous variables 
are £101 normally distributed, they arc reported as 50th 
(me;m 251h, 75th) percentiles. Ranges arc often also in-
duded, Only descriptive data are reported, and no sta-
tistical tests were perfOimed, 
RESULTS 
All 22 palients from our pilot experience meeting the 
criteria were analyzed for this report. TIle infarct artery 
was the left anterior descending in 12, the circumflex in 
2, and the right coronary m1el), in 8, Acute tllerapy con-
sisted of only thrombolytic dmgs in 10, only angioplas-
ty in 2, and both in 10, Median time from chest pain 
onset 10 initiation of ST monitoring was 4.3 (2,9, 7.6) 
hOllIS, Median time from ST monitoring (0 onsel of 
acute therapy was -0,8 (-1.8, 0.3) hours, 
AI the firsl contrast injection the infarct mtery was 
patent in 8 (36%) ~Uld occluded in 14 (64%) patients. At 
least I period of ST recovel), was seen before angiob'Ta-
phy in 8 patients (100%) with patent arteries, and in II 
(79%) with occluded vessels, More than 2 transitions to 
reelevalion or J'ecovery were seen before catheterization 
in 3 patients (38%) with patent arteries, and in 8 (57%) 
with occluded vessels. 111e 50th, 25th and 751h percen-
tiles, and nmges for time 10 first 50% ST recovery, the 
number of tI'tUlsitions over the monitoring period, and 
patent physiology index in patients with patent versus 
ocduded ruteries are shown in Figure 3, Patients with 
angiographically occluded vessels had a somewhat 
shorter time interval from onset of thempy to some evi-
dence of tHUlsient reperfusion than did patients with 
1.0 
0.0 
0.6 
PPI 
0.4 
0.2 
0.0 
----
t2Za Occluded 
f1GURE 3. Range, 60th, 25th mrl 76th percentile valua3 of tiroo to 111"$t SY rocovruy (T), fill!l'ibfi of frond liansitiontl (N), UId 
patent phYllHofogy indax (PPI) Nmwn subgroopsd by Ctl'foo.ruy iwhHIof;Y st/rlU9 at II1itJru ~aphy. 
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patent vessels. TIle stability of reperfusion <md duration 
of reperfusion physiology over the 6 hours monitored 
were similar whether the initial angiogram showed a 
patent vessel or an occluded one, 
In all 22 patients, <50% ST recovery or ST reeleva-
lion was 100% sensitive and specific for simultaneous 
angiographlc occlusion on first contra~1 injection. Of the 
44 angiograpiIically documented patency changes in 
these 22 patients, sensitivity and specificity for angio-
graphic occlusion were 90 and 92%, respectively, 
In 16 of our 22 patients, ST-segment monitoring was 
initiated before therapy. Of these 16 patients, ST-seg-
men! recovery occurred at least once before therapy 
(suggesting spontaneous rcperfusion) in 5 (31%) (Figure 
lB), 
DISCUSSION 
The m,tior findings of this study arc hvofold. First, 
serial instantaneous assessments of ST -segment recov-
FIGURE 4. ST-mooitor 
dam from 3 pa1ioots 
(A fo OJ, all of whom 
had pa1ent left antOfi.. 
or descending COfO> 
nary arteries at initial 
catheterization, shown 
in &amO format as Fig. 
liTe 1. Time to first ST· 
s.egnwnt recovery (R), 
"16 number of tronsi-
tions (T) and tho 
patent physiology 
index (PPI) are shown 
for each pa1ioot. Soo 
text for discussion. 
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cry using continuously updated reference points appears 
to predict simultaneous infarct artery patency, even over 
multiple changes of patency. Second, patency defined 
acutely by a single angiographic procedure does not ap-
pear to correlate with the rate, stability and duration of 
ST recovery quantified cumulatively over time periods 
broader than tbe catheteriziltion itself. We interpret these 
findings to indicate that unstable ST-segment recovery 
reflects cyclic flow change. .. in the infarct vessel that may 
occur before, during or after the brief period of lime 
documented by angiography. In our study group, 50% 
of patients exhibited ST-segment evidence of cyclic flow 
before catheterization. 111e incidence of tIns observation 
is similar across all 5 other studies that have used con-
tinuous electrocardiographic monitoring early in myocar-
dial infarction,L2r'i--1 Of our 16 patients in whom ST 
monitoring was begun before therapy, 31 % showed evi-
dence of spontaneous reperfusion, similar to our findings 
in previous worLll 111is spontaneous behavior suggests 
" • 
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that cyclic How changes may not result from therapy, but 
rather may be Ule underlying paUlOphysiology of early 
infarction on which therapy is superimposed, 
It has previously been suggested that cyclic changes 
in infarct artery patency may have functional impor-
tance.2 Correlations of slow or unstable ST-segment re-
covery with poor regional wall motion, larger enzymat-
ic infarct size, and poor clinical patient outcome and sur-
vivaI6,14--17 have been rep0l1ed. None of these reports, 
however, have detailed quantitative pruameters for cu-
mulative ST recovery over time. The ranlifications of 
such a method are illustrated in Figure 4. In a multifac-
torial trial design comparing Ulfomoolytic regimens us-
ing acute angiographic patency tmd correlating acute 
patency to predischarge left ventricular function? all 3 
patients in Figure 4 were described as having patent left 
anterior descending infarct arteries. However, ST -re-
covery patterns suggest dille rent HItes, stability and du-
ration of reperfusion within tltis "homogenous" angio-
graphic group (Figure 4). '111e patient in Figure 4A 
shows early cyclic flow changes and early stable reper-
fusion. The patient in Figme 4B shows persistent occlu-
sion until just before ,Ulgiography, with stable reperfu-
sion Ulereafter. 111e patient in Figme 4C shows the ear-
liest evidence of reperfusion, but with ongoing cyclic 
flow changes and velY low duration of patency over a 
4-hour period before and after angio!"Hlphy. N. our pilot 
data suggest, quantification of cumulative ST recovery 
over time with parameters rellecting the speed, stability 
and duration of reperfusion may pIOvide an independent 
physiologic context for the interpretation of acute angio-
grapltic anatomy. 
'I1Ie data we report represent a pilot experience ac-
quired while fantiliarizing conununity and university 
hospitals WiUI the use of 12-lead ST monitors, 11lese 
data do not represent a prospective or formally blinded 
analysis, a consecutive patient population, or a slmlple 
size large enough to draw rigorous conclusions aoout the 
accuracy of Ule method for real-time patency prediction. 
Acute angiography was performed by protocol in some 
and by cllitical selcction in others. No functional out-
come or Icft ventricular function data were analyzed, so 
inferences aoout ST recovery and functional outcome 
remain unproven. 
Despite the,se lliltitations, the implications of the 
method and the pilot results are no less intriguing. An-
giographically homogenous subgroups appear to be 
physiologically heterogenolls as quantified by continu-
ous ST -recovery analysis, Scventy-nine percent of our 
patients wiUI occluded vessels at angiography had at 
least 1 episode of ST recovery before catheterizutioIl, 
suggesting transient repcrfusion. 'Ole time to first evi-
dence of reperfusion was somewhat earlicr in paticnts 
WiUl angiograpltically occluded vessels Ulatl in those 
with patcnt arterics, Evcn our lintitcd data show llll-
equivocally how vulnerable a single angiograpltic 
assessment lIlay be to "undersampling" a dynamic 
phenomenon such as an ongoing myocardial infarction, 
Dctcmtination of the actual additional infonnatioll COII-
tent provided by quantification of continuolls ST-seg-
ment recovery must await a proper prospective trial 
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design in a suitable number of patients. Such research 
is cunently underway. 
Serial instantaneous patency assessments ba<;ed on 
ST-seglIlent recovery analysis also have clinical man-
agement and investigational potential. Current teelmol· 
ogy makes 12-lead ST-segment mOititoring with a por-
table device leasible in small conmllutity hospitals as 
well !l<; during tnmsport between hospitals, as was fre-
quently done in this pilot. Thus, unlike angiography, ST-
segment monitoring C,Ul be initiated from the onset of 
thc-rapy, and cml be continued for as long a~ the patient 
is at bed rest. Triage of patients given thrombolytic ther-
apy to aggressive or conservative therapeutic strategies 
could be better studied und managed with u continuous 
noninvasive marker of failed or unstable reperfusion that 
was accurate over serial assessments in feul time. A 
prospectivc, blindcd cxperience including acute catheter-
ization by protocol in a larger paticnt popUlation is cur-
rently being analyzed to bettcr assess thc method's per-
fonnance in Utis respect. 
Thus, Utis pilot experience demonstrates that contin-
uous 12-lead ST-segment monitoring Cat) be initiated in 
a timely and practical fasltion using currently available 
tedmology. Paired WiUI our method of ST-segment re-
covery analysis using self-referenced, continuously up-
dated measurements, ooth real time and retrospective 
determination of the speed and stability of reperfusion 
appear likely to provide unique and useful infomlation 
for ooth investigational lUld clinical purposes, More rig-
oruus assessment of tltis potential must await further 
study. 
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APPENDIX: SUMMARY OF ST·MEASUREMENT 
AND PARAMETER DEFINITIONS 
ST-measuremom matrix (trend): (1) tllC most abo 
normal single lead frum Ule ma.xinmlly abnoffilal elec-
trocardiogwm (default), or (2) sunmlated deviation (sum 
of absolute differences per lead) if either (A) UlC single 
most abnomlal lead desigt1<'ition changcs across ;a leads, 
or (3) Ulere are ~2 precordial zones show ST elevation. 
Trmumion points: TRANsmON PEAK; the Illost abnor-
mal electrocardiogrtilll ulmlediatcly precedulg a period 
of ~O% ST-segment recovery. 
lRA.t~smo:-.l TROUGH; the most nonnalized electrocar-
diogram immediately preceding a period of ST ree!eva-
tion. 
ST~gment recovery and reefevation: ST·SEGMENT 
RECOVERY; (I) resolution of ~O% of the ullmediatcly 
previous transition peak, or 35 to 49% of the immediate-
ly previous transition peak and ~O% of the 1ll0s1 ab-
nomlal matrix level over the entire recorduig period up 
to the CUllent electrocarJiognun, and (2) developing with-
in 3-hour period, 
ST-SEmiEJ\'T REELEVATIO:-l: (I) ST-reelevatioll devel-
oping within a I-hour period; and (2) lasting >60 sec-
onds; .md (3) in matched "Iingerprint" zone; and (4) 2 
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leads ;,ISO fL Veach; or (5) I 1c,1d ;,200 fL V or ~ST level 
of inmlediately previolls transition peak, whichever first. 
ST-RECOVERY INTERVAL: the lime from the first e1ec~ 
trocardiogram achieving ST -segment recovery to the 
time of the first electrocardiogram achieving ST-segment 
reelevation. 
Trend pai"MlMer&: TJMH TO FIRST EVIDENCE OF REfER-
FUSION: the time from the onset of lytic therapy to the 
onset of the first ST-segment recovery intelVaJ. 
PATENT PHYSIOLOGY INDEX PERCENTAGE (PPl%): the sum 
of the duration of all ST-recovery intervals divided by 
the duration of the total recording period X 100. 
NUMBER OF TRA..'1SmONS: the total number of transi-
tion peaks and troughs over the recording period. 
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ABSTRACT 
BACKGROUNO: COlllillllollSly IIpdaled 12-lead ST-segllleni recovery allalysis for 
prediction of ill/arci arlery palency depellds all 1111111011 illieractioll willi a compllieri-
zed review slalioll. To lesl Ille variabilily of Illis lIIelllod, 3 III""/ill opera lars 
allalyzed a COIIIIIIOII grollp of ill/arctioll recordings following Illrolllbolylie Illerapy. 
METHODS: ST-seglllelli recordillgs frolll 50 paliellis were IIsed for illier-observer 
lestillg, alld 30 were re-rend for in Ira-observer lestillg. All were allalyzed over bolll 
90 alld 360 lIIinllles. Eacll reader idelllified all ST-seglllellilrelld Ir/illsiliolls alld 
logged a patelley assesslllelli alille md of encll 1II0lliiorillg period. Kappa slalistics 
were IIsed for cOlllparisolls of all calegorical alld cOlllillllOIlS variables, illelllding 
compariso1l of each render's assessment of each minute of eacll study. Concordance 
was described by Kappa vollies as: 0.85 - 1.0 = sllperior; 0.70 - 0.84 = excellelll; 0.1 
- 0.69 = poor 10 fair; 0.0 = ralldolll; -1.0 = discordallce. 
REStltTS: Dyuamic ST-segmc1l1 fe-elevation with ~ 2 transitions occurred itl 20-
30% of silldies, alld 81 - 100% were illierpreled as palelll alille elld of tire 90 alld 
360 millllte periods. Over Ille firsl 90 lIIillllles, bolll illlra- alld illier-obsenier 
cOllcordallce for bolll calegorical alld cOlllillllOIlS variables was sllperior. Variabilily 
illcreased slightly for all variables wllell observaliolls were carried 0111 over 360 
minutes, although concordance overall rC11IaitlCd excellent to superior. Sources of 
variabilily illelllded differellces ;'1 illierprelatioll of low ST alllplitllde /IIigll liaise 
ECGs, anterior ST-segmenl depressioli, and gaps ill the data stream, as well as 
operalorfatiglle. 
CONCLl/SION: COlltilllIOIISly IIpdaled 12-lead ST-seglllelli recovery alwlysis call be 
leamed 10 a IIigll level of illlra- alld ill ler- observer cOllsislellcy. 
INTRODUCTION 
Continuously updated ST segment recove-
ry analysis has been developed for real-
time evaluation of coronary patency in 
patients given thrombolytic therapy for 
acute myocardial infarction,l,2 In the hands 
of an experienced interpreter, ST-segment 
recovelY analysis has been shown to iden-
tify shnultaneous angiographic coronary 
occlusion more accurately than other 
bedside clinical descriptors.2 As a conti-
nuous objective marker, ST-segment reco-
very analysis can quantify both the speed 
and stability of reperfusion, providing a 
unique method for the evaluation of 
thrombolytic regimens. 
As a computer-assisted method, paten-
cy assessment with ST-segment recovery 
analYSis remains dependent on the human 
operator interacting with the program. The 
human operator combines a structured set 
of quantitative rules! with more qualita-
tive judgements to accomplish this interac-
tion. Interpretative determination of reper-
fusion or re-occlusion and the timing of 
reperfusion or subsequent re-occlusion 
could be grossly aHected if differences in 
judgement among operators were signifi-
cant, frequent, or accumulated over the 
time interval monitored. 
To test the inter- and intra-observer 
variability of this technique, 3 human 
operators of vmying experience performed 
ST-segment recovery analyses on a cohort 
of patient studies over 2 time intervals in 
a prospective h'ial design, including blind-
ed repeat analysis of over half the studies 
by each operator. Differences within and 
between operators in all patency inter-
pretations over every minute of every 
study were assessed. 
METHODS 
Patiellt studies 
ST-segment monitor studies were selected 
&om a recently completed acute myocardi-
al infarction (TAMI 9) trial.' Inclusion 
criteria for that trial included: onset of 
chest pain within 6 hours of presentation; 
diagnostic ST elevation or anterior ST 
depression suggesting posterior infarction 
of > 200 pY not reversed by sublingual 
nitroglycerin; and no contra-indication to 
thrombolytic therapy. All patients were 
treated with tissue pJas-minogen activator 
(rt-PA), systemic heparin, and aspirin. 
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Patients also received systemic perfluoro-
carbon in 50% of cases. For the purposes of 
our investigation, the !irst 50 studies retro-
spectively identified with the following 
characteristics were selected: ST monito-
ring begun at or before the administration 
of Uuombolytic therapy and continued for 
at least 6 hours; normal QRS conduction at 
the onset of monitoring; no ST monitor 
technical failure of > 1 hour out of the first 
6 hours of monitoring. No other technical 
factors, including study noise level, dyna-
mic ST-segment behavior, peak ST-seg-
ment level, or infarct location, were used 
to bias sh.dy selection. 
ST-Seglllellt MOllitorillg alld Study Prepara-
tiOl1 
Our technique of 12-lead continuous ST-
segment monitoring has been previously 
described in detail.'·'·4 Modified limb lead 
positions and irnpedance-metered skin 
preparation were used in aU cases, as we 
have described." 4 11,e Mortara ST-Seg-
ment Monitor (Mortara Instrument, Mil-
waukee) is a digital 12-lead ECG monitor 
that meets fidelity criteria for standard 
ECG carts.5 In all cases the device was 
programmed to acquire and store a 12-
lead ECG every 20 minutes. In addition to 
this mandatory minimum storage interval, 
"surveillance" of ST levels over all 12 leads 
was performed automatically every 17-20 
seconds. With any change from each pa-
tient's own baseline of > 100 ~lV in any 2 
leads or > 200 pY in any 1 lead that persi-
sted 01' worsened for> 60 seconds, additio-
nal ECGs were stored every 30 seconds 
over a 3 Ininute period. 
All data from each ST monitor study 
were downloaded to a floppy disc as a 
digital data stream. Prior to distribution to 
the operators, two electronic "marks" were 
imbedded into each patient's data stream: 
one at the ECG acquired 90 minutes fol-
lowing onset of thrombolytic therapy and 
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one at the ECG acquired 6 hours follow-
ing onset of thrombolytic therapy. The 
electronic marks prevented the operator 
from seeing any further ECG information 
beyond the marked ECG, thus preventing 
any interpretative bias by "future" infor-
mation. This blinding procedure was 
identical to that used in the TAM! 7 ST-
segment analysis.2 
Of the 50 studies selected, 30 were 
randomly selected for re-reading to gene-
rate intra-observer comparisons. The 80 
total studies thus prepared for analysis (50 
studies and 30 re-reads) were sequenced in 
random lots of 10 uniquely for each opera-
tOf, with attention to avoiding re-reads in 
close proximity to one another by a single 
operator. 
For each study each operator received a 
folder which contained the hard copy ECG 
that originally qualified the patient for 
Ulfombolytic therapy, the time of onset of 
chest pain, the time of onset of thromboly-
tic therapy, and a "marked" floppy disk 
containing the ECG data. Operators were 
blinded to all other clinical data. In each 
patient, analysis was completed first up to 
the 90 minute mark, then lip to the 6 hour 
mark, in sequence. The results of each 90 
minute analysis was logged on a compute-
rized data entry screen. TIlis system then 
stored these responses in a file, unreh"ieva-
ble by the operators, before the six haUl' 
interpretation began. TIlis method was 
used to prevent any editing of the 90 mi-
nute responses during completion of the 6 
hour analyses. 
ST-SEGMENT RECOVERY ANALYSIS 
Method and Tmining Level 
Our method of ST~segment recovery ana-
lysis using this program has been descri-
bed in detail.' In brief, there are two stages 
in the process. First, a matrix of ST rneasu-
rement is selected for use as a trend over 
time. As guided by published rules' the 
measw'ement Ill.atrix may be either a h·end 
of the most abnormal single lead over time 
or a trend of summated ST deviation over 
all 12 leads. Once the matrix is detenni-
ned, transition points or "peaks" and 
"h'Oughs" within the trend of the mah'ix ST 
level over lime are identified and used to 
demarcate the monitoring period into 
intervals of ST "recovery" or "re-elevati-
on.,,1 ST recovery intervals are interpreted 
as the result of a patent infarct artery. ST 
re-elevation intervals are interpreted as the 
result of an occluded infarct artery. If the 
"marked" ECG occurs during an apparent 
but incomplete ST transition, arterial pa-
tency is interpreted as indetermjnate. 
Operator training consisted of two 
parts. Conceptual underpinnings of the 
methodology were conveyed in didactic 
sessions. Experience was conveyed 
through individual and "classroom" expo-
sure to acute infarction recordings from 
previous studies (none of which were 
included in the current study test set). At 
the time of the current study, it was esti-
mated that the most experienced operator 
(Reader A) had over-read > 400 acute 
infarction recordings, the least experienced 
operator (Reader B) had overread < 50 
such recordings, while the third operator, 
Reader C, was between these two. 
Analytic Endpoints 
The endpoints of interest were two-fold. 
For each study, the times of transition 
from patency to occlusion or vice versa 
were recorded, along with the patency 
assessment at the transition times. These 
measures were made during the first 90 
minutes and during the subsequent 4.5 
hours of monitoring. Secondly, patency 
was assessed at the time of initiation of 
monitoring, at the 90 minute marked ECG, 
and at the 6 hour marked ECG. Each pa-
tency assessment was considered a stable 
definition of the patient's condition until a 
new transition point was identified, crea-
ting consistent intervals of patency or 
occlusion, I Therefore, a patient's patency 
status was definable over the entire 90 
minute or 6 hour monitoring period for 
evelY minute within those periods. 
Statistical Methods 
11,e categorical endpoints of patency at 90 
minutes, patency at 6 hours, number of 
h'ansitions within the first 90 minutes, and 
nurnber of transitions over the first 6 hours 
were analyzed using Kappa statistics. A 
Kappa of 1 implies total agreement. A 
Kappa of -1 implies perfect disagreement. 
A kappa of 0 implies random chance. For 
the purposes of this study, Kappa values of 
0.85 -1.0 were con-sidered superior concor-
dance, values of 0.70 - 0.84 excellent con-
cordance, values of 0.55 - 0.69 good con-
cordance, and 0.1 - 0.54 poor to fair COllC01'-
dance.6 "Conti-nuous" agreement over 
each of the 90 minute and 6 hour time 
periods was measured by first deterrnining 
the patency decision for every minute 
within the time period of interest for a 
patient. The Kappa was then derived 
between observers for that patient across 
all 90 minutes and again across all 360 
minutes. The intra-observer reliability 
across the time period of interest was 
calculated over the 30 patient studies as an 
average of tile 30 Kappas. The inter-obser-
ver reliability across the lime period of 
interest was calculated for each pair of 
observers over the 50 patient studies as an 
average of the 50 Kappas. 
Following analysis of the data, the 
operators reviewed all discrepancies be-
tween any two readers in every patient. 
An open consensus was used to identify 
the source of each discrepancy. These 
characteristics were categorized into grou-
pings according to common underlying 
principles of interpretation. 
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RESULTS 
Intra-observer variation 
All 3 operators completed each of 30 ran-
domly selected studies up to both 90 mi-
nutes and 6 hours twice. As characterized 
by Reader A, these studies included 6 
patients (20%) with ~ 2 transitions at 90 
minutes and 7 patients (23%) at 360 minu-
tes, ranging overall from 0 to 9 transitions. 
At 90 minutes, 25 of the 30 studies were 
interpreted as patent, 5 as occluded and 0 
as indeterminate. At 6 hours after throm-
bolytic therapy all 30 studies were inter-
preted as patent. 
As shown in Table 1, there was perfect 
agreement within each of the 3 operators 
in both the total number of transitions and 
determination of patency at 90 minutes, 
with superior concordance over each of 
the 90 minutes within each patient's study. 
Slight deterioration of the intra-observer 
readings was seen at 360 minutes, particu-
larly in the least experienced reader B. 
Overall however, concordance within each 
reader remained excellent. 
Inler-observer variation 
All 3 operators completed each of the 50 
randomly sequenced studies up to both 90 
minutes and 6 hours. As characterized by 
Reader A, after 90 minutes there were 13 
palients with ~ 2 transitions (26%), ran-
ging from 0 to 6. At 90 minutes, 41 of the 
50 studies were interpreted as patent, 9 as 
occluded, and 0 as indeterminate. After 6 
hours there were 15 patients with ~ 2 
transitions (30%), ranging from 0 to 9. At 6 
hours after onset of therapy, 48 studies 
were inter-preted as patent, 2 as occluded, 
and 0 as indeterminate. 
The inter-observer variability for the 
categorical variables across a113 operators 
and between each pair is also shown in 
Table 1. Agreement was excellent in both 
the prediction of patency and the number 
30 
of transitions. Although more reliability 
existed in the 90 minute assessments than 
at 6 hours, the level of agreement even out 
to 6 hours remained excellent. 
Median Kappa statistics from compari-
sons of every 1 minute assessment over all 
3 operators and for each pair over the 90 
minute and U1e 6 hour monitoring periods-
are also shown in Table 1. As can be seen, the 
median Kappa was 1 in every com.parison. 
Table I: lntra- and Inter-Observer Comparisons: Kappa Statistics 
# Trallsitiolls 
90 min 6 hour 
Reader(s): 
Avs.A 1.0 0.92 
Bvs. B 1.0 0.77 
Cvs.C 1.0 0.91 
Avs. B 0.82 0.74 
Bvs.C 0.89 0.80 
Avs.C 0.82 0.76 
Overall 0.88 0.77 
inter-obs. 
Patency Assessment 
90 min 6 hour 
1.0 1.0 
1.0 1/30 dis" 
1.0 1/30 dis" 
0.79 0.65 
0.93 0.85 
0.79 0.79 
0.86 0.76 
Continuous" 
90 min 6 hour 
1.0 0.92 
1.0 0.83 
1.0 0.99 
1.0 1.0 
1.0 1.0 
1.0 1.0 
1.0 1.0 
* Agreement as average of Kappa every minute over entire monitored 
H No Kappa due to zero's in 2X2 tables. 
SOllrces ojDiscrepallcy 
Of the 50 studies and 30 re-reads, each 
read over both 90 and 360 minute inter-
vals, there were no examples of discrepan-
cy in which all 3 operators disagreed. A 
total of 23 examples were identified in 
which 1 reader varied from the other two. 
In 3 examples one operator deferred an 
interpretative conclusion until the next 
available ECG due to marginal noise le~ 
vels, causing periods of 2 ~ 19 minutes of 
discrepancy. In 5 additional instances 
operators differed in judgements on whe~ 
her to include or exclude noisy ECGs that 
affected measurements sufficiently to 
cllange interpretations. In 4 of these 5 this 
judgement involved a single ECG that 
created a measurable transition point if 
included which was absent if the ECG was 
excluded. In the fifth example, a period of 
ECGs all with increased noise content 
were taken as an ST re~elevation event by 
1 operator and as artifact by 2 operators. In 
ailS instances judgements on noise rejec~ 
lion that affected clinical interpretation 
occurred during study periods when ST 
levels were low relative to the noise level 
itself. 
In 7 cases the operator's decision on 
how to handle anterior ST depression led 
to some interpretative discrepancy. In 4 
instances, one operator used 12~lead sum~ 
mated ST deviation for the ST-segment 
measurement matrix, interpreting the 
anterior ST depression as posterior injury 
current associated with inferior ST eleva~ 
tion, while 2 operators used the single 
most abnormal lead for the ST-segment 
matrix, taking the anterior ST changes as 
"reciprocal depression.1I In 2 instances 
anterior ST depression either persisted or 
recurred after inferior ST elevation had 
resolved. One operator interpreted these 
as evidence of infarct vessel occlusion, 
while the other two considered them evi-
dence of distant ischemia but not defini-
tive re-occlusion. In 1 case, both inferior ST 
elevation and anterior ST depression resol-
ved, however the anterior leads subse-
quently became grossly elevated. One 
operator took these changes as pathologic 
while hvo took them as nonspecific. 
Discrepancies in 4 cases resulted from 
the operator's interpretation of a data gap. 
In all 4 cases, ST recovery of > 50% occur-
red during the interval between the hard-
copy admission ECG and the first ECG of 
the monitored period (the interval during 
which the patient gave informed consent 
and was randomized into the TAMI proto-
col prior to being hooked up to the ST 
monitor). In all cases these changes prece-
ded administration of thrombolytic thera-
py and the hard copy ECG represented the 
maximal ST levels compared to the ST-
11l0lutored portion of the study. Two ope-
rators interpreted patency at the onset of 
monitoring based on inclusion of the pre-
monitoring hard copy ECG, while 1 inter-
preted the onset of ST mOlutoring as inde-
terminate. 
In 4 cases discrepancies resulted from 
erroneous application of the pre-defined 
methodologic criteria' by the operator. In 
3 instances 1 operator defined the ST-
segment measurement mah·ix as the single 
most abnormal lead despite changes in the 
location of the peak ST levels over the 
course of the studies. In 1 case 1 operator 
interpreted a period of ST re-elevation as 
pathologic, although the ST amplitudes 
did not meet criteria for such. 
DISCUSSION 
With the ability to continuously characte-
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rize dynamic changes in real time, 
computer-assisted methodologies can 
enhance physiologic monitoring. TIle 
vulnerabilities of this direction in medical 
technology are twofold: in the ability to 
incorporate false assumptions into soft-
ware; and in the variability of the human 
operators who interact with the programs. 
We have pursued the noninvasive detec-
tion of reperfusion and reocclusion using 
continuously updated 12-lead ST segment 
recovery analysis. l, 2 We have previously 
shown that, in the hands of an experienced 
operator, the assumptions within this 
computer-assisted method correlate well 
WiU, angiographically docwnented infarct 
artery patency." , The data presented in 
our current study suggest human opera-
tors can learn this methodology to a high 
level of both intra- and inter-observer 
consistency. 
It is important to note that "interpretati-
ons" of infarct artelY "patency" or "occlusi-
on" in this particular study were not corre-
lated with any external "gold standard," as 
has been done previously. I, 2 This trial 
design sought only to elucidate the 
amount and sources of intra- and inter-
observer variability as different operators 
with different levels of experience applied 
our methods to the identical patient stu-
dies. It is also important to note that the 
operators were aU didactically "trained" in 
the methodology in an effort to achieve the 
most consistent possible analyses, and so 
do not necessarily represent the capabili-
ties of physicians without such training. 
The dynamic behavior of ST segment 
levels early in infarction, the noise level 
inherent in many EeG recordings in acute-
ly ill patients, and the operator's role com-
bining quantitative ltrules" with qualitative 
judgements were the focus of our trial 
design. TIle presence or absence of physio-
logically important events, the number, 
timing, onset and resolution of each event, 
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and the interpretation of each event rela-
tive to infarct artery patency were all 
tested in our trial design. Over the 450 
hours of monitoring compared within each 
of the 3 operators, there was almost no 
intra-observer variability in any of the 
parameters assessed in any operator, al-
though performance of the least experien-
ced operator deteriorated somewhat more 
over the 6 hour periods. Over the 1,125 
hours of monitoring compared across the 
3 operators, inter-observer variability was 
strikingly small, again as evaluated over 
evelY parameter assessed. Again, there did 
appear to be a trend showing slightly 
greater variability in later periods (around 
6 hours after thrombolytics) than in the 
very acute periods (90 minutes after 
thrombolytics). 
Specific sources of variability fell into 4 
broad categories: artifact rejection; anterior 
ST depression; data gaps; and operator 
error. Judgements on the signal VS. noise 
content of any particular ECG led to inter-
pretative discrepancies only when the ST 
levels during that period were low. In such 
instances, the interpretation of "new" ST 
changes represented by a worrisome look-
ing but noisy ECG might best be inter-
preted in the context of a real patient's 
clinical status rather than through a 
tlstand-alone" ST recovery analysis. New 
technical strategies in noise filtration may 
also help with this problem. Predominant 
anterior ST depression, particularly in the 
setting of resolving inferior ST elevation, 
remains a dilemma, albeit a relatively 
infrequent one. With larger data sets we 
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Abstract: Patients in whom early and stable reperfusion through the infarct 
artery falls after thrombolytic treatment might benefit from further revasculariza-
tlon therapy. A reliable noninvasive technique able to detect both reperfusion 
and reocclusion would be useful to lest this hypothesis. However, no such tech· 
nlgue presently exists. Sr-segment recovery anal~'sis using continuous digital 
12·!ead ST monitoring has been ShO\'\fIl to be an accurate predictor of infarct 
artery patency in real time. This method was dependent on a trained clinician's 
analysis of the recordings on a personal computer, For optimal bedside applica-
tion, salient prindples of this ST-segment recovery analysis were converted Into 
algorithms and built into the ST monitor software. The essentials of these algo-
rithms are described In this report. Key words: acute myocardial infarction, 
patency assessment, noninvasive, ST-segment, continuous electrocardiography, 
automated algorithm. 
Patients in whom early and stable reperfusion 
through the infarct artery fails after thrombolytic 
treatment might benefit from further revasculariza-
tion therapy. 1_9 A reliable, noninvasive assessment 
technique able to detect both reperfusion and reoc-
clusion of the infarct artery would be useful to deter-
mine the need for further reperfusion therapy, and 
would thus enable the testing of this hypothesis. 
However, no reliable, practical technique has been 
reported. The Duke University method of ST-seg-
ment recovery analysis, using dynamically updated 
measurements during continuous digital 12-lead 5T 
monitoring. has been shown in the Thrombolysis 
and Angioplasty in Myocardiol Infarction (TAMI) 7 
trial to predict infarct artery patency in a real time 
emulation. lo•11 As a component of the TAMI 7 trial 
design, serial analysis loops of prospective patient 
sets were used to distill logistic principles from the 
original heuristic method of 5T recovery analysis. 12 
This method was dependent on a trained clinician 
using an off-line personal computer for completion 
of the analysis. For optimal bedside application, pa-
tency assessment based on ST-segment recovery 
*l'r.wllhi Ischemia Moniron'/IiJ LaboTalNY, Division o/O!Tdiology, 
Dllki University Medical emler, Dllrham, Norili Carolina. 
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analysis should be an on-line component ofa bedside 
5T monitor. As the next step in device evolution to 
the level of practical utility, salient principles of the 
Duke method were converted into algorithms and 
incorporated into a portable interactive bedside 5T 
monitor. The essentials of this automated patency 
assessment program are described in this report. 
Materials and Methods 
ST-Segment Monitor 
The 12-lead ST-segment monitor has been previ-
ously described in detail. l ),14 Briefly, the 5T monitor 
(STIDD, Mortara Instrument, Milwaukee, WI) ac-
quires and digitizes standard 12-lead electrocardi-
ograms (EeGs) every 20 seconds, recognizing QRS 
onset in all 12 leads simultaneously and creating a 
"median beat" complex out of each 10 second acqui-
sition period. The first acquired EeG is used as a ref-
erence for comparison of ST -segment amplitudes 
measured at 60 ms after J point. If subsequent EeGs 
show a change in 5T -segment amplitude more than 
a preset threshold, nonnally 200 f-lV in a single lead 
or 100 ftV in two leads, the violating EeG plus an-
other eight EeGs are stored over a 3 minute peliod, 
after which the last recorded EeG serves as an up· 
dated reference. In the absence ofST-segment ampli-
tude changes an EeG is stored every 20 minutes by 
default. Trendlines of ST-segment deviation versus 
time are stored for all 12 leads, using the measure-
ments in all median beats, for later use In the patency 
assessment algorithm. Torso lead placement in fixed 
positions with radiotransluccnt electrodes and 
impedance-regulated skin prep (Quik Prep, Quinton 
Medical, Seattle, WA) are used to reduce noise. 
Patency Assessment Algorithm 
Continuously updated surveillance of all 12 leads 
is used to select the most active lead, defined as the 
single lead showing the highest ST-segment eleva-
tion up to that moment in the monitoring period. 
Amplitude measurements in this most active lead are 
then used to identify two ECGs used for comparison 
to the assessment EeG: the "last transition" EeG and 
the "maximum" EeG. The last transition EeG is de-
fined as the last EeG prior to the assessment EeG 
where the trend of ST-segment amplitude over time 
changes from worsening (upsloping) to improve-
ment (downsloping) or vice versa. The maximum 
EeG is defined as the EeG displaying the most ST-
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segment elevation in the most active lead during the 
recording period up to the moment of patency assess-
ment. Figure 1 is a graphic display of the definition 
of these ECGs in three sequential periods of an ST 
trend during a brief occlusion of a coronary artery in 
a single patient. As can be seen, with each updated 
patency assessment, the EeGs representing the maxi-
mum EeG and the last transition EeG may change. 
In this example, in the upper trend the maximum 
ECG and the assessment EeG are the same. Minutes 
later, in the middle trend, as the assessment EeG is 
updated, the maximum and the last transition EeG 
arc the same. Minutes later, in the bottom trend, the 
updated assessment EeG, the maximum EeG, and 
the last transition ECG each define unique EeGs. 
Analog waveforms from all three EeGs (assess· 
ment, maximum, last transition) are printed In hard 
copy for inspection by the clinician (Fig. 2). Using a 
single button push, the clinician may reject any ECG 
that contains unacceptable noise or conduction dis-
turbance. 
After confirmation of satisfactory noise levels, two 
elements of ST recovery are automatically quantified: 
the percent ST recovery (amplitude recovery) and the 
peak ST trend slope between the last transition EeG 
and the assessment ECG (Fig. 3). The percent ST re-
covery is defined as the difference in the ST ampli-
tude in the most active lead between the maximum 
ECG and the assessment EeG, presented as a per-
centage of the absolute amplitude of the maximum 
ECG. The peak ST trend slope is defined as the peak 
V. V shift in the most active lead within a floating 2 
minute window that mIlS from the assessment EeG 
backward in time to the last transition EeG. 
Once quantified, the percent 5T recovery and the 
peak ST trend slope are then conveyed through a 
simple logic flow to produce a fmal interpretative 
statement about coronary patency. Details of this 
logic flow are given in Figure 4. The first branch point 
is whether or not the maximum ST amplitude is 
equal to or greater than 200 ftV. If "no," a special 
statement is printed that the amplitudes are too low 
to perform a patency assessment. If "yes," the next 
branch point asks whether ST recovery from the 
maximum EeG to the assessment EeG is greater or 
less than 50%, The third series of branch points asks 
whether the peak 2 minute 5T slope since the last 
transition EeG is upsloping (~ 50 f-lV/2 min), 
downsloplng (::5 - 50 v.V/2 min), or flat. Flow 
through these branch points leads to an interpreta-
tive statement of vessel patency as occluded, indeter-
minate, or patent. Figure 5 gives an example of an 
actual interpretative statement printout. 
Looking again at the three periods during an 
evolving ST trend shown in Figure I, the dynamic 
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Fig. 1. Three sequential periods of an ST-trend during a brief occlusion ofa coronary arter}' in a single patient. The positions 
of the three ECGs essential to the algorithm are represented by the abbreviations placed above the trend. The waveforms 
in the most active lead in these three EeGs are depicted on the right half. A = assessment ECG, M = maximum ECG, LT 
= last transition EeG. 
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Fig. 2. ST monitor printout of the maximum ECG (top), the lasl transition EeG (middle). and the assessment EeG (boltom) 
In a comparison plot. The most adive lead is captured In the redangular box, 
performance of the logic flow can be illustrated. In 
the upper trend, seconds after occlusion orthe coro-
nary artery, there is more than 200 !-tV ST elevation 
in the maximum EeG, the assessment EeG does not 
show any recovery from the maximum EeG, and 
the peak ST trend slope is upsloping. The program's 
interpretation is "occluded," In the middle trend, 
after (eperfusion of the coronary artery, the assess-
ment EeG shows more than 50% recovery from the 
maximum EeG, and the peak ST trend slope since 
the last transition EeG is downsloping. The pro-
gram's interpretation in this case is "patent." In the 
IV 
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M·A/M x 100 
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.. t.ST/2mln. 
FIg. J. Quantification of the two elements of ST -segment 
recovery: the recovery in ST-segment amplitude in the as-
sessment ECG as a percentage of the maximum ECG ST-
segment amplitude and the peak ST trend slope as the peak 
It V shift within a floating 2 mInute vvindow that runs from 
the assessment ECG backward in time to the last transition 
ECG. A = assessment ECG, M = maximum EeG, LT = 
last transition EeG. 
bottom trend the coronary artery has reocduded. At 
this time, the assessment ECG still shows more than 
50% recovery from the maximum ECG; however, 
the peak ST trend slope since the updated last transi-
tion ECG is upsloping again. The program's interpre-
tation at this moment is "ocduded." 
Discussion 
The Duke University method orST -segment recov-
ery analysis on continuous digital 12-lead ST moni-
tor recordings has been shown to be able to predict 
infarct artery patency in a real time emulation. IO•11 
To make this technique practical in a critical care 
Max ST ?.200jlV? ~ no occlusIon detected 
Jves 
amplitude peak 
recovery slope Interpretation 
< 50% > -50jlV/2mln. OCCLUDED 
< 50% ~ -SOjlV/2mln. INDETERMINATE 
?. SO% ~ -SOjlV/2mln. PATENT 
?. 50% > 50j1V/2mfn. OCCLUDED 
Fig. 4. Details of the automated patency assessment pro-
gram's logic flolV that will lead to an interpretative state-
ment regarding the coronary artery patency as ocduded, 
indetenninate, or palent. 
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Fig, 5. Example of an ST monitor printout orthe automated patency assessment. On the left half is a printout of the most 
active lead's trend of ST-amplitudes over time plus the trends 0[1\">'0 consecutive leads. Measurements of ST amplitude in 
the maximum ECG, the last transition EeG, the assessment EeG, the percent ST recovery, and peak ST trend ~lope are 
given in the right upper comer. Under this the patency assessment is given. 
setting in real time, we derived the salient principles 
of this method into algorithms and incorporated 
them into the portable bedside ST monitor itself. This 
report describes the essentials of these algorithms. A 
study to test the program's ability to detect coronary 
occlusion and reperfusion, using coronary angio-
plasty as a well-controlled human model of brief cor-
onary occlusion and reperfusion, is currently under-
way_ A large clinical field experience in acute 
myocardial infarction, including simultaneous an-
giographic documentation of infarct artery patency, 
is also underway_ 
The use of a minimum threshold of 200 f.1Y ST-
segment elevation in the worst lead to detect occlu-
sion, like the use of standard 12-1ead EeGs, may In-
troduce some anatomic bias, especially with circum-
flex artery occlusion, which will need to be 
quantified. This arbitrary threshold is adopted from 
criteria common in many thrombolytic trials, since 
the intended application of the patency assessment 
program is in this patient group. 
The simplistic nature of the program's design 
makes it vulnerable to artifact from noise or conduc-
tion aberrancy introducing nonischemic sr values. 
The clinician's ability to eliminate EeGs with these 
abnomlalities by review of the hard copy analog 
waveforms at the m'oment of assessment provides 
one solution to this problem. Rather than subjecting 
the EeG signals to additional electronic filtering, 
with potential infomlation loss, the clinician acts as 
the final "noise filter." Further experience with sta-
tistical filtering may obviate this need in the future. 
In its current design, the program is fully operative 
within the portable bedside monitor on a "push-but-
ton" basis, consistent with the demands of real time 
use, If, with further testing, the algorithms can accu-
rately and dynamically reassess coronary patency 
over time, then noninvasive monitoring for failed re-
perfusion or abmpt reocclusion may achieve practi-
cal capability for clinical or investigational appli-
cation. 
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ABSTRACT 
COlltilluously updated ST-seglllellt recovery mlalysis has beeu showlI to 
accurately predict ill/arct related artery patellcy. Saliellt prillciples were 
cOllVerted ill to algorithllls alld illcorporated ill to a portable ST mOllitor for 
optimal applicatioll. This study tested the automated program's ability to detecl 
occll/sioll al/d repeljllsioll durillg ballooll allgioplasty. 
All 35 illflatiolls col/sillg peak ST mllplitudes ~ 200 IN were detected. All five 
illflatiolls cousillg < 200 I' V were also detected, but ollly whell preceded by all 
illflatioll COlISillg ~ 200 I' V. OCclllSioll was detected a mediall of 40 secollds after 
illflatioll, reperfllsioll a lIlediall of17 secollds after deflatioll. Peak ST elevatioll 
~ 200 IN occurred ill 19/26 LAD illflatiolls (73%), 1/22 LCX illflatiolls (5%), 
alld 15/30 RCA iliflatiolls (50%). Five differellt leads idelltified peak ST 
elevatioll Ihrollgh 12-lead surveillallce. 
The alllolllaled palellcy assessmelll progralll appears 10 delect corollary 
occll/sioll alld reperfusioll withill secollds ill all OCclllSiollS cal/sillg ~ 200 IIV 
peak ST elevatioll. Field testillg as a practical 1I0llilIVasive Iriage 1001 ill 
lIlyocordial illfarctioll patiellis seellls warrallied. 
INTRODUCTION 
Patients suffering acute myocardial infarc-
tion in whom thrombolytic therapy fails 
to provide early and stable reperfusion 
might benefit from additional pharmaco-
logie or mechanical revascularization 
therapy.'" To study these patients without 
subjecting all patients to catheterization 
would require a practical, accurate non-
invasive method able to detect both reper-
fusion and reocclusion in real time. 
ST-segment recovery analysis has been 
shown to accurately predict infarct artery 
patency in a real-time emulation using 
dynamically updated reference measure-
ments during continuous digital 12 lead 
ST-segment monitoring,'(J-12 However, this 
method of patency assessment required 
transfer of the ECG data to a separate 
personal computer review station for 
further analysis by a trained clinician. To 
enhance bedside application, the ST-seg-
ment recovery analysis should be a com-
ponent of the free standing monitor itself, 
accessible to less intensively trained phy-
sicians. Salient principles of the analysis 
method were therefore converted into 
algorithms and incorporated into the 
portable monitor as an interactive auto-
mated patency assessment program.13 1his 
study was designed as a first phase of 
testing the ability of this automated paten-
cy assessment system to detect known 
periods of coronary occlusion and reperfu-
sion and the speed thereof, using angio-
plasty as a controlled human model. 
METHODS 
Population 
Patients undergoing elective percutaneous 
transluminal coronary angioplasty of 1 or 
more subtotal (75-99%) stenotic lesions 
were selected prospectively to equally 
represent the three major coronary ar-
teries. Patients with a previous coronary 
artery bypass operation, within the first 3 
days after acute myocardial infarction, 
with a chronic total occlusion as a target 
lesion, with an abnormal conduction pat-
tern, Of undergoing an intelvention with a 
device other than a conventional balloon, 
were excluded. Coronary angioplasty and 
ST -segment monitoring were performed 
according to standard practice in our 
institution. 
ST monitoring 
The 12 lead ST monitor (STlOO, Mortara 
Instrument, Milwaukee) has been descri-
b d · d'l . I IH6 I e In etal preViOUS y. n summary, 
the ST monitor acquires and digitizes a 
standard 12 lead ECG every 20 seconds, 
recognizing QRS onset in all 12 leads 
simultaneously and creating a median beat 
complex out of each acquisition. For the 
purpose of this study, all acqUired ECGs 
were stored in the monitor's memory. 
Torso lead placement'S with radiotrans-
lucent electrodes and impedance-regu-
lated skin preparation (Quik Prep, Quin-
ton Medical, Seattle) were used to reduce 
noise. 
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Automated patency assesslllent 
Details of the automated patency assess-
ment method have been described pre-
viously.13 Briefly, continuously updated 
surveillance of all 12 leads is used to select 
the most active lead, defined as the single 
lead shOWing the highest ST -segment 
elevation up to that moment. Amplitude 
measurements in this most active lead are 
then used to identify 2 ECGs for compari-
son to the assessment ECG: U,e "last trans-
itionll ECG and the lImaximum" ECG. As 
shown in Figure 1 the "last transition ECG" 
is defined as the last ECG prior to the 
assessment ECG where the trend of ST-
segment amplitude over time changes 
from worsening (upsloping) to improve-
ment (downsloping), or vice versa. The 
"maximum ECG" is defined as the ECG 
displaying the most ST-segment elevation 
in the most active lead during the recor-
ding episode up to the moment of assess-
ment. With each new assessment ECG, the 
most active lead and the ECGs representing 
the maxinuun ECG and the last transition 
ECG are automatically re-defined. 
Analogue waveforms from all 3 ECGs 
(asseSSlnent, maximum, last transition) are 
printed in hard copy as a comparison plot 
for inspection by the clinician. By pushing 
a button, the clinician may reject any ECG 
that contains unacceptable noise or con-
duction disturbance, after which the pro-
gram selects a new ECG. After visual 
confirmation of satisfactory noise levels, 
two parameters of ST recovery are 
automatically calculated: 1) the ST ampli-
tude recovery in the assessment ECG as a 
percentage of the maximum ECG ST am-
plitude; and 2) the peak 2 minute ST trend 
slope between the last transition ECG and 
the assessment ECG (Figure 1). A window 
between 2 points 2 minutes appart is used 
Ilfloating" backward from the assessment 
ECG to determine the slope between these 
2 points at each 20 seconds interval: wor-
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sening (upsloping , 50 pV / 2 minutes), 
improvement (downsloping < - 50 pV / 2 
minutes), or flat. The last transition ECG is 
the last ECG prior to the assessment ECG 
where the trend of ST amplitudes over 
tiine in the worst lead changes from up-
sloping to downsloping or vice versa 
(Figure 1). 
As was previously descrlbed/3 the 
results of these 2 calculations are then 
conveyed through a simple logic flow 
(Figure 2) to produce a final interpretative 
statement about coronary patency as "oc-
cluded", "indeterminate", Of IIpatent". If 
less than 50% recovery has occurred and 
the peak 2 minute ST slope is flat or up-
sloping the infarct related artery is con-
sidered to have remained occluded. A 
recovery of ,,50% from the peak ECG as 
well as a peak 2 minute ST slope < - 50 P V 
/ 2 minutes is required to assess the infarct 
related artery as patent to differentiate 
from gradual amplitude diminution due to 
loss of tnyocardial mass producing injury 
current. If a recovery < 50% has occurred, 
but the peak ST slope is downsloping it is 
believed that this might be the advent of 
reperfusion without enough certainty and 
the patency assessment is therefore in-
determinate. When 50% recovery has 
occurred with the required downslope of 
< - 50 pV / 2 minutes, but is than followed 
by an upsloping ST trend, it is believed 
that this is due to recurrent occlusion of 
the infarct related artery and this leads to 
an interpretation as occluded. 
If none of the recorded ECGs have an 
ST amplihlde " 200 pV, a special state-
ment is printed that the amplitudes are 
below the programmed threshold to per-
form a patency assessment. 
Endpoints 
For the purpose of this study a patency 
assessment was performed every 20 se-
conds before, during and after each bal-
loon inflation lasting at least 60 seconds. A 
balloon induced occlusion was considered 
"detected" if the program produced at least 
1 interpretative statement saying "occlu-
ded" during that inflation. For all detected 
balloon inflations, the following perfor-
mance parameters were evaluated: 1) Time 
from balloon inflation to the first assess-
ment ECG with an interpretative state-
ment saying "occluded"; 2) time from 
balloon deflation to the first assessment 
ECG with an interpretative statement no 
longer saying "occluded"; and 3) duration 
of the episode during which interpretati-
ve statements said "occluded" as compa-
red to the actual duration of balloon 
inflation. 
Statistics 
All continuous variables are represented 
as median values, 25th - 75th percentile, 
and in relevant cases range. Categorical 
parameters are represented as numbers of 
patients or number of inflations. Detection 
rates are reported as absolute numbers, 
percentages and 95% confidence limits. 
Difference in detection rates over all infla-
tions were tested using the Fisher exact 
test. P-values < 0.05 were considered sig-
nificant. 
RESULTS 
A total of 78 transient coronary occlusions 
were recorded from 31 coronary sites in 30 
patients. The recordings of 6 patients were 
excluded for analysis: 2 underwent PTCA 
of a totally occluded artelY, 2 underwent 
angioplasty with a perfusion balloon ca-
theter, 1 had continuous RBBB, 1 had 
incomplete LBBB with axis changes during 
inflation. Table 1 summarizes sonle of the 
characteristics of the study population. 
The vessel dilated was the left anterior 
descending artery (LAD) in 10 patients (26 
inflations), the left circumflex artery (LCX) 
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ST ~segment deviation over time measured in the peak lead (III) during 3 consecutive balloon 
inflations. TIle definition of the maximum EeG (M),iast transition EeG (LT), and assessment EeG (A) 
are represented above the trendline, Two arrows on the right side represent tile 2 measurements that 
are used in a logic flow to come to an interpretative statement regarding patency of the coronary 
artery: the recovery in ST elevation in the assessment EeG as a percentage of the maximum ST 
elevation (% fee); and the 2 minute peak slope in the trendline between the last transition ECC and 
the assessment EeG, 
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Representation of the logic flow implemented in the automated patency assessment program. The 2 
measurements demonstrated in Figure 1 are used to come to a final statement regarding infarct 
related artery patency. Modified affer veldkamp et al.: Evolution of an automated ST-segment recovery 
ar/(/Iysis program for dynamic real-time, tlonhlVasive detection of corol/ary occlusion arid reper/lisioll, 
J Elecirocardiol.1993 (13). With permission ofCllllrchill Livirlgsfolle Publishing CompallY, New York. 
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Table 1: Patient descriptors 
Gender: 
male 
female 
15/30 (50%) 
15/30 (50%) 
Age: 
Hypertension: 
median 68 years (quartile range 51-75, range 40-84) 
18/30 (60%) 
Diabetes Mellitus: 
Previolls AMI same region: 
non q-wave 
q-wave 
Indication: 
angina pectoris 
unstable angina 
post AMI 
syncope 
Extent of disease: 
1 vessel 
2 vessels 
3 vessels 
12/30 (40%) 
5/30 (17%) 
5/30 (17%) 
15/30 (50%) 
10/30 (33%) 
4/30 (13%) 
1/30 (3%) 
14/30 (47%) 
8/30 (27%) 
8/30 (27%) 
pre-angioplasty stenosis: median 95% (quartile range 75-95, range 75-99) 
Descriptive characteristics of the population studied. AMI :::: acute myocardial infarction; post AMI 
:::: > 3 days post acute myocardial infarction. 
in 10 patients (22 inflations), and the right 
coronary artery (RCA) in 11 patients (30 
inflations). Median duration of inflation 
was 183 seconds (quartile range 126 to 189; 
range 62 to 912). Median peak ST devia-
tion pe, inflation was 165 !IV (quartile 
range 34 to 258, range -190 to 968). Median 
peak ST deviation was 240 !IV for LAD 
inflations (quartile range 115 to 303, range 
65 to 968), - 20 ~IV for LCX inflations (quar-
tile range - 95 to 15, range - 190 to 820), 
and 205 ~IV for RCA inflations (quartile 
range 78 to 275, range - 20 to 395). Median 
peak ST deviation was 175 ~IV for first 
balloon inflations (quartile range 15 to 235, 
range -115 to 687) and 160 !IV for repeated 
balloon inflations (quartile range 50 to 260, 
range -190 to 968). aut of the 78 inflations, 
there were 35 (45%) causing;" 200 !IV peak 
ST amplitude, including 19 out of 26 LAD 
inflations (73%), lout of 22 LCX inflations 
(5%), and 15 out of 30 RCA inflations 
(50%). All 35 inflations (100%) with;" 200 
!IV peak ST amplitude were detected. af 
the 43 balloon inflations that caused < 200 
!IV ST elevation, 5 were also detected (1 
LAD, 1 LCX, 3 RCA). In all 5 instances the 
inflation followed a prior inflation that did 
cause;" 200 !IV ST elevation. 
In the 40 detected infla tions, median 
time from balloon inflation to detection of 
occlusion was 40 seconds (quartile range 
20 to 80; range 0 to 120). Reperfusion by 
balloon deflation in those same 40 occlu-
sions was detected at a median of 17 se-
conds (quartile range - 2 to 16, range - 92 
to 126). The median duration of occlusion 
defined by the automated patency assess-
ment program was 120 seconds, out of the 
actual median balloon inflation duration 
of 181 seconds in these 40 detected infla-
tions. During 6 inflations 1 or more BeGs 
were not analyzed due to conduction 
changes (1,2,2,3,3, and 4 consecutive ECGs 
excluded respectively) and 1 ECG during 
1 inflation was not analyzed due to the 
high noise content. 
After splitting the 78 balloon inflations 
around the median duration of inflation, 
no correlation was found between infla-
tion duration and the program.'s detection 
performance (p = 1.0). Neither was there 
any difference in detection of first versus 
repeated balloon inflations: 15 out of 30 
versus 25 out of 48 respectively (p = 1.0). 
TI,e precordial location of the peak lead 
activity varied with the artery occluded. 
Of the standard 12 leads monitored, the 
following peak leads were used to detect 
occlusions: leads VI (2), V2 (8), V3 (8), V4 
(2) for LAD occlusions; lead III (2) for LCX 
occlusions; and lead III (18) for RCA occlu-
sions. TIUts, detection of the occlusions 
occurred in 5 different leads. 
DISCUSSION 
TI,e results of this study show that this 
automated patency assessment program 
wholly contained within the ST monitor's 
architecture detected all occlusions pro-
ducing injury current ~ 200 pV, equivalent 
to entry criteria used III some thrombolytic 
trials. Detection of multiple episodes of 
occlusion and reperfusion was within 
seconds of their actual occurrence. Longer 
inflations did not increase the chance of 
detection in this model. This is probably 
due to our standard angioplasty practice 
of deflating the balloon earlier if ischemia 
induced by the occlusion is more severe, 
while dilating for longer periods if the 
patient tolerates it well with no ischemia. 
In spontaneous occlusion and infarction, 
longer acute occlusions would be expected 
to produce higher ST-segment amplitudes. 
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Repeated inflations were detected as well 
as first inflations. Although one might 
expect lower amplitudes in repeated bal-
loon infla tions, this was not the case in this 
population. Furthermore, after an initial 
occlusion causing ~ 200 pV ST elevation 
the program relies on ST -trend slopes and 
amplitudes relative to the peak ST eleva-
tion rather than on absolute amplitudes. 
It is notable that the peak lead selected 
varied over the precordium with the artery 
occluded. This suggests that automated 
detection of coronary occlusion is not only 
a matter of updated assessments of ST 
amplitudes, but is also dependent on the 
ability to select a monitoring lead central 
to the geographic pattern of ST de-
viation.!7.2! 
Limitatio1ls 
Elective coronary angioplasty is an imper-
fect model to test a program designed for 
acute myocardial infarction applications, 
as is evidenced by the fact that only 40 of 
the 78 balloon inflations produced enough 
injury current to fulfill the preset require-
ment of 200 l'V. Taken from the entry 
criteria used for some thrombolytic trials, 
such ST levels are somewhat more COUl-
man in the milieu of prolonged occlusion 
necrosis typical to actual acute myocardial 
infarction. In a standard 12-lead ECG 
format, such criteria have been demon-
strated to prornote an anatomic bias 
against left circumflex artery occlusions!7 
and is unfortunately paralleled in these 
data taken during coronary angioplasty 
with markedly lower peak amplitudes 
during occlusions of the left circulllflex 
artery. In this regard the PTCA model 
emulated acute myocardial infarctions 
well, with most left circumflex balloon 
occlusions failing to produce the minimum 
injury current required by the automated 
patency program. 
Despite these limitations coronary angi-
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oplasty provides a hurnan model of coro~ 
nary occlusion and reperfusion of known 
duration and location, which is very llse-
full for preliminary testing of a prototype 
patency assessment program. Every recor-
ded ECG could thus be correlated with 
sitnultaneotls angiographic documenta tion 
of the location and flow status of the arte-
ry. The previous work on which this pro-
gram was modelled has demonstrated U,at 
during infarction the myocardium genera-
tes and resolves injury current abruptly 
enough to make continuous ST recovery 
analysis a usefully accurate non-invasive 
marker of patency,lO·12 The results in this 
study suggest that further investigation 
into the performance of the auto-mated 
patency assessment program during actual 
acute myocardial infarction is warranted. 
The time course of ST-segment change 
during acute myocardial infarction may be 
substantially different from trends ob-
tained during coronary angioplasty and 
might be more heterogenous. Whether the 
anatomic bias or the overall performance 
of the program could be further optimized 
by changing minimal amplitude require-
ments or slope rates is beyond the scope of 
this balloon angiaplasty model and needs 
further investigation in the acute myocar-
dial infarction setting. Use of additional 
leads or modified lead systems might also 
I f 26. 21 • II en lance per onnance,' especcJa y to 
reduce the anatomic bias against left cir-
cumflex artery occlusions, although the 12-
lead system is practical due to universal 
familiarity. TIle variety of leads used to 
detect coronary occlusion suggest that 
more restricted lead systems would risk 
decreasing the accuracy of the algorithm. 
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ELECTROCARDIOGRAM DURING ACUTE MYOCARDIAL 
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ABSTRACT 
Continuolls ST-seg11lellf recovery flIlnlysis lias been prove1l to be a useful nOll-
illvasive illdicalor of failed repelfllsioll or recllrrelll oCc/llsioll of Ihe illfarct relaled 
arlery, Lead syslellls olher Ihml Ihose proposed for arrhylhlllia delectioll might proof 
sllperior for Ihis pllrpose, Elecirocardiograllls recorded ill 361 Throlllbolysis alld 
Allgioplasly ill MyocardialIllfarclioll (T AMI) 9 lrial paliellis were allalyzed alld 
relaled 10 Ihe mlgiographicnlly delerlllilled illfarci relaled arlery, The righl cO/'Ollary 
arlery was Ihe illfarci relaled arlery ill 179 paliellis (50%), Lead III was 1II0si 
eleva led ill 156 (87%) mId illjllry cllrrelll was predolllillmltly localed ill lead 1Il, 
a VF, alld II. The left aIllerior descwdillg arter!! was Ihe illfarci relaled arlery ill 142 
paliellis (39%), Mosl eleva led were leads V2~V4 ill 139 (98%) mId Ihose were also 
mosloflell illvolved ill Ihe illjllry cllrrelll pallel'll, The left circllllzjlex arlery was Ihe 
illfarct relaled arlery ill 39 patiellis (11 %), Localioll of Iheir lIlosl eleva led lead was 
more dispersed: 17 (44%) ill III, 7 (18%) lead II, 5 (13%) lead V5, mId 4 (10%) lead 
V6 as was Ihe illjllry cllrrelll palleYll, 330 Paliellis (91%) had ~ 1 lead with ~ 200 
IIV ST elevalioll, COIlll>illillg leads 1Il, V2, mId V5 wOllld record 01 leasl 1 lead wilh 
~ 200 IIV ST elevatioll ill 321 paliellis (89%), 
CONCWSION: For COlltillllOIlS ST~segmelll recovery allalysis a 3 lead syslem should 
be adequale 10 record 01 leasl 1 lead wilh slljficielll ST devialiOiI ill a majoril!! of 
myocardial illfarclioll paliellis selecled for Ihrolllbolylic Iherapy, Twelve~lead or 
vectorcardiographic ST~mollitorillg syslems will illcrease Ihe sellsilivily for ST 
devialioll especially ill slllaller illfarcliolls mId will facililale compm'isoll of Ihe ST 
devialiollpallel'll dllrillg rewrrelll elevatioll with Ihe primary ST elevalioll episode 
to assess wlrether it indeed signifies reoCcillSioll. 
INTRODUCTION 
Continuous ST -segment recovery analysis 
has been shown to be a useful noninvasive 
indicator of failed reperfusion or recurrent 
occlusion of the infarct related artery. The 
presence of rapid ST recovery coincides 
with reperfusion of the infarct related 
artery, while rapid ST fe-elevation in the 
same precordial pattern as the primary 
pattern indicates reocclusion at the same 
coronary 10cation.1-4 With this technique 
different therapeutical strategies to achie-
ve early and stable reperfusion can be 
compared.s-7 Implementation in coronary 
care monitoring systems can lead to a 
better selection of patients who have re-
ceived intravenous thrombolytic therapy 
for additional treatment sHch as rescue 
angioplasty or a regimen "tailored" to their 
own reperfusion behavior.s-lO So far elec-
trocardiographic lead systems for moni-
toring have been oriented to arrhythmia 
detection in acute coronary care or ambu-
latory studies and various modifications 
have been proposed for arrhythmia ana-
lysis 01' ischemia monitoring during exer-
cise electrocardiography or using Holler 
monitoring systems.1I -14 Other lead sets 
might proof superior for the purpose of 
ST-segment monitoring during acute 
Inyocardial infarction. 
The purposes of this study are to deter-
mine the optimal lead positions and ntun-
bel' of leads for continuous ST-segment 
monitoring of patients with acute myo-
cardial infarction in correlation with the 
angiographically determined infarct rela-
ted artelY. 
METHODS 
Palielli popl/lalioll 
All 430 patients from the multicenter 
TIuombolysis and Angio-plasty in Myocar-
diallnfarction (T AMI) 9 trial were conside-
red for this study. Details and main outco-
mes of this study have been published 
previously.ls Briefly, patients presenting 
within 6 hours after symptom onset, wit-
hout contra-indications for thrombolytic 
therapy, and able to give informed consent 
were eligible. Emollment in the TAMI 9 
trial required ST elevation ~ 100 pV measu-
red 0.02 seconds after i-point in > 2 of the 
precordial leads or in > 2 inferior leads with 
ST depression > 100 flV in the anterior 
leads. Patients were randomized to stand-
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ard treahnent with "h"ont-loaded" recombi-
nant tissue plasminogen activator or to addi-
tional treaonent with Fluosolim, a perfluoro-
carbon wiU, oxygen carrying capacity. 
Excluded for the purpose of this study 
were 35 patients in whom no coronary 
angiography was performed, 4 patients 
with an indeterminable infarct related 
artelY, 13 patients with right or left bundle 
branch block, and 17 patients without any 
recorded electrocardiogram prior to treat-
ment or during the acute phase of myocar-
dial infarction. 'n1erefore the remaining 
population consisted of 361 patients or 
84% of the total TAMI 9 population. In the 
study population 73% of the patients were 
male, 43 tyo had multi-vessel or left main 
disease, and the median age was 58 years, 
ranging from 22 to 88 years. Median time 
from onset of symptoms to onset of throm-
bolytic therapy was 153 minutes, with a 
quartile range of 107 to 215 minutes, and a 
range of 30 to 525 minutes. 
Electrocardiographic mwlysis 
Together with other information a copy of 
the enrollment electrocardiogram had to 
be transmitted to the central databank and 
coordination center. Per protocol ST-seg-
ment moni-toring with the Mortara ST 100 
continuous digital 12 lead electrocardio-
graph was initiated prior to or as soon as 
possible after onset of thrombolytic thera-
py and continued for 24 hours. TI,e essen-
tials of this automated device and it's 
applications have been described previou-
sly.16, 17 All electrocardiograms recorded 
with the ST monitor were transferred to a 
floppy disk for later analysis in the core 
laboratory with a personal computer ba-
sed program (3D, Tampa Cardiovascular 
Associates, Tampa, Florida). As described 
previous-ly,I,16 this program allows analy-
sis of the ST monitor recording 12 lead 
electrocardiograms in full disclosure as 
well as in a 3 dimensional trend of ST 
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deviation over time in each lead. For the 
purpose of this study the maximally devia-
ted single lead defined by the maximum 
ST elevation or reciprocal ST depression 
representing transmural ischemia in either 
the enroll-ment electrocardiogram or the 
ST monitor recording was determined for 
each patient, measLU'ing the ST-segment 60 
milliseconds after the j-point. If more than 
one lead displayed maximal ST deviation, 
the one with the m.ost ST deviated contigu-
ous lead was selected as the maximum 
lead. In the electrocardiogram displaying 
maximum deviation the deviation in the 
other leads was annotated for further 
analysis. 
Allgiography 
A protocol coronary angio-graphy was 
scheduled pre-discharge, on clinical de-
mand an emergency catheterization could 
be performed as wel1. ls Cine-angiograms 
were then analyzed at the core angiogra-
phic laboratory at the University of Michi-
gan. Criteria for the selection of the infarct 
related artery were: 1) the presence of 
occluding or severely stenosing lesions; 2) 
Thrombolysis In Myocardial Infarction 
(TIMI) flow grade; 3) presence of throm-
bus, haziness, or filling defects; and 4) wall 
motion defects. At least 2 different obser-
vers determined the infarct related artery, 
in case of disagreement a consensus was 
sought. In some unclear cases the en-
rollment electrocardiogram was also used 
to correlate with the angio-graphic infor-
mation. Depending on these findings 
patients were divided into 4 infarct related 
artery groups: 1) the Right Coronary Arte-
ry (RCA) including the posterior descen-
ding branch; 2) the Left Anterior Descen-
ding (LAD) including diagonal branches 
and the ramus intermedius; 3) the Left 
Circumflex (LCX) including marginal 
branches and posterolateral branch; and 4) 
TIle Left Main Stem (LM). 
Da/a analysis 
Taken over all patients as well as per 
infarct related artery location the most 
elevated 01' peak lead was determined. TIle 
presence of ST depression as reciprocal 
injury current from the posterior left vent-
ricular wall was also analyzed when this 
ST depression had higher absolute ampli-
tudes than theST elevation present in any 
of the elevated leads. TI,e frequency of 
occurrence of ST-elevation ~ 200 pV in 
each lead for all patients and separated per 
infarct related artery was also analyzed. 
Median, 25th and 75th percentiles of ST 
deviation in each lead for the patients with 
RCA, LAD, or LCX occlusion were deter-
mined. Optimal combinations of I, 2, ... 12 
leads were sought to include as many 
patients as possible with at least one lead 
with ~ 200 II V ST eleva-tion in the combi-
nation of leads. 
RESULTS 
From the 361 patients selected for this 
study 179 (50%) had the Right Coronary 
Artely (RCA) as the infarct related artery, 
142 (39%) the Left Anterior Descending 
(LAD), 39 (l1"!O) the Left Circumflex (LCX), 
and 1 the left main stem. TIle electrocar-
diogram selected as peak electrocardio-
gram for further analYSis was the enroll-
ment electrocardiogram in 200 patients 
(55%), in the remaining 161 patients the 
peak electrocardiogranl selected was re-
corded with the digital ST recorder. The 
median time from the peak electrocardio-
gram to thrombolytic treatment was 18 
minutes, with the peak ECG ranging from 
267 minutes before treatnlent (treahnent 
delay) to 786 minutes thereafter (late peak 
ECG). In a total of 228 patients (58%) the 
electrocardiogram selected was recorded 
prior to thrombolytic treatment and in 133 
thereafter. 
For the 179 patients with the RCA as an 
57 
Table 1: Listed are 16 patients in whom ST depression amplitude considered to represent 
reciprocal injury current exceeded the maximum ST elevation amplitude present. 
Shown for eadl patient is the location of the most elevated (5T1) and the most 
depressed lead (ST I) and their amplihtdes. 
/I IRA 5Tt 
1 RCA III 
2 RCA III 
3 RCA III 
4 RCA III 
5 RCA III 
6 RCA III 
7 RCA III 
8 RCA II 
9 LAD aVL 
10 LCX III 
11 LCX III 
12 LCX III 
13 LCX III 
14 LCX II 
15 LCX II 
16 LCX V5 
inlarct related artery lead III was the most 
elevated lead in 156 (87%). For the 142 
patients with the LAD as an inlarct related 
artery one 01 the leads V2-V4 were the 
most elevated lead in 139 (98%). The most 
elevated leads lor the 39 patients with an 
LCX as the inlarct related artery were 
more widely dispersed: 17 (44%) wW,lead 
I1I,7 (18%) with lead II, 5 (13%) with lead 
V5, and 4 (10%) with V6. The 16 patients 
(4% 01 the study population) in whom the 
peak electrocardiogram showed more ST 
deviation in the depressed leads than in 
the elevated leads are listed in Table 1. In 
14 of these patients the electrocardiogram 
suggested inlarction 01 the posterior wall. 
The maximum ST deviation in those pa-
tients was most often seen in leads V2 or 
V3. 
Table 2 shows the Irequency 01 occur-
rence 015T-elevation ;, 200 flV in each lead 
amplitude 51'1 amplitude 
(flV) (flV) 
150 V2 -200 
250 V2 - 300 
150 V3 - 250 
230 V3 - 250 
494 V3 -504 
200 V3 -500 
400 V,I - 500 
200 V" ,. - 300 
297 III - 430 
85 V4 - 518 
100 -150 
500 V2 -550 
460 V3 - 670 
100 V3 -150 
400 V2 -500 
295 V3 -415 
lor all patients and separated per infarct 
related artery. The distribution 01 leads 
with;, 200 flV 01 injury current followed a 
similar pattern as the distribution of the 
peak leads per inlarct related artery. The 
inferior lead III and to a lesser extent II 
and a VF were most often involved in the 
pattern of injury current in patients with 
the RCA as their infarct related artery. The 
anterior leads V2-V4 were most often 
involved in the patients with the LAD as 
their inlarct related artery. For the patients 
with the LCX as the inlarct related artery 
the pattern 01 injUlY involved inlerior, 
anterior as well as apical leads. 
Figure 1 shows the median, 25th and 
75th percentile 01 ST deviation in each lead 
lor the three inlarct related artery groups. 
For the patients with the RCA as inlarct 
related artery the highest amplitudes were 
seen in lead III. For the patients with an 
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Table 2: Occurrence of ST-elevation ~ 200 ttY in each lead for all patients and separated per 
infarct related artery. 
RCA LAD 
(n=179) (n=142) 
aVL 14 (10%) 
I 47 (33%) 
-aVR 26 (15%) 4 (3%) 
II 126 (70%) 3 (3%) 
aVF 138 (77%) 2 (1%) 
III 155 (87%) 3 (3%) 
VI 12 (7%) 60 (42%) 
V2 4 (4%) 126 (89%) 
V3 21 (12%) 123 (87%) 
V4 27 (15%) 114 (80%) 
V5 37 (21%) 63 (44%) 
V6 34 (19%) 18 (13%) 
LAD as the infarct related artery the hig-
hest amplitudes were seen in lead V3 with 
lead V2 as a close second. For the patients 
with the LCX as the infarct related artery 
the highest amplitudes were seen in the 
inferior leads II, aVF, III. 
Optimal combinations of 1, 2, .. .12 leads 
were sought to include as many patients as 
possible with at least one lead with ~ 200 
pV ST elevation in the combination of 
leads. TIle maximum percentage of pa-
tients achievable will) combinations of I, 2, 
... 12 leads are shown in Figure 2. Of the 
361 patients included 330 or 91% had at 
least 1 lead out of the 12 leads with ~ 200 
flV ST elevation. All of these 330 patients 
would have at least 1 lead with ~ 200 flV 
ST elevation in a combination of 8 leads, 
excluding - aVR, aVF, VI, and I. Subopti-
mal results were achieved with combina-
tions of 2 or 3 leads, being 310 or 86% of 
the patients with the combination of leads 
III and V2 and 321 or 89% of the patients 
with the combination of leads III, V2, and 
V5. Table 3 lists the most optimal com-
binations of 2 or 3 leads to have as many 
patients as possible with at least 1 lead 
LCX All 
(n=39) (n=361) 
1 (3%) 15 (4%) 
10 (3%) 
5 (13%) 35 (10%) 
21 (53%) 150 (42%) 
22 (55%) 162 (45%) 
21 (54%) 179 (50%) 
1 (3%) 73 (20%) 
5 (13%) 137 (38%) 
3 (8%) 148 (41%) 
6 (15%) 147 (41%) 
11 (28%) 111 (31%) 
15 (38%) 67 (19%) 
with ~ 200 pV ST elevation within the 
combination of leads. 
DISCUSSION 
In this study optimal lead sets were sought 
for'the purpose of continuous ST-segment 
monitoring either as a bedside (CCU) 
monitoring system or for ischenlia moni-
toring in comparative trials. Peak electro-
cardiograms of 361 myocardial infarction 
patients enrolled in the TAM! 9 trial, all 
with protocol coronaIY angiography and 
ST-segment monitoring for 24 hours, were 
therefore analyzed and compared with the 
angiographically determined infarct rela-
ted artery. Most elevated leads and distri-
bution of ST elevation over the 12 leads 
monitored were markedly different for 
patients with an LAD occlusion versus 
those with an RCA or LCX occlusion. The 
latter 2 groups are indistinguishable on the 
standard 12 lead electrocardiogram as has 
been published previously. IS Monitoring 
of reciprocal ST depression as a reflection 
of posterior injury current Illight be useful 
in a small subset of patients in whom the 
Table3: 
2 leads 
III, V2 
III, V3 
III, V4 
aVF,V2 
aVF,V3 
II,V2 
aVF, V4 
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Optimal combinations of 2 and 3 leads respectively to detect at least one lead with ~ 200 
pV ST elevation in as many patients as possible. TIle listing of combinations ends where 
UlC 95% confidence interval (behveen brackets) from a combination falls outside the 95% 
confidence interval of the combination listed as best. 
3 leads 
86% (82-89%) III, V2, V5 89% (86-92%) 
84% (81-88%) III, V2, V4 89% (86-92%) 
82% (78-86%) III, V2, V3 88% (85-91%) 
81% (77-85%) III, V2, V6 87% (84-91%) 
80% (76-84%) III, V3, V5 87% (84-90%) 
78% (74-82%) II, III, V2 87% (84-90%) 
77% (73-81%) III, V3, V4 86% (83-90%) 
III, aVF, V2 86% (83-90%) 
III, VI, V3 86% (83-90%) 
III, aVL, V2 86% (83-90%) 
III, V3, V6 86% (82-89%) 
III, VI, V2 86% (82-89%) 
III, -a VR, V2 86% (82-89%) 
I, Ill, V2 86% (82-89%) 
II, Ill, V3 86% (82-89%) 
III, aVL, V3 85% (81-89%) 
III, aVF, V3 85% (81-89%) 
III, VI, V4 84% (81-88%) 
III, -a VR, V3 84% (81-88%) 
I, III, V3 84% (81-88%) 
aVF,V2,V4 84% (80-88%) 
aVF, V2, V3 84% (80-88%) 
aVF, V2, V5 84% (80-88%) 
aVF, V2, V6 83% (79-87%) 
II1,aVL, V4 83% (79-86%) 
III, V4, V6 83% (79-86%) 
III, V4, V5 83% (79-86%) 
aVF, V3, V5 82% (78-86%) 
II, III, V4 82% (78-86%) 
aVF, V3, V4 82% (78-86%) 
aVF, VI, V3 82% (78-86%) 
Ill, aVF, V4 82% (78-86%) 
II, aVF, V2 82% (78-86%) 
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Figure 1: Median (squares) and quartile ranges (bars) of amplitudes in the 12 leads separated per 
infarct related artery. 
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Figure 2: Sensitivity of detecting occurrence of at least 1 lead with ST~elevation:?:: 200 f)V in the 
1110St optimal combination of 1 to 12 leads respectively. Most optimal combinations 
were: 1. III; 2.m + V2; 3.m + V2 + V5; 4. III + V2 + V3 + V5; 5.m + V2 + V3 + V5 + V6; 
6. III + V2 - V6; 7.m + aVL + V2 - V6; 8. III + aVL + VI -V6; 9-12. at random plus I, II, 
aVF, -aVR, Vertical bars indicate the 95% confidence intervals. 
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reciprocal change has markedly more ST 
deflection than the ST elevation commonly 
seen in the inferior or apical leads. This 
reciprocal ST depression is normally maxi-
mal in lead V2 or V3. Prom the data de-
rived in this study combinations of moni-
toring leads can be proposed. It seems 
logical to distinguish the options accor-
ding to technical possibilities of lead sys-
tems. 
l-lend system 
A single lead system seems archaic now 
most CCU monitoring sys-tems and Holter 
recorders offer at least 2 monitoring leads. 
However, the option of dedicating one 
lead to arrhythmia moni-toring (e.g. an 
"atrial lead") while the other lead is dedica-
ted to ST-segment monitoring must be 
considered. Clearly, no fixed lead position 
can be recommended since anterior infarc-
tions have such dif-ferent injury current 
patterns than inferior, lateral, or posterior 
infarctions. To suit the variety of ST eleva-
4 5 6 7 12 
Leads 
tion patterns, an ex-ploring lead would be 
necessary. The placement of this lead 
should be guided by for instance the 12-
lead electrocardiogram, looking for the 
maximum injury current detectable. This 
requires skillful interpretation of the elec-
trocardiogram by trained personnel and is 
probably prone to error in emergency 
situations. 
2- nlld 3-lead systems 
These are the lead systems commonly seen 
in CCU moni-toring systems and Holter 
recorders. An optimal 2 lead system would 
have 1 lead oriented inferiorly (III or a VP) 
and one anteriorly (V2 or V3). TI,e inferior 
lead would detect the injury current in 
patients with an RCA occlusion as well as 
many of the patients with an LCX occlusi-
on. The anterior lead would detect the 
injury current in patients with an LAD 
occlusion as well as the reciprocal ST de-
pression in patients with a posterior infarc-
tion (RCA or LCX occlusions). In a 3-lead 
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system an apically oriented lead should be 
added (V5). TIus lead would add sensitivi-
ty for ST elevation especially in patients 
with an LeX occlusion. A combination of 
2 and 3 leads was able to detect an injury 
current of :, 200 pV in 310 and 321 out of 
330 patients with at least 1 lead exceeding 
200 pV respectively. However, this would 
not necessarily be the peak lead. The com-
bination of leads III and V2 would capture 
the' peak lead in only 238 or 66% of the 
patients and this would be so in 248 or 
69% for the combination of leads Ill, V2, 
and VS. If patency prediction algorithms 
are lIsed based on absolute amplitudes a 
lead system containing more than 3 leads 
should be preferred.' It has been shown 
that accuracy of continuously updated ST-
segment recovery analysis is related to the 
maximum recorded ST amplitude,l9, 20 It 
may be speculated that a patency algo-
rithm based on relative recovery of ST 
elevation and or STwrecovery and fe-eleva-
tion slope rates may be less dependent on 
the maximum recorded ST amplitude, but 
this remains to be tested,21 Furthermore, a 
Holter recorder lead set with orthogonal 
orientations can be used with the possibi-
lity of reconstructing a full 12-lead electro-
cardiogram. TIlis option will be discussed 
later. 
Multi-lead systems 
As shown in Figure 2 little sensitivity for 
detecting injury current is added when 
combinations of more than 3 leads are 
used. As mentioned before however, the 
chance of finding a lead with higher ST 
elevation does increase markedly when 
more leads are added. A logic lead system 
would be the 12-lead system due to its 
universal familiarity. TIle data for this 
study where derived from continuous 
electrocardiogram recordings made with a 
continuous digital 12 lead ST-segment 
monitor that is commercially available 
(STIDD, Mortara Instrument, Milwaukee). 
As described previously, 1,2,13,22 the use of 
multiple leads enhances the possibility to 
recognize reocclusions as a "fingerprint" of 
the first recorded occlusion. Reocclusion of 
the same coronary artelY gives a matching 
fingerprint of ST deviation over the pre-
cordium, although absolute alnplitudes 
might be different. If ST deviation occurs 
in a different pattern, either as depression 
alone or as elevation in a different lead 
pattern, thus not matcl\ing the fingerprint, 
there is an increased chance that this is not 
due to a reocclusion of the infarct related 
artery. The use of multiple leads will opti-
mize the chance of recording the maxi-
mum ST -segment amplitude, thereby 
leading to better recognition of the dyna-
rmc ST changes and improved accuracy of 
continuously updated ST-segment recove-
ry analysis. 19, 20 Use of additional leads or 
modified lead systems might also enhance 
continuous ST-segment monitoring, espe-
cially in isolated high lateral or posterior 
infarction, but clinical experience with 
these lead systems is limited.23,2-1 
Orthogonal leads 
An orthogonal lead system, such as propo-
sed by Frank 25 deserves attention since it 
is used in a commercially available ST-
monitoring unit as well.3,26 Stri~Uy spoken 
it is a 3 lead system with lead orienhltions 
directed inferiorly, anteriorly, and lateral-
ly. Parameters derived from the vector 
loops and their development over time 
however are independent of these orienta-
tions. In addition one can reconstruct a 12 
lead electrocardiogram through the so 
called Dower transfonnation.27 One can 
also reconstruct the maximum single ST 
vector at a fixed time after the J-point, 
thereby reconstructing a "virtual exploring 
lead" towards the epicenter of the current 
of injwy. Although on theoretical grounds 
one nught expect greater sensitivity for ST 
deviation with this lead system, the advan-
tage relative to the standard I2-lead sy-
steIn has not been proven in clinical appli-
cations. Furthermore, the exactness of the 
Dower transformation derived leads relati-
ve to a true lead registration should be 
investigated in abnormal electrocardio-
grams. 
Limitations 
The entry criteria for the TAM! 9 study 
required minimal ST elevation present in 
2 precordial leads or in 2 inferior leads 
with ST depression in the anterior leads. 
This has introduced a bias against small 
infarctions, especially of isolated high 
lateral and posterior location. Thereby this 
study can not answer whether the propo-
sed lead sets are suitable to these infarct 
locations as well. However, the proposed 
anterior leads V2 or V3 can be expected to 
be able to detect posterior injury current as 
reciprocal change if enough current is 
generated. The advantage of taking a trial 
population for this study on the other 
hand is that all patients received protocol 
angiography and continuous ST -segment 
monitoring so that data are less biased by 
clinical presentation. 
TI,e choice of 200 pV as a threshold for 
selecting optimal lead combinations seems 
rather arbitrary. At this level of ST devia-
tion changes due to reperhtsion or reocclu-
sion of the infarct rela ted artery can be 
clearly distinguished from random noise. 
In the setting of coronary angioplasty we 
have shown that an algorithm based on 
relative recovery and slopes of ST recovery 
over time rather than absolute changes is 
able to detect reperfusion and reocclusion 
with high accuracy, independent of the 
maximum amplitude present in the lead 
observed.28 
Clillical implications 
For continuous ST-segment monitoring a 
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3 lead system should be adequate to re-
cord at least I lead with sufficient ST devi-
ation in a majority of patients selected for 
thrombolytic therapy. Previously Aldrich 
proposed a 2 lead system consisting of III 
and V2.11 Krucoff et all. proposed a 3 lead 
Holter system WiU, inferior (a VF), anterior 
(V2), and inferolateral orientation (V5).I3 
The study by Alldrich interpreted ECGs 
with an anterior pattern (n = 68) or an 
inferior pattern (n = 80) without correla-
tion with infarct related arteries detenui-
ned through coronary angiography. TI,e 
lead set proposed by Krucoff et all. was 
not based on patient data. A task force of 
the American Heart Association CaIne with 
specific reconunendations for electrocardi-
ographic monitoring in special care units.29 
Based on the studies by Alldrich and by 
Krucoff they suggested the use of 3 
pseudo-orthogonal leads, one oriented 
anteriorly (VI or V2), one inferiorly (a VF), 
and one apically (V5). This combination is 
expected to give sufficient information for 
rhythm analysis and ST-segment monito-
ring. These data confirm their proposed 2 
and 3 lead systems respectively in an 
independent larger group of patients who 
underwent protocol coronalY angiography 
for O,e purpose of continuous real-time ST-
segment monitoring. Hohnloser et all. 
published a study using a 2-channel Hol-
ter recorder with leads oriented towards 
V5 and aVF to assess the patency asses-
sment accuracy of ST -segment recovery 
analysis.'" Only 65% of the patients exhibi-
ted ~ 1 Bun ST elevation in at least 1 lead, 
thus in 35% of the patients the recording 
failed to display sufficient amplitudes for 
further analysis. 
More important is the finding that a 
limited set of preferably 3 leads can be 
applied for the purpose of continuous ST-
segment monitoring without a profound 
loss in sensitivity for ST deviation as com-
pared to multiple lead systems. Whether 
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accuracy 01 continuously updated ST-
segment recovery analysis is allected by 
the decreased maximum ST amplitude 
recorded remains to be tested,19, 20 TIle 
possibility 01 lead reduction has been 
shown previously under the dillerent 
physiologic circumstances of exercise 
electrocardiography. I' In that study a 
(pseudo) orthogonal lead system was 
proposed, similar to the lead set proposed 
in our data. 
The importance of matching the fe-
elevation pattern ("fingerprinting") to the 
original pattern 01 ST deviation would 
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ST-Segment Recovery as an Endpoint in 
Acute Myocardial Infarction Trials 
Past, Present, and Future 
Rolf F. Veldkamp, MD, James E. Pope, MD, Sharon T. Sawchak, RN, 
Galen S. Wagner, MD, Robert M. Califf, MD, and 
Mitchell W. Krucoff, MD 
Abstract: Traditional, comparative acute myocMtiiai i"f.:nelion trials have used 
morbiditr and mortality as endpoints, requiring large study populations. teft 
vcntriC11far function and angiographlc infarct-related artery patency have, there-
fore, been used asaitemativeendpoints. These assessments arccos!I}" risk-laden, 
and put a large demand on re'iOurces nut available in every hOSpit.11. This has 
led to an increased interest in oon1n\,.151\'(' endpoints for comparatiw·trlals. This 
study describes the history and possibilities of ST-segment remvery analysis as 
an endpoint in acute myocardial infarction trials. Key words: ,Kute myocaHlial 
Infarction, clinical trials, ST-segment. continuous monitoring, noninvasive pa-
tency assessment. 
Traditional Endpoints 
Traditional acute myocardial infarction (AMI) 
trials have used moroidit~' and mortalit~' as end-
points, These endpoints occur relativel~' infrequently 
during the observation period and require large stud~' 
populations. Left ventJicuiar function and angio-
graphic infarct-related artery patency have, there-
fore, been used as alternative endpoints. These as-
sessments arc costly, risk-laden, and put a large 
demand on resources not ,wailable in every huspital. 
FurthemlOre, the relationships among patency, Jeft 
ventricular function, and mortality have not yet been 
F",m Ih, Dil'isiIJII ,,/cardiot.>gy. D<T,nllltfl1IIJ/MCdidlle, Dill:< Ulli· 
l'enilY ,\I,'di((l/ efilier. Dllrham. N,llih C<lr,,/illa. 
Reprint requests: MJ!,hell W. Krucofr. MD. ischemIa Monitur· 
ing l,lbor,llory, Box 3968, Duke Universily Medkal Cenler, DUr-
ham. NC 27710. 
resolved. I- 3 This has led to an increased interest in 
noninva~ive endpoints for comparative trials.4.~ 
Static Electrocardiographic 
Methods: Surrogate for 
Angiography 
Observations of marked ST recovery at the mo-
ment of angiographicall~' documented reperfusion 
Jed to several studies correlating quantitative ST re-
covery to infilCCl-related arlery patenr~'. Several 
methods comparing ST-segment deviation between a 
post-treatment elertrucardiograrn (ECG) and a fixed 
pretreatment reference ECG have been reported.t;-II 
These methods measure the ST -segment deviation in 
one or' a few post-treatment EeGs ilt intervals Iypi-
call~' 60-180 minutes after onset of thrombolytic 
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Tallie 1. Sensitivity for Failed Reperfllsion, Specificity, and Accural)' as Reported by Five 
Methods 
Methud Sensitivity (%) specificity (%) AcUHJC'{ (%) 
" 
von E\~cn cl ,11." IVO 100 100 56 
110):),: cl a[? 67 93 88 17 
Saran Cl ,11:" 4J 97 80 45 
clcmmemcn ct al? SO 88 85 53 
Hohnlo,cr ('I ,11. 10 95 84 87 82 
These methods m('a~ur(' ST-s('gmmt r('(OvCfY in ,1 ]l(lst-trcatU1ent ECG as " fraclional thange of a /IxI'd. 
prctrcatnlcnt rderence ECG ST level. n = numher of p~ticnt5 indudl'<1 il11he SlUd)'. 
treatment. If the 5T-segment has recovered below a 
threshold expressed as a fmctional change of a fixed, 
pretreatment reference ECG ST level, (cperfusion is 
considered to have occurred. If the ST-segment did 
not rccover Lelow this threshold, r('perfusion is con-
sidered to have failed, Reported sensitivity for 
occluded infarct-related arteries, and the specificity 
and accuracy for nve of these methods are listed in 
Table I. 
Continuous ST·Segment 
Monitoring: Real·tlme Triage 
and Beyond Anglographlc 
Surrogate 
Continuous 5T -segment Illonitoring llsing Holter 
recorders was developed to better document the tim-
ing of reperfusion. Recordings were analyzed retro-
sJleclivel~' and distinguished patients with reperfused 
infarct-related .uteries from those in whom the 
infarct-related artery faited to reperfuse after treat-
ment.7 - 12 Holter recordings Me limited in tlte 
amount of leads used and accessibility at the bedside 
for guidance of clinical care. Subsequently, a real-
time oriented, digital12-lead electracMdiograph was 
developed that makes continuous registration of the 
ST-segment deviation over time in all leads accessible 
at the bedside. Essentials of this ST monitor (STIDD, 
Moriara Instrument, Milwaukee, WI) have been pre-
viously published. 13• 14 Briefly, the ST monitor ac-
quires and digitizes a I 2-le<1d ECG every 20 seconds. 
The first acquired ECG is used as a reference for sub-
sequent comparison of ST-segment amplitudes mea-
sured 60 ms after the J point. If subsequent ECGs 
show a persistent change in ST -segment de\'iation 
over I minute more than a preset threshqld, nor-
mali}' 200 J1. V in a single lead or 100 J1. V in two leads, 
th~ violating ECG and an additional eight ECGs are 
stored over a 3-minutc episode. An audible alarm 
warning the clinician of (his ST change is optional. 
Trendlines of ST -segment deviation over lime and 
futl disclosure 12-lead ECGs on hard-copy arc imme-
diate1y available at the bedside. The last acquired 
ECG then serves .1S an updated reference ECG for ST-
segment comparison. In the absence of SoT-segment 
deviation changes an ECG is stored every 20 minutes 
by default. A similar device recording vectorcardio-
grams continuously has been developed in Sweden 
(Ortivus Medical Laboratories, Tab}') and is also 
col11mercl.111y available. 15 
Reports using continuous ST-segment monitoring 
have indicated that 25-50°/" ofpaticnts treated \\'ith 
intravenous (hrombol~'tic (herap}' show unstable ST-
segment recovery suggesting q'clic reperfusion of the 
infarct-rdated .utery. 1(.-1') A new method of ST -seg-
ment recovery analysis using updated reference 
ECGs over multiple "peaks" and "troughs" was 
therefore developed to allow patency assessments 
not only during the phase of stable ST-segment re-
covery, but also in real time during the unstable, 
earl~' phase prior 10 and immediately after initiation 
of thrombolytic trcatment. 20 Details of this algorithm 
have been previously described.21 During periods of 
increasing ST-segment elevation, the reference ECG 
is continuously updated to the BCG with the most 
ST-segment elevation. ST-segment recovery of 
~50% from this most abnormal or peak reference 
ECG is used to denne periods of reperfusion. During 
such periods of ST-segment recovery, the reference 
ECG is continuously updated to the ECG with the 
least 5T-segment elevation. Subsequent ST-segment 
reelevation of ~ 150 J1. V in two leads or ~200 J1. V in 
one lead, relative to this most normalized or trough 
reference ECG, is used (0 define periods of recurrent 
occlusion. Subsequent peaks and troughs arc used 
as continuously updated reference points over the 
entire 5T monitor recording. 
This method of continuously updated ST-segment 
recovery analysis was tested in the thrombolysis and 
angiopla~ty in myocardial infarction 7 (TlMI) trial 
against simultaneous angiography in 144 patients.n 
Of the patients with TIMI grade 3 flow, 94% showed 
ST-segment recovery by the time of angiography. 
This was reduced to 81 % in patients with TIMI grade 
2 flow. Fifty-seven percent of the palients with TlMI 
70 
pIIBIII.IIIIII 
30111111 ••• BII 601111111111111 
0011111111.1111 
Fig. 1. Serial 12-1ead ECGs [..-corded every 30 minutes from a patient presentin~ with all acute m\,ocarJiai infarction of 
Ihe anterior wall. ST-segment dcviatiom in the peak lead (Vl ) from conscC1ltive post-treatment ECGs afC compared with 
the fixed reference sr level of 5.8 mill Illea~ured In the prctrc<ltment ECG (P). At 30 and 60 minutes, ST re\'eI~ are 7.7 
and 6.6 lIun, respectively, and at those moments the infarct-related artery is cornidered to have rcmainetl (Kduded. At 
90 minutes, the ST level is 2.6 TIlm, a 65% recovery from the pretreatment rderence ST level, suggesting reperfusion. Fwm 
Kntcoff ct alY' With permission. 
grades 0-1 flow with collateral blood flow to the 
infarcted area showed ST-scgmenl recovery, while 
this was true for onl~' II % of patients without collat-
eral support. This spectrum suggests that ST-segmcnt 
recovery can give physiologic infomlation on suc-
cessful reperfusion of the infarct area that is more 
than just a surrogate for the somewhat controversial 
gold standard of angiographic patency. 
When assessments are performed during the more 
stable phase of ST-segment recovery, the method of 
continuously updated ST-segment recovery analysis 
appears to be as accurate as the methods comparing 
ST-segment deviation between a post-treatment ECG 
and a ft.xed, pretreatment reference ECG. As can be 
seen in Figures 1 and 2, the use of continuously up-
dated reference ECGs instead of a fixed, pretreatment 
reference ECG seems to give important additional in-
formation during the earlier phase after thrombolytic 
treatment when cyclic flow Is present.12 ·23 
Cumulative Parameters of 
ST-Segment Recovery: 
From Reperfuslon Physiology 
to Clinical Outcome? 
As previously descr'lbed,~ I continuously updated 
ST -segment recovery analysis allows cumulative as-
sessments over the early phase of treatment, prm'jd-
ing documenl,ltion of the speed and stability ofreper-
fusion for comparison hetween drug regimens. Speed 
of reperfusion is defined as the time from the onset 
of thrombolytic treatment to the !irsl e\'idence of 
SO°!" 5T -segment recovery from an updated, peak 
referCtlce ECG. Stability of reperfusion is rdlected in 
the number of reocclusion and reperfmion events 
over the course of the infarction. The patent physiol-
ogy index rclkcts the overall success of reperfusion 
therapy and is defined as the tolal duration of ST-
segment recovery intervals as a percent<lge of the 
monitoring peliod. Parameters of speed and stability 
of reperfusion are currently being used ill the ST 
monitoring substudy of the Global Utilization of 
Streptokinase and tPA for Occluded arteries 
(GUSTO) trial to elucidate differences in four differ-
ent thrombol~'tic regimens. The ongoing registration 
of the onset and stability ofreperfusion allows a llon-
vasivc triage to select patients with faited or unstable 
reperfusion for trials that test the value of more ag-
gressive secondary treatment strategies. 
More quantitative approaches in addition to the 
detection of patency of the inf,lrct artery or the dctt'r-
mination of speed and stability of reperfusion Me 
being sought. Serial precordial mapping studies pcr-
formed by Maroko and Braunw,lld's group in the 
19705 provided the first correlations between the se-
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-Fig. 2. Continuousl}' updatetl ST-segment recovery analysis in thl' 5Jmc patient ilS shown in Figure I. Trends of summated 
ST-segment deviation over time, at right, with markers indicating the timing of selet"ted ECGs, at left, as well as the updated 
reference peak or trough. The rderence 51' level is conHnuollSlr updated as ST-segment elevation of 5.8 mm in lead v) 
of the pretreatment ECG (P) gradually worsens to 7.5 mill by 6 minutes after the onset of therapy. From this reference 
peak, ST-segment recovery to 3.7 mm (or 50%) 27 minutes following the onset of therapy suggests reperfusion of the 
infarct-related artery. From this updated reference trough, rapid reelevation over 3 minutes to 7.7 mm in the same fingerprint 
pattern sugge~ts recurrent OCdL1Sioll, with progressive ST· segment elevation to the tme maximum peak of 18 mm elevation 
at thc pCilk 50 minutes after the onset of therapy. Using this latest pe.)k as an updated reference for further comparison, 
ST recovery of >50% occurs 10 minutes latd when the ST level Is 6.6 mm, suggesting that the infarct·related artery has 
.lgain become (Mtent. Thus, while the analysi~ using a static pretreatment reference ST level only detects the onset of 
reperfusion 90 minutes following the onset of therapy (Fig. I), the continuously updated 5T-segment recovery analysis 
method identific.:~ two reperfusioll episodes: the first one starting 27 minutes following the onset of therapy and the second 
one starting 60 minutes following the onset of t!tecilPY. From Krucoff 1.'1 alP With permission. 
verity and extent ofST-segment deviation with myo-
cardial mass at risk and clinical outcome.24 Barbash 
and co-workers correlated acute ST-scgment recov-
ery with the salvage ofm),ocardium and showed that 
acute ST-segment recovery was a strong predictor of 
favorable dinical uutcome. 25 The se\'erit~' of is-
chemia is generally determined as the amount of ST-
segment elevation seen on the acute ECG. Continu-
ous monitoring might improve the definition of the 
maximum amount of ischemia in patients with cyclic 
reperfmion in whom a single or few static ECGs \vere 
taken during periods of actual ST-segment recovery. 
The detection of the extent of the ischemic area re-
fleeted in the Humber of leads with ST-segment de-
viation could be similarl), improved. The integration 
of the d~'namics in the severity and extent {)fischemia 
over time as a time-severity index provide an exciting 
potential to elucidate the response to treatment as a 
relationship among infarct-related artery patenC)', 
the amount of myocardium salvaged, and clinical 
outcome. Developing such a model will require a 
thorough process of statistical modeling or neural 
network development that includes other routinely 
available noninvasive descriptors to yield a practical 
probabilistic, patient-specific, prediction of infarct 
outcome, 
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Overview 
Continuously updated ST-segmcm recovery anal-
~'sis in conjunction with frequent electrocardio-
graphic acquisition allows accurate, noninvasive as-
sessment of the perfusion status of the infarct aC('<1. 
ST-segment rc(overy strongly conelatcs with perfu-
sion either through the infarct artery or through col-
lateral blood supply_ Lack uf ST-segment recovery 
has consistently been correlated with failure to reper-
fuse the infarct-related artery or the more severely 
depressed left ventricular function.<i--12.1fd 8.]\I. 
21_23,25 Continuous registration of ST-scgment de-
viation allows the registration of the onset and stabil-
ity of [('perfusion, and thus, gives more informatiun 
than "snap-shot" assessments made with (oronary 
angiograph}'. Noninvasive identification of failed or 
unstable reperfusion using continuousl}' updated ST-
segment recovery analysis can be useful in trials lest-
ing the value of more aggressive sc('{)ndary revascu-
larization strategies for these selected subgroups. 
Continuous ST monitoring is applicable in Ihe ma-
jority of pnlients. It has not yet beell validated in 
patients with delayed ventricular condudion, bUI 
that comprises a small part of the populntion. More 
restricting is the requirement that initial ST -segment 
devintion relledive of coronary occlusion be present 
when ST monitoring is initiated. This is a common 
source of anatomic bias, favoring anterior auov(' infe-
rior infarctions and both above posterior infarctions. 
This also requires that 5T monitoring be initiated in 
an early phase, preferably before trealment. The 
availability of hard·copy ECGs recorded during coro-
na .. y occlusion can substitute missing 5T monitoring 
data in the early phase to assess patency, but this 
limits the detection of the onset and 5Iabilit\' ofreper-
fusion. Cornbinations of 5T monitoring with other 
noninvasive markers of reperfusion, such as enzyme 
measurements, need to be investigated.ll. 26-}(I 
While these markers do not provide a cumulative 
assessment of reperfusion status over time, they 
might improve the accuraq' of 5r monitoring. Thq' 
can substitute sr monitoring in patients where ST 
monitoring is not feasible due 10 the absence of an 
injury cUTrent Of the presence of confounding factors. 
In this era clinicians can choose from a wide thera-
peutic arsenal of intravenous and intrc1('oronary 
thrombolytic treatments-mechallical revasculari-
zation, emergency coronar~' bypass operation, anti-
coagulant and mlliplatelet therapy, perfusion and ox-
ygenation assist device~-and many additional 
forms of phamlacologic treatmcnts 10 modify the 
nalural course of AMI. However, the value of thcse 
strategies needs to be compared and should be opli-
mized for individual patients. An accurate noninva-
sive marker of reperfusion, stich as sr monitoring 
with the additional benefit of cumulative assess-
ments over time, ('an serve as a noninvasive tool. It 
is easy to apply and is a relatively inexpensive end-
point for comparative trials for AMI, ,1nd can en-
hance the understanding of the underl~'ing physi-
ology. 
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The Impact of Autoperfusion on 
Quantitative Electrocardiographic 
Parameters of Ischemia Severity, Extent, 
and "Burden" During Salvage of Elective 
Coronary Angioplasty 
Mitchell W. Krucofi, MD, Rolf F. Veldkamp, MD, Prapti M. Kanani, MD, 
Suzanne Crater, RN, Steven R. Sawchak, RN, Nancy M. Wildermann, BS, 
James R. Bengtson, MD, MPH, James E. Pope, MD, Michael H. Sketch, JI', MD, 
Harry R. Phillips, MD 
ABSTRACf: Long angioplasty Inflalions have been reporled using an autoperfuslon system 
that delivers oxygenated blood distal to the balloon segment. TI\e safely and efficacy of this sys-
tem has been demonstrated in anatomically selecled patients. The clinical usc, however, is (re-
quently to stabilize intimal dissection in "nselected patients. We reviewed 12-lead continuous 
electrocardiographic (ECG) recordings in 40 patients in whom prolonged salvage with auloper(u« 
sion was attempted. Sub-opti01al results wefe stabilized in 36 of 40, while 4 patienls had urgent 
bypass. The presence of ischemia, as ;;: 100 uV ST elevation over the 12 lead ECG, and the tolal 
ST deviation over all leads over the entire inflation perlod (tolal ischemic "bmden") were com~ 
pared within each patient between the longest standard balloon and auloperfusion inflations. 
Median dmation of inflation was 3.03 min. with balJoon vs. 15.6 min. with autoperfuslon (p < 
0.00002). Of the 40 patients, 35 (87%) had ECG ischemia with balloon vs. 18 (45%) with autoper~ 
fusion (P < .00002). Median severlty of peak ST deviation was 321 uV with balJoon vs. 132 uV 
wHh autoperfusion (p",O.OOOl). Median extent of ST elevation was 3 leads with balloon vs. 0 
leads with autoperfusion (p=O.oool). Median lolal ischemic burden was similar with balloon 
(1173 uVmin) and autopedusion (1083 uVmin, NS) despite Ihe fivefold longer inflation duration 
with autoperfusion. 11ms, in patienls selected by dinicalnecessily rather Ulan optimal anatoD1Y, 
severlty and exlent of ST elevation were significantly reduced, although not entirely eliminated, 
byautoperfuslon. 
J INVAS CARDIOL 1994;6:234-240 
Key words: coronary angioplasty, myocardial ischemia, ST-segment 
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Prolonged balloon inflations are widely used 
to stabilize intimal dissection and avoid urgent 
bypass surgery when shorter balloon inflations 
produce sub-optimal angioplasty results,l-s 
While brief interruption of coronary flow is gen-
eraHy well tolerated, ischemia from longer bal~ 
loon inflations may be complicated by severe 
chest pain, hypotension, or arrhythmias from the 
resultant metabolic perturbation of myocyte 
metabolism,6.7 
Autoperiusion of the myocardium distal to the 
dilatation site has been described using a balloon 
catheter (Stack Perfusion Balloon Catheter™, 
Advanced Cardiovascular Systems, Inc" Santa 
Clara, California) with side holes cut through to 
the center lumen proximal and distal to the bal-
loon segment.8-14 When the guidewire is with~ 
drawn, the difference between mean arterial 
blood pressure and mean coronalY wedge pres~ 
sure drives oxygenated red blood cells into the 
center lumen, exiting distal to the inflated bal-
loon, perfusing the myocardium at approximate-
ly 60 cc/min. The safety and efficacy of autoper~ 
fusion with this device has been described in 
selected patients.8--14 TIle impact of autoperfusion 
on ischemia in an unselected population in whom 
the autoperfusion balloon is used clinically to sal-
vage sub--optimal angioplasty results has never 
been quantified, 
Continuous multi-lead ST segment monitoring 
provides a comprehensive electrocardiographic 
record for the objective quantification of ischemia 
during transient coronary occlusion,IS-17 From a 
database of elective angioplasty patients under~ 
going ST -segment monitoring, electrocardio-
graphic parameters of ischemia were reviewed in 
all patients in whom autoperfusion was secon~ 
darily used to improve a sub--optimal angioplasty 
result following dilatation with a standard bal~ 
loon catheter. With ea·ch patient serving as their 
own control, parameters of ST -segment deviation 
were compared between periods of standard bal~ 
loon occlusion and auto perfusion at the same 
coronary artery site to quantitatively assess the 
impact of autoperfusion on procedural ischemia. 
METHODS 
Patient Population. All patients were referred 
for elective angioplasty based on routine clinical 
indications in our institution, The patients includ-
ed in this study were retrospectively identified 
from the Ischemia Monitoring Laboratory data~ 
base. Patients in the Ischemia Monitoring 
laboratory database represent an unselected sub-
set of our total elective interventional population, 
up to the limits of the ST -monitoring equipment 
available. Patient selection criteria for this study 
included all of the following: complete 12-lead 
ST monitor data from the angioplasty procedure; 
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normal conduction on baseline electrocardiogram 
(ECG); standard balloon selected primarilYi iden-
tical lesion also dilated with an autoperfusion bal-
loon for "salvage" during the same procedure, 
Angioplasty. All patients were premedicated 
with 325 mg aspirin and 1O,OOO~12,OOO units of 
intravenous heparin prior to the start of the pro~ 
cedure. Angioplasty equipment selection, includ~ 
ing the use of autoperfusion, and the duration of 
balloon inflations were solely at the discretion of 
the operators clinical judgement. In all patients, 
autoperfusion was accomplished with the Stack 
Perfusion Balloon Catheter. Angiographic Jlsuc~ 
cess" was defined as a final luminal stenosis that 
was both a >20% reduction of the pre-angioplas~ 
Iy lesion and a final lum.inal narrowing of .s50% 
based on visual consensus assessment between 2 
or more operators. 
ST -segment monitoring. All patients were 
monitored with a digital 12-lead electrocardio-
graphic monitor (Mortara ST~100 Monitor, 
Morlam Instrument, Milwaukee, WI) as has been 
described previously in detail.ls-19 In summary, 
this device acqUires a standard digital 12-lead 
ECG every 17~20 seconds. All BCG data are 
downloaded to a PC computer for retrospective 
analysis lIsing custom written software.1U5 Full 
disclosure, superimposition scanning of all ECG's 
and 3-dimensional graphic display of ST -seg-
ment levels, measured 60 milliseconds beyond 
the J-point, across the precordium trended over 
time (Figure 1) were used for scanning of all 
patient studies. 
Catheterization laboratory clock times and 
diary sheets indicating periods of balloon infla~ 
tion and deflation as well as device used are syn~ 
c1uonized routinely with the digital clock times of 
the ST -segment monitors for the Ischemia 
Monitoring Laboratory database. From these syn-
chronized periods, the longest standard and 
longest autoperfusion balloon inflation periods 
were identified within each patient for further 
quantitative analysis and comparison. In all cases, 
inflations were compared only for angiographi~ 
cally identical coronary site occlusions by both 
the standard and the autoperfusion balloons. 
From each srody, three ECGs of interest were 
identified as part of the quantitative analysis: the 
pre-procedure baseline; the pre-deflation of max~ 
imaHy abnormal ECG during the longest stan~ 
dard ballon inflation (peak PTCA)i and the 
pre--deflation or maXimally abnormal ECG dur~ 
ing the longest auto perfusion inflation (peak 
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PBC). Identification of all "peak" deviation EeGs 
and all measurements of deviation were taken as 
relative to, or the "delta" from each patient's own 
baseline ST levels for each of the 12 leads. 
Electrocardiographic parameters of ischemia 
were quantified by comparing the amount of 
change between the baseline and peak PTCA 
EeG to the amount of change between the base-
line and the peak PBC EeG. Electrocardiographic 
"ischemia" was defined as ~lOO uV of new ST ele-
vation in at least 1 lead. Three electrocardio-
graphic parameters were retrospectively ana-
lyzed, as summarized in Figure 2, "Severity" of 
ischemia was defined by the peak amplitude of 
ST deviation in the most deviated single lead out 
of the standard 12-1eads. "Extent" of ischemia 
was taken as the total number of leads over the 
precordium showing ::!:100 uV of new ST -segment 
elevation. "Total ischemic burden" was taken as 
the total summated absolute ST -segment devia-
tion over all 12 leads over the entire duration of 
each balloon inflation (calculated as the area 
" 
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under the trend of 12-lead ST deviation from 
baseline over time). In each case, these ECG para-
meters were examined as changes only relative to 
other ECG measurements with each patient serv-
ing as their own control. No attempts were made 
to relate the severity, extent, or total "burden" 
parameters of ischemicaHy Inediated quantitative 
ECG changes to myocardial mass or any 
nOll-ECG measme. 
Statistical analysis. All analyses were per-
fOlTIled on the change in the ECG measmes from 
the standard balloon inflation to the autoperfusion 
inflation with each patient serving as their own 
conh·ol. A Wilcoxon signed rank test was used for 
"severity," "extent," and "burden" to evaluate 
'\vhether or not these changes were significantly 
different from zero. McNemar's test was used to 
test for agreement in occurrence of ischemia 
between the two dilatation methods. All continu-
ous variables are presented as medians and quar-
tile ranges (25th-75th percentiles). All categorical 
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Figure 1. FOllr spatial rotatiolls of graphic depiction of ST segmellt level (Y--(lxis, or "severity") for each of the 12 
feads monitored (X-axis, or "ex/et//") COlltillllOlISly oller 5 hours lime (Z--(1xis) in a patiellt duril/g stalldard balloon 
(PTCA) illflations al/d thell mtfol'erfllsioll (PBe) illflation to salvage LAD allgioplasty threa/elled hy tll/stahle il/ti-
mal dissection. Five bal/ooll inflations (PTCA 1-5) rangillg serially from 1.5 fo 5 millllfes produced 5-11 millimeter 
ST elel/atio" hilt did Hot stabilize dissectio1l. A 30 mil/lite autoperfllsiOlI illflatioll (PBC) was tolerated wilh little 
ischemic ST deviation, alld produwi a staNe filial result. 
valiables are presented as mmlber of patients with 
the event or characteristic. For the munber of tests 
rull on this small population, the p-value consid-
ered significant was adjusted to s 0.0125. 
RESULTS 
A total of 40 patients meeting all criteria were 
identified from our database. Patient characteris-
tics are shown in Table 1. In all cases the operator 
switched from a standard balloon system to a 
perfusion balloon system to salvage a sub--opti-
mal result or an unstable intimal dissection. In 36 
of the 40 patients a successful end result was 
achieved, while in 4 patients urgent coronary 
bypass grafting was subsequently performed. In 
all 4 of these patients the deflated perfusion bal-
loon was left across the stenosis en route to the 
operating room. 
Ischemic ST elevation in at least 1 lead 
occurred in 35 of the 40 patients (87%) during 
standard balloon inflation. During autoperfusion 
only 18 of the 40 (45%) had ischemic ST elevation 
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(p < 0.00002). The median duration of the longest 
balloon inflation was 3.0 minutes (1.6, 4.0 min-
utes) for standard angioplasty and 15.6 minutes 
(15.0, 23.0 minutes) for autoperfusion (p < 
0,00002), 
Electrocardiographic parameters of ischemia 
with and without autoperfusion are shown in 
Figure 3. The median severity,of ST deviation 
during angioplasty was 321 uV (188,468 uV), 
compared to 132 uV (70,183 uV) during autoper-
fusion (p < 0.0001). The range of peak ST devia-
tion from baseline was 42-1837 uV during angio-
plasty and 28-568 uV during autoperfusion. The 
median EeG extent of ischemia as number of 
leads showing> 100 uV deviation from baseline 
during standard balloon inflation was 3.0 leads 
(3.0,6.0 leads), compared to 0 leads (0.0, 3.0 leads) 
during autoperfusion (p<O.OOOl). The range of 
leads deviated was 0-7 for both. The median total 
"burden" of ischemia during the longest standard 
balloon inflation was 1173 uVmin (698-1683 
uVmin), compared to 1083 uVmin (560, 1360 
uVmin) during the longest autoperfusion dilata-
~I'" I,; : : :: "'+!-'-i-i.:m::;;'~;i~;:"";: ' PTCA: 4 min ::' : ," :':' 1I"::::'m~.q::I4P 1 , II I. ,I, " 1 , . 1 1 1 , , Figure 2. Allaloglle ECGs alld tl trend of 12-1ead summated ST deviatioll over 
time, from the case 
described ill Figure 1. 
ECG "A" shows 11 
millimeter (mterolat-
eral ST elel/alioll 
dllrillg stalldard bal-
10011 illflation. While 
isclJemia over the 30 
minute atlloperfllsion 
illflntioll is visible ill 
the sUIIHlwfed trelld, 
ECG "B" shows ollly 
diffuse ST depression 
after 24 mil/lites. 
SUMMATED 
STTREND-----.--~~--,,--------.-----
PBC: 24 min r-"_'~'_Ho+l+c~_'"F+f1_";,!-:H-'.~."\tfti.I''''' : -I , "I ,,~ " • I ,I , • I.
; ' 1 1 
. I~ ":'1" 
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Table 1. Baseline Chamcteristics 
DESCRIPTOR Number (%) (25th, 75th Percentile) 
59 (53,66) Age (years) 
Male Sex 
Vessel disease: 
28 (68) 
1 vessel 
2 vessel 
3 vessel 
17 (43) 
14 (35) 
9 (22) 
Artery dilated: 
LAD 
Circumflex 
Right 
17 (43) 
7 (17) 
16 (40) 
Stenosis: 
95 
25 
(75, 95) 
(15,38) 
pre-PTCA 
post-PTCA 
Dissection post-PTCA 
Successful post-PICA 
Complications: 
27 (67) 
37 (93) 
None 
Urgent bypass 
Death 
36 (90) 
4 (10) 
o 
lion (NS). The range of ischemic burden was from 
181 to 4,581 uVmin during standard angioplasty 
compared to 110 10 6561 uVmin during autoper-
fusion. As defined, ischemic burden included the 
entire duration of the longest dilatation, and so 
was acquired over a fivefold longer period for the 
auto perfusion inflations compared to the longest 
standard balloon inflations. 
DISCUSSION 
Elective selection of patients for long autoper-
fusion dilatations has focused on more proximal, 
focal sites not contiguous with large side branch-
es8-14, and the safety and efficacy of autoperfusion 
in such patients is well demonstrated.S-14 In clini-
cal application, however, the autoperfusion sys-
tem is generally used to salvage unstable angio-
plasty results. In many such patients, standard 
balloons are initially selected due to some 
anatomic constellation that is considered relative-
ly unfavorable either for the delivery of or for the 
function of the autoperfusion system. Our 
patients were further subselected by the change 
of the elective procedure to a "salvage" situation, 
as indicated by the median standard balloon 
inflation duration of around 3 minutes and the 
10% acute bypass surgery incidence even with 
the use of auto perfusion. While this "salvage" 
application represents the most common clinical 
use of the device, to our knowledge there was no 
data in the literature showing that autoperfusion 
actually reduced ischemia when used with clini-
cal urgency. 
Using each patient as their own control, our 
data show that using autoperfusion a five-fold 
increase in the inflation time for salvage of the 
dilatation site was obtained with a reduction in 
most quantitative BeG parameters of ischemia, 
including a trend towards reduction of the total 
ischemic "burden" of EeG deviation despite this 
prolongation of the inflation time. In 45% of 
patients there was no detectable ST elevation 
across the 12-lead EeG during autoperfusion. In 
most patients, however, some ischemic EeG 
changes did occur. Total ischemic burden accrued 
over 15 minutes of inflation using autoperfusion 
was similar to that which accrued over 3 minutes 
with standard balloon inflation. 
There are several noteworthy limitations to our 
data. As a retrospective analysis taken from the 
Ischemia Monitoring Laboratory database, more 
precise or prospective information on why a stan-
dard balloon was initially selected by each opera-
tor is not available. In addition, not all autoperfu-
sion salvage cases were recorded with 12~lead 
EeG monitors, hence these 40 patients represent 
only a subset of our total dinical''bailout'' use of 
autoperfusion. EeG parameters of ischemia 
"extent," "severity" and total "burden" in this 
study are not correlated with ventricular dysfunc-
tion, myocardial mass or any nOll-BeG measures. 
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Finally, it has been observed in some patients that 
multiple conventional balloon inflations may 
cause "fading" of ischemia onset or precondition-
ing of the myocardiuml6 and in all of our cases 
the autoperhlsion inflations were subsequent to 
the standard balloon inflations. Despite these lim-
itations, however, it can be pointed out that these 
cases evolved with the truly unpredictable nature 
of the real world practice of angioplasty, within a 
population undergoing ST -segment monitoring 
with no discrete bias as to case selection other 
than a standard balloon was selected initially. 
Our 40 cases represent 100% of the relevant cases 
in our data base. TIle ECG parameters, although 
not referenced per se to a non-ECG measure, 
were all analyzed using each patient as their own 
control, and so represent a fairly robust means of 
detecting anti-ischemic effects, as demonstrated 
by the statistical power of the observations 
despite the relatively small number of patients 
overall and the adjusted significance level used 
for p values. Finally, while preconditioning 
effects are measurable in human patients, the 
ability to achieve a five--fold increase in dilatation 
time with reduction in all quantitative ECG para-
meters is, in our opinion, unequivocal objective 
evidence of nutritive blood flow through the 
autoperfusion system in tltis setting. 
"Severity" of ischemia concephtally reflects the 
progress from reversible to irreversible cellular 
injury inflicted by continued metabolic demand 
in an oxygen deprived environment.2o Over this 
spectrum, more complete or more prolonged 
interruption of blood flow results in a more rapid 
and complete inability to actively maintain 
trans-membrane ionic gradients, resulting in 
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focal potassium leakage reflected electrocardio-
graphically by progressive amplitude of ST eleva-
tion. In Figure 1, standard balloon inflations in 
the same patient at the same coronary site pro-
duce from 5 millimeters ST elevation during a 2 
minute inflation to 10.7 millimeters elevation dur-
ing a 5 minute inflation. TIle marked reduction of 
peak ST segment deviation and the elimination of 
any ST elevation during a 30 minute inflation 
with autoperfusion most likely reflects the ability 
of the device to deliver metabolically nutritive 
blood flow to the distal myocardium even in this 
semi-urgent application. 
More "extensive" ischemia conceptually 
reflects the geographic mass of myocardium 
insulted, either by a more proximal stenosis, a 
stenosis in a larger artery, or in a setting where 
multiple territories might be simultaneously 
affected. More extensive ischemia as electrocar-
diographically demonstrated by more wide-
spread lead activity over the precordium has 
been associated with greater left ventricular dys-
function during coronary occlusion.21 The 
marked impact of autoperfusion in our patients 
in reducing the number of leads with ST eleva-
tion is particularly interesting since occlusion of 
an important side branch by the perfusion bal-
loon segment would still be likely to pmduce ST 
elevation somewhere on a 12-lead BCG. The 
median number of Jeads showing ST elevation 
during autoperfusion was zero in our patients, 
suggesting that adequate positioning was achiev-
able in most patients despite the fact that initial 
decisions to use standard balloons Illay have 
reflected anatomic concerns about side branches. 
Total "burden" of ischemia conceptually inte-
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grates the severity and extent of the metabolic 
derangement as accumulated over time. The clini-
calor intuitive appreciation of the impact of 
autoperfusion on this parameter is reflected by 
the clinical operator decisions leading to the 
five-fold longer inflation times during auloperfu-
sian. Objectively, the ability to prolong inflation 
time without increasing the electrocardiographic 
ischemic burden supports the ability to mechani-
cally stabilize dissected coronary intima using 
longer dilatation times. It is equally noteworthy, 
however, that wIllie ischemia was reduced to the 
p'oint of improved tolerance, it was not entirely 
eliminated. 
The perfusion balloon catheter continues to 
evolve as a flexible tool for angioplasty. 
Considerable data has shown that the perfusion 
balloon catheter provides excellent procedural 
tolerance in selected patient populations.8-14 In 
addition, our data show evidence of the metabol-
ic effectiveness of this device in the semi-urgent 
salvage of angioplasty procedures, as is common 
to the clinical use of the device. The longer dilata-
tions used to stabilize such intimal dissections 
were accompanied by significant reduction in 
quantitative electrocardiographic parameters of 
ischemia even in this population whose anatomy 
was initially considered potentially unfavorable 
for autoperfusion. 
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Comparison of Continuous STwSegment Recovery 
Analysis with Methods Using Static 
Electrocardiograms for Noninvasive Patency 
Assessment During Acute Myocardial Infarction 
Rolf F. Veldkamp, MD, Cindy L. Green, MSc, Michelle L. Wilkins, James E. Pope, MD, 
Sharon T. Sawchak, RN, Jill A. Ryan, RN, Robert M. Califf, MD, Galen S. Wagner, MD, 
and Mitchell W. Krucoff, MD, for the Thrombolysis and Angioplasty in Myocardial 
Infarction (TAMI) 7 Study Group 
Continuous ST-segntent recovery analysis and 6 
static mothods using ST-ssgJnent comparison be-
tween a pre- and post-treatment electrocardio-
gram were compared for their abUtty to predict 
Infarct-rolated artery patency In 82 patients with 
acute Inyocardial Infarction who underwont an-
giography a median of 124 minutes after onset 
of thrombolytic treatment. Accuracy at the mo--
ment of angiography was 85% (95% confidence 
Interval [el] 77% to 93%) for the continuous 
method, and 68% (el 6'1% to 78%), 78% (el 69% 
to 87%), 83% (el 74% to 91%), 82% (el 73% to 
90%), and 80% (el 71% to 89%) for the static 
m&thods. At the moment of angiography the 
most accurato static method and the continuous 
mothod agreed In patency assessment In 90% of 
the patients (el 84% to 97%). Agreement was re-
duced to 83% eCi 76% to 91%) of patients whon 
8 patency assessment was performed earlier at 
90 minutes after treatment onset, and was only 
77% (el 68% to 86%), at 60 minutes. Earty dis-
agreement was mainly seen when tho cont'nu~ 
oos ST recording showed ST recovery from a de-
layed peak ST elevation after the pretreatment 
static electrocardiogram Of when dynamIc Sf 
changos suggesting cyclic reperfuslon occurred. 
Continuous ST-segment recovery analyBls ap-
pears to be a8 accurate as tho most accurate 
static methods. Continuously updated reference 
points appear to give Important additional Infor-
mation when ST recovery followa a delayed peak 
ST elevation Of when reelev8tlon occurs, sug-
gesting cyclic flow changes. Such findings ap-
pear to affect about half of patients with acute 
myocardial Infarction treated with Intravenous 
thrombolysis, particularly early after administra-
tion of therapy. 
(Am J CardloI1994,73:106!l-1074) 
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Patients with acute myocardial infarction in whom coronary patency is not restored after intravenous thrombolytic therapy may benefit from additional 
phannacologic or mechanicaltherapy.l-IO Because it is 
not feasible to subject all patients to acute coronary an-
giography. an accurate noninvasive patency assessment 
method is desirable. Several methods using assessment 
of ST -segment recovery between a single pretreatment 
electrocardiogram and ~l static post-treatment electro-
cardiogram have been correlated with infarct-related 
artery patency. U-15 However, only I study included si-
multaneous electrocardiographic and angiographic as-
sessments. More recently, continuously updated ST-seg-
ment recovery analysis for real-time noninvasive patency 
assessment has been reported using digilai ST moni-
torS. I6-IS It uses a continuous streanl of l2-lead electro-
cardiograms, recognizing true maximal and minimal ST 
deviations as they occur rather than making assessments 
at static intervals.J6---20 TIle added demand for a dedicated 
ST monitor and use of a more complex algorithm must 
be weighed against simpler static methods. This retro-
spectiye study assessed such differences in a single pop-
ulation of patients with acute myocardial infarction. in-
cluding those difrerences at the moment of sinmltaneous 
angiography. 
METHODS 
Patient population: One hundred forty-four patients 
from the TIlTombolysis and Angioplasty in Myocardial 
Infarction (TAM!) 7 trial with ST monitoring and acute 
coronary angiography as previously described l8•2J were 
considered for this study. Briefly, patients presenting 
within 6 hours after symptom onset, wilhout contra-
indications for tllTombolytic therapy, and able to give in-
fomled consent were eligible. Enrollment in the TAM! 
7 trial required ST elevations of ~ 100 f.L V measured 0.02 
second after the J point in (I) 2 inferior leads. (2) 2 pre-
cordial leads. (3) leads I and aVL, or (4) ST depression 
of the precordial leads consistent with posterior infarc-
tion. Patients were not enrolled if they had evidence of 
a previous Q-wave infarction in the same area of ST el-
evation. Patients received "front-loaded" reginlens ofre-
combinant tissue-type plasminogen activator and acute 
catheterization per the TAMI 7 protoco1.21 TIlirty-four 
patients whose ST monitoring was initiated >30 minutes 
after onset of thrombolytic treatment were excluded from 
this study. In addition, 10 patients were excluded because 
a pretreatment electrocardiogram was missing, and 18 
more were excluded whose ST monitoring was inter-
rupted or confounded by noise or transient conduction 
abnonnalities for >30 minutes before catheterization. 
TIlUS, oflhe 144 patients with angiography and ST-seg-
ment monitoring in the TA1v1I 7 trial, all 82 who could 
be analyzed for the purposes of tills study were included. 
Anglography: Angiograms were analyzed at the core 
angiographic laboratory at the University of Michigan, 
where investigators were unaware of all electrocardio-
graphic data after onset of therapy. As described previ-
ously,l& angiographic patency was evaluated at the fint 
contrast injection of the infarct-related artery. TIle 
TIuombolysis in Myocardial Infarction (TIMI) trial flow 
o to I was taken as occluded and TlMI flow 2 10 3 as 
patent. Collateral flow was nol considered. 
ST montiorlng: All patients were connected to the 
digital 12-iead ST monitor previously described. 16 All 
eiectrocardiogranls recorded with the ST monitor were 
transferred to a floppy disk for later analysis. An ST mon-
"v 
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itor electrocardiogram simultaneous to the first contrast 
injection of the infarct-related artery was printed out for 
the static electrocardiographic comparisons. 
ST-montioring analysis: Continuously updaled ST-
segment recovery analysis, the specific criteria and abil-
ity t~ predict infarct-related artery patency have been de-
scribed in detail. 11•1& In contrast to static methods, during 
periods of ST-segment worsening, the reference elec-
trocardiogram is continuously updated to the electrocar-
diogram with the most ST elevation. ST recovery of 
::::50% from this most ST-elevated electrocardiogram is 
used to define periods of reperfusion. During such peri-
ods of ST recovery, the reference electrocardiogram is 
continuously updated to the electrocardiogram with the 
least ST elevation. Subsequent ST reelevation of ::::150 
11. V in 2 leads or ::::200 J.t V in 1 lead relative to tltis most 
ST-normalized electrocardiogram is used to define peri-
ods of recurrent occlusion. Subsequent points of maxi-
mal or minimal ST deviation arc used as continuously 
updated reference points over the entire recording. Time 
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FIGURE 1. FIve different 
patterns of SY tooover)' 
are Identified on the con-
tinuous recordings before 
angiography: (1) continu-
Ing Sf elevation, (2) 6T re-
cover)' without reolev& 
tlOll, (3) ST recovery after 
a detayed peak (Increali0d 
Sf elevation after the pr& 
treatment electrocardio-
gram ~Ii%), (4) SY recov-
ery followed by ~ Sf 
reelevatlon eptsode, and 
(6) ST recovery after a de-
layed peak and followed 
by 21 reelevatlon episode. 
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TABLE I Description of Each of the Sialic Electrocardiogram Recovel)' AnalysIs Methods· 
SToRed. TIm, 
Method Author Leads 1/1 Measured (%) (min) 
, von Essen ll 1,11, III t and 1 J + 60ms >55 60 
II Hoggl2 Worst lead 1 J point >50 180 
"' 
Saran 13 Worst lead 1 J point >25 180 
IV Had,worthyl4 12 leads 1 J+40ms >40 60,120 
V Clemmensen15 11 leads 1 J point >20 90 
m~~~~ ~n~~i~;~~~t~~'7~n;:i)~!Jr~~"~er,tt~df~:~ta~o~~'t~'~nn~t t~n~i~!~tnt~~t1:~~f~?~ 
mOf~n~~ !\'e~,~~~';'l a~~~~,s;on 
R~d, = !'\'duction 
TABLE" Occlusion Detection Rate, Patency Detection Rate, 
and Accuracy for Each of the Stalic Methods (I to V) and for the 
CQntinuous Melhod* 
Sensiti~ity Specificity Accuracy 
Method (%) (%) (%) Indel. 
, 71 (52-gIl 66 (53-79) 68 (57-78) 8 (10%) 
II 63 (43--82) 84 (75--94) 78 (69-87) 1(1%) 
"' 
58 (39-78) 93 (86-100) 83 (74-91) 1 (1%) 
'V 60 (41-79) 93 (86--100) 8203-90) 
V 48 (27-68) 93 (86--100) 80 (71-89) 2(2%) 
Continuous 64 (45--83) 93 (86--100) 85 (77-93) 
'TM ~vroo, oj l~determi"3te predictions that Wl1nl ewludal from tft<! denominator 
in e",h of the statiC methods are ~,~n in the fa' right coi"mn 
Ind,L = indiltermlnate pnldlct,o~S. 
from onset of thrombolytic therapy to !irst evidence of 
patency, the number of recurrent occlusions before an-
giography, and time to stable patency were recorded for 
each patient. Patency was considered slable if from Ihat 
moment onward no recurrent occlusions occurred before 
angiography. Patients were then classified into 1 of 5 pat-
terns of ST recovery (Figure J), similar to those de-
scribed by DeUborg et al.20 
static electrocardiogram methodology: AU 5 pub-
lished methods comparing static pre- and post-treatment 
electrocardiograms to predict infarct-related artery pa-
tency were selected for their ability to reproduce the 
method with available electrocardiograms.1l- 15 Table I 
summarizes their essential features. Reported accuracies 
of these methods have previously been published.22 
Hard-copy electrocardiograms before therapy and at the 
moment of angiography were hand-measured as speci-
fied by each published method by an experienced tech-
nician unaware of all other data. Predictions of "patent" 
or "occluded" were detennined for each patient using 
the threshold for ST recovery of each method. An "in-
detemlinate" prediction was given if a method could not 
be applied owing to absence of the required ST devia-
lion in the leads specified for measurement. 
Data analysis: The ability to predict the angio-
graphic status correctly was described as sensitivity, 
specificity, and accuracy. Sensitivity was defined as the 
number of patients correctly predicted as "occluded" as 
a percentage of the total number of patients with an an-
giographically occluded infarct-related artery. Speci-
ficity was defined as the number of patients correctly pre-
dicted as "patent" as a percentage of the total number of 
patients with an angiographicaHy patent infarct-related 
TABLE III Number of Disagreements In Patency Assessments 
Between the Continuous Method and Static Method IV LIsted 
According to Source of Disagreement and In Which ST-Recovery 
Pattern Group They Occur 
Minutes 
Disagreem€nt 
Source Pattem 60 90 Angiography 
Dela,'oo pea~ 3,5 14 10 4 
Reei€vation 4,5 I I 0 
Threshold 1,2 4 3 4 
No disagreement (%) 63 {77} 68 (al) 74 (90) 
(68--86) (75-91) (84-97) 
'Pen:entilges of the total popu'at;.;.r, ac,oj 95% {ornMnc~ l'm;15 are given oot ... een 
t.tao,ets.Se~ /tcdlo, e.>:plaoa\jQn 
artery. Accuracy of a patency assessment method was 
defined as the overall number of correct predictions as 
a percentage of the study population. Patients whose pre-
dictions were "indeterminate" owing to inapplicability 
of a static method were excluded from the denominator 
of that method. To determine the likelihood of interpre-
tative dilJerences over the course of early patient man-
agement. assessments of the continuous method and the 
most accurate slatic method at angiography were also 
compared at 60 and 90 minutes after onset of treatment. 
Disagreements were related to the overall ST recovery 
pattem registered with the ST monitor. 
RESULTS 
Eighty-two patients were included in this study, of 
whom 82% were men, with a median age of 56 years 
(quartile range 47 to 66). Age and gender distribution 
were not significantly different from the TAM! 7 patients 
not included in this study. Thrombolytic treatment was 
initiated a median of 156 minutes (quartile range 114 to 
235) after symptom onset. First injection of contrast in 
the infarct-related artery occurred a median of 124 min-
utes (quartile range 93 to 163; range 20 to 336) after on-
set of thrombolytic therapy. The infarct-related artery 
was the left anterior descending in 37 patients (45%), 
left circumflex in 11 (13%), and right coronary artery in 
34 (42%). Multivessel disease was seen in 41% of the 
patients. TIMI flow was grade 0 to I in 25 patients (30%), 
grade 2 in 13 patients (16%), and grade 3 in 44 patients 
(54%), 
Sensitivity, specificity, and accuracy with which each 
method predicted infarct-related artery patency is listed 
in Table II. Method I considered limb leads only, and so 
was indetenninate in 8 patients (10%) with isolated an-
terior ST deviation. In 3 other static methods, 1 or 2 pu~ 
tients were excluded as indetemlinute because they only 
hud ST depression, although the methods specified ST 
elevation. Ninety-five percent confidence intervals were 
wide, but sensitivity, specificity, and accuracy of the con-
tinuous method seemed equal to those of static methods 
II 10 V. 
The frequency with which each of the 5 patterns of 
ST recovery occurred in this population is shown in Fig-
ure 2. Timing of ST evidence of patency, recurrent oc-
clusions, and stable patency were highly variable and 
did not correlate with any suggested static assessment 
pattern 3 16% 
(7·22%) 
~v 
900 
TTX 
I 
600 -t.-} 4""0"'%-' 
300 
paltern 4 18% 
(10·26%) 
60' 
1 
p 
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moment. Median time to first reperfusion was 40 min-
utes, ranging from 39 minutes before to 136 minutes af-
ter onset of thrombolytic treatment. At least 1 recurrent 
occlusion was seen in 32 patients, with a median of 1 
and a maximum of 8 recurrent occlusion(s). Stable reper-
fusion was seen a median of 97 minutes (range 50 to 
204) after onset of thrombolytic therapy. 
The most accurate slatic method IV was compared 
with the continuous method at 60 and 90 minutes after 
onset of thrombolytic therapy in addition to the moment 
of angiography a median of2 hours after onset of throm-
bolytic therapy. Table ill shows the frequency of dis-
agreement at each assessment time relative to the over-
pattern 6 21% 
(12·30%) 
FIGURE 2. Occurrenco of ST recov-
ery patterns as (1) continuing ST 
elevation, (2) ST recovery without 
reelevatlon, (3) ST recovery after 
o delayed peak, (4) Sf recovery 
followed by ;d ST reelevatlon 
episode, and (6) ST recovery after 
a delayed peak and followed by ;d 
reelevatlon oplsode. The percent· 
age of tho study popula1lon In 
each group Is given, with the 95% 
confidence limits In parenthesos. 
90' ANGlO 
1 1 
OL-__________________ ~----------------------~ 
2 hours 
continuous method , 
static method IV 
FIGURE 3. ST-segment deviation over time recorded In lead V2 In 8 patient with a delayed peak (pattern 3). When 
the continuous method Identified 60% ST recovery from 0 delayed peak (P) and ossessed the Infarct artery all 
patent, tho ataUc method predicted an oecluded Infarctofolated artery, because of <40% ST Utcovery from tho pre-
treatment electroeardlogram referenco ST level {dashed line}. Further Sf recovery progressed below tho static 
method threshold 13 mlnutos later, loOOlng to concordance In assestmlent from that moment onward. ThUD, al-
though the continuous method and static method IV disagree In patency assessment at 60 mlnutos after onset of 
thrombolytiC therapy (TTX), they agree 90 minutes and at the moment of angiography almost 2 hours after onset 
of treatment. The 4 venlcel snows Indicate timing of the following: onset of thrombolytic therapy (nX), patency 
a&sessments performed at 60 minutes (GO') and 90 mlnutos (90') aft~r onset of treatment, and the moment of an-
giography {ANGlO}. The 2 horlzonfal atrows Indicate the time during which tho continuous method or static method 
IV would 88$&SS the Infarct-related artery os patent. Angiography revealed Thrombolyala In Myocardial Infarction 
trial grade 3 flow through a proximal left anterior descending artery lealon. 
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all pattern of 81' recovery. Disagreement in patency as-
sessment was more common earlier after thrombolytic 
therapy and was most often related to ongoing dynamic 
behavior in 81' recovery (patterns 3, 4 or 5), 
DISCUSSION 
A method of continuously updated 81' -segment re-
covery analysis was developed using identification of 
true maximal and minimal 81' deviation as they occur 
to allow real-time noninvasive patency assessment of the 
infarct-related artery.I6-18 TIle added computational de-
mands and need for a dedicated 81' monitor must be 
weighed against simpler methods comparing static pre-
and post-treatment electrocardiograms. TIlcse data sug-
gest that static methods may undersample during dy-
namic periods early in acule myocardial infarction and 
therefore miss important additional infonnation regard-
ing ST recovery or reelevation, Relative concordance 
between the continuous method and 4 of the 5 static 
methods was seen when compared with simultaneous 
angiography a median of 2 hours after onset of throm-
bolytic treatment. Population size restricted detection of 
modest differences (type II error), Disagreements early 
after therapy were mainly seen after a delayed peak ST 
level (Figure 3), At least 5 patterns of ST recovery could 
be characterized, similar to descriptions by Dellborg et 
al.20 One cannot predict in advance which pattern a pa-
tient will follow early after thrombolytic treatment. It is 
our supposition that often the liming of monitoring on-
set relative to the onset of infarction defines these pat-
terns. When cyclic flow is present, varying onset of ST 
monitoring may result in pattern changes. Other reasons 
for these dynamic patterns could be the effect of coJlat-
erals,23--26 or worsening of ischemia due to reperfusion 
injury.21 Whereas these data do not further clarify un-
derlying mechanisms, the frequency of these patterns is 
notable. In additioll, precisely which patients may evi-
dence which pattern, and when ST recovery or recurrent 
elevation are likely to occur arc also highly unpre-
dictable. Definition of the ST recovery pattern in indi-
vidual patients requires frequent electrocardiographic 
sampling, which can be facilitated with an automated 
device. 
Study limitations: Only 82 of the 144 TAM! 7 pa-
tients with analyzable ST-monitor recordings were se-
lected for this study. Strict criteria were set to accom-
modate stipulations of all methods as closely as possible. 
TIlliS, the resultant population size was small. Subtle ac-
curacy diJrerences relative to angiography could there-
fore not be evaluated, 
Although early infarct-related artery patency is a ma-
jor deternLinant of survival, [-10 characterization of phys-
iologically adequate reperfusion or benefit of secondary 
reperfusion strategies remains controversial. 1l1is is ~ar­
ticularly true in patients with TIMI grade 2 l1ow28,2 or 
collateralized occiusion.2J-26 Earlier published reports 
stated that 8 of 10 patients with TI1vII grade 2 flow and 
4 of 10 patients with collateralized occlusion display ST 
recovery,18 and could therefore be considered patent. De-
spite the controversial nature of the angiograplLic "gold 
standard" itself, all ST-recovery methods would be ex-
pected to be sinillarly affected, 
Patients with prior Q-wave infarctiolls in the same 
area of ST elevation were not enrolled in the TAM! 7 
trial, It is not known whether tlLis may somewhat limit 
ihe generalization of the performance of these methods, 
It is expected that the continuous and static methods 
would be similarly affected. 
Clinical implications of cyclic reperfusion are not yet 
fully understood, although preliminary evidence sug-
gests that it has functional significance.19,20 A single 
electrocardiogram only gives a "snap-shot" assessment 
and would miss this diagnosis by undersarnpling. Con-
tinuous ST monitoring can help define clinical relevance 
and response to treatment of such unstable infarct-re-
lated artery behavior, 
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DISCUSSION 
I: INTERMIlTENT CORONARY REPERFUSION 
Hacket and co-workers demonstrated the 
close temporal relation between ST-seg-
ment elevation and coronary occlusion in 
45 acute myocardial Infarction patients 
prior to and following intracoronary infu-
sion of streptokinase using continuous ST-
segment Holter monitoring with concomi-
tant serial angiographic observations.' 
Fifteen patients demonstrated 29 episodes 
of transient ST normalization, 12 (In 8 
patients) occurred spontaneously prior to 
coronary angiography, and 17 (In 8 pa-
tients) during coronary catheterization of 
which 13 (in 7 patients) occurred during 
streptokinase infusion. Occlusion was 
always found during episodes of ST-seg-
lllent elevation and patency coincided 
with resolution of ST-segment elevation 
(Figure 1). Coronary occlusion in the early 
phase of myocardial Infarction was fre-
quently intermittent and was reflected by 
ST-segment recovery and fe-elevation. 
Table 1 lists the percentages of patients 
with ST evidence of intermittent reperfu-
sion in 7 different studies.'" While diffe-
rent therapies aimed at reperfusion were 
applied, intermittent reperfusion was 
observed consistently in approximately 
37% of the patients (95% confidence inter-
val 34 to 40%), of which 27% (19 to 36%) 
occurred before either thrombolytic thera-
py or coronary angioplasty was initiated. 
This may be explained by unstable pla-
ques resulting in intermittent coronary 
occlusion, the dynamics of the thrombus 
formation and breakdown under influence 
of both treatment with vasodilators, aspi-
rin, heparin, or thrombolytics, coronary 
spasm, or intermittent collateral blood 
supply.'4"'10 It has been reported that 
patients with intermittent occlusion as 
evidenced by dynamic ST changes had a 
larger Infarct size as recognized by higher 
maximum Lactate Dehydrogenase-llevel, 
a more pronounced change in QRS vector 
after 24 hours, a longer time to peak Crea-
tine Kinase, and a (non-significant) ten-
dency towards higher 1 year mortality 
than patients who do not show ST evi-
dence of intermittent reperfusion.4 Fur-
thermore, it was noted that a beneficial 
effect of rt-PA could not be shown In enzy-
matic parameters of infarct size, electrocar-
diographic parameters of Infarct limita-
tion, or clinical outcome when compared 
with the placebo group in the patient 
group with ST evidence of intermittent 
reperfusion.' In 618 patients of the 
GUSTO-I ECG substudy a weak but signi-
ficant inverse relationship was found 
between the presence of recurrent ST 
elevation and left ventricular ejection 
fraction (I' = - 0.16, P = 0.001).' 
It is not known whether Ulese unfavora-
ble outcomes are caused by for instance re-
peated reperh,sion injury, longer total 
occlusion duration, or higher incidence in 
more proximal coronary lesions, or whe-
ther this is largely due to the fact that 
intermittent repel' fusion is more obvious 
when infarction generates higher ST-seg-
ment amplitudes. Although more studies 
into the pathophysiology and clinical 
relevance of intermittent reperfusion are 
needed, these data sb'ongly suggest that 
cyclic reperfusion might have clinical 
significance regarding outcome and effect 
of treabnent. Whether there is a difference 
in mechanism and outcome betvveen early 
versus late recurrent occlusion may also 
need further investigation. 
II: ACCURACY OF CONTINUOUSLY UPDATED 
ST-SEGMENTRECOVERY ANALYSIS 
The most reliable method to assess COfO-
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Figure 1 
Streptokinase 
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COlnputerized analysis of a continuous ambulatory electrocardiogram (Holter· ECG) from a patient 
with recurrent ST-segment elevation and coronary reocclusion during continuous Streptokinase 
infusion, Initially, ST-segment elevation was recorded at 9:06 hours, and after intra-coronary 
isosorbide dinitrate (ISDN), the ST-segment returned to baseline, ST-segtnent elevation recurred with 
angiographically documented coronary occlusion at 9:30 hours during continuous Streptokinase 
infusion, After additional ISDN, the ST-segment again returned to baseline WiU1 angiographic 
documentation of coronary recanalization, ST-segment elevation recurred at 9:58 hours, but coronary 
angiography was not performed during this episode, After additional ISDN the ST-segment again 
returned to baseline, Reprinted by permission of The New England Journal of Medicitle, Hacket D, Davies 
G, Cllierchia S, Maser; A; volume 317: pp 1055-9, 1987, Copyright 1987, Massachusetts Medical Society, 
All rights reserved, 
nary reperfusion status is repeated coro-
nary angiography, TIlis, however, is a 
burden on the patient and hospital resour-
ces, while catheterization laboratory facili-
ties are not available to all hospitals. A re-
liable, noninvasive assessment technique 
able to detect reperfusion and recurrent 
occlusion over time would therefore be 
useful. As indicated above, ST changes 
correlate with angiographic patency. 
However, it should be appreciated that 
static patency assessments comparing a 
single post-h"eahuent ECG with a pre-
treahuent ECG will misrepresent the phy-
siologic behavior of reperfusion when one 
or multiple recurrent occlusions occur or 
when ST recovery occurs following a late 
peak in ST eievation,6, II, 12 For this reason 
continuously updated ST-segment reco-
very analysis has been developed. Table 2 
lists performance parameters of 4 studies 
using continuously updated ST-segment 
recovery analysis to predict simultaneous 
angiographic coronary flow status of the 
. f I d 313-15 C t' I In arct re ate artery,' on muous y 
updated ST-segment recovery analysis has 
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Table 1 
Author N treatment A(ST intermittent reperfusion before b"eatment 
Davies 2 9 IC-SK A+ST 6 (67%) 1 (11%) 
Hackett' 45 IC-SK A+ST 22 (49%) 8 (21%) 
Krucofr' 22 IV-TTX A+ST 11 (50%) 5 (31%) 
PTCA 
Dellborg' 103 rt-PA ST 35 (34%) 16 (34%) , 
Placebo 
Kwon 5 31 IV-TTX ST 11 35%) not reported 
Veldkamp' 82 IV-TTX ST 32 (39%) not reported 
Langer 7 618 IV-TTX ST 221 (36%) not reported 
910 338 (37%) 30(110 (27%) 
Occurrence of intermittent reperfusion in acute n\yocardial infarction as reported in 7 different 
studies. I.7 N ;:;: the number of patients in the study; A ;:;: serial angiographic observations; ST ;:;: 
continuous electrocardiographic ST-segment monitoring; IC-SK:::: intracoronary streptokinase; IV-TTX 
:::: intra-venous thrombolytic treatment; rt-PA =: recombinant tissue type plasminogen activator; >I- in 
the placebo group. 
shown to be a useful noninvasive indica-
tor, although especially the sensitivity for 
occlusion may be improved. Use of conti-
nuously updated ST-segment recovery 
analysis has not yet been validated in 
patients with delayed ventricular conduc-
tion, but this comprises only a small part 
of the population of acute myocardial 
"f t" t" t J3 16 17 M t " t" 111 arc IOn pa len s. " ore res rIC mg 
is the requirement that initial ST deviation 
indicating coronary occlusion is still pre-
sent when ST monitoring is initiated. In 
fact, accuracy of patency assessment by 
continuous ST -segment recovery analysis 
strongly depends on peak ST deviation"ls,1S 
This requirement favors the analysis of 
anterior above inferior infarctions and 
both above posterior infarctions. '9, 20 Avail-
ability of hard-copy electrocardiograms 
recorded during coronary occlusion can 
substitute missing data prior to initiation 
of ST-segment monitoring, but this limits 
the detection of the onset and stability of 
reperfusion. 
III: ST MONITORING FOR TRIAGE FOLLOWING 
THROMBOLYrIC TREATMENT 
To avoid unnecessary bleeding risk, 
thrombolytic therapy might be disconti-
nued in acute myocardial infarction pa-
tients when ST recovery evidences early 
Table 2 
Author 
Krucoff' 
Krucoff13 
14 Dellborg 
Kl "k" ootwlJ_ 
N 
44 
144 
96 
302 
TIMIO-1 Sens. 
90% 
39 (27%) 64% 
26 (27%) 73% 
105 (35%) 44% 
Spec. Ace. 
92% 
90% 83% 
83% 80% 
84% 70% 
PPV NPV 
71% 87% 
61% 89% 
59% 74% 
Comments 
pilot study; formal algorithm, 44 serial 
observations in 22 pts.; not blinded; few 
data on performance 
correct study design; formal algorithm 
correct study design; both Sf nd QRS 
information used; only partially forma-
lized algorithm 
complex study design; formal simple 
algorithm; late onset of monitoring; 
relatively inexperienced participants 
Four studies 11:orting the performance of continuously updated ST-segment recovery analysis as compared against simultaneous coronary 
angiography.3,l3- N = number of observations; TIM! 0-1 = thrombolysis in myocardial infarction flow grade a or 1 All studies considered TIM! flow grade 
2 or 3 to reflect infarct related artery patency, presence or absence of colhteral blood supply was not taken into account; Sens. = sensitivity, the ability 
to detect an angiographically occluded infarct related artery; Spec. = specificity, the ability to correctly predict an angiographically open infarct related 
artery; Ace. = accuracy, the percentage of correct predictions overall; PPV = positive predictive value, the percentage of correct predictions of an occluded 
infarct related artery; NPV = negative predictive value, the percentage of correct predictions of a patent infarct related artery; - = information was not 
reported or reconstructible from given data. 
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Figure 2 
Possible treatment options (right colunu1) that could be chosen depending on the reperfusion behavior 
following thrombolytic therapy for acute myocardial infarction as evidenced by continuously updated 
12·lead ST-segnl.ent recovery analysis (2 colullms on Ule left side), In the 3 dimensional graphs in the 
far left column the X-axis represents each of the 12 leads, the Y-axis represents the ST deviation 
measured 60 milliseconds after I-point, and the Z-axis represents time,) TIle third column explains 
clinical implications of the different types of reperfusion behavior. Early stable reperfusion is 
associated with limitation of infarct size, electrical stability of the myocardium, and improved 
Stuvival.42-t9 Early cyclic I'eperfusion is associated with large infarct size and decreased survival:l, 7 No 
reperfusion is related with larger infarcts, electrical instability, and decreased survival.42-51 Recurrent 
occlusion, potentially resulting in recurrent infarction is associated with increased morbidity and 
mortality,51,:>'1 
It has been suggested that thrombolytic therapy may be stopped once ST recovery signifying 
reperfusion has occurred ,21, 21 When ST recovery is followed by recurrent ST elevation suggesting 
cyclic reperfusion, addition of anti-coaRilants, pJatelet inhibitors, or higher doses of vasodilators may 
be helpful in stabilizing reperfusion,1,2:~t.1 When no reperfusion occurs following throm.bolytic Ulerapy, 
or when late recurrent occlusion occurs/rescue Ulfombolytic therapy,3+37 or angiography with rescue 
PTCAJa-ro or intra-coronary thrombolytic therapy41 may be considered. Trials testing these strategies 
following triage with continuously updated ST-segment recovery analysis and other noninvasive 
patency assessments are warranted. 
reperhlsion of the infarct related artery.21,n 
Patients suffering frolll acute myocardial 
infarction, in whom thrombolytic therapy 
fails to provide early and stable reperfu-
sion might benefit from additional treat-
ment such as rescue angioplasty, rescue 
thrombolysis, or from additional medical 
treahnent stich as antithrombin or anti-
platelet compounds.23-u FigtU'e 2 illustrates 
the possible treahuent options that could be 
chosen depending on the reperfusion be-
havior as evidenced by continuously up-
dated ST-segment recovery analysis. Many 
of these options are under debate or have 
not yet been investigated, partly because a 
usehll (continuous) non-invasive patency 
assessment method was not available until 
the development of continuous real-time 
ECG analysiS. 111e potential value of stop-
ping thrombolytic treatment once reperfu-
sion has been achieved, rescue thrombo-
lytic therapy, and rescue coronary angio-
plasty (PTCA) will be discussed below. 
Further research into the reperfusion pat-
terns following thrombolytic therapy and 
treatment strategies dependent on the 
specific reperfusion pattern is required, so 
that h'eahnent regimens can be optimized 
according to the individual's response. 
Sioppilig Ihrombolytic Ireolmelll ollce reperfu-
sioll !tas been achieved 
When rapid ST-segment recovery indicates 
reperfusion through the infarct related 
artery administration of the thrombolytic 
agent might be discontinued to reduce the 
risk of intracranial hemorrhage.22 Further-
therapy should be aimed at preventing 
recurrent occlusion. One might consider 
that continuation of thrombolytic drug 
administration beyond the moment of 
reperfusion could help to resolve the remai-
ning Uuombus. However, little if any bene-
fit of prolonged administration of rt-PA was 
observed in a trial addressing this issue,s1,55 
while prolonged administration of throm-
bolytics might increase the risk of bleeding 
complications." It shotdd there-fore be 
investigated wheUler cessation of thrombo-
lytic therapy with subsequent anti-platelet 
or anti-coagulant therapy once ST evidence 
of reperfusion occurs does indeed reduce 
bleeding complica-tions without compromi-
sing stability of reperfusion. 
ST pattem I suggesting clinical suggested action 
early stable small infarct size stop thrombolytic therapy 
~ I .. p,,,'US;O" electrical stability 
.-.-~ 
. - .. , I I 
survival 1" 
early cyclic I large infarct size I stop thrombolytic therapy 
reperfusion , 
, anti-coagulants 
platelet inhibitors 
, survival .... vasodilators 1" 
no I large infarct size repeat thrombolytic therapy 
reperfusion electrical instability 
I 
urgent angiography & PTCA 
I 
survival ........ 
late recurrent infarction repeat thrombolytic therapy 
recurrent 
occlusion 
urgent angiography 8. PTCA 
, survival ........ I 
'"' 
" 
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Rescue thrombolytic therapy 
In patients with persistence of ST eleva-
tion, indicating failure of thrombolytic 
therapy, or with recurrent ST elevation 
following initial signs of successful reper-
fusion, addition of a second thrombolytic 
agent or prolonged infusion of the same 
drug might be successful ("rescue throm-
bolysis"). So far the efficacy and safety of a 
second dose of thrombolytic therapy for 
recurrent occlusion following initial 
thrombolytic therapy has been addressed 
in a llinited number of patients in 4 reports 
(Table 3).",37 These studies suggest high 
short term efficacy with a modest increase 
in bleeding complications following re-
treabnent with either recombinant tissue-
type plasminogen activator (alteplase) or 
streptokinase. Repeat administration of 
streptokinase may be accompanied by 
allergic reactions, and neutralizing anti-
bodies sufficient to inhibit conventional 
doses of streptokinase may develop as 
early as 4 days after the initial administra-
tion." Repeated administration of strepto-
kinase or streptokinase containing anistre-
plase (APSAC) should therefore be avoid-
ed. TI,e small groups preclude definite 
conclusions and in neither of these studies 
a comparison was made with other strate-
gies or placebo. It is therefore not known 
whether recurrent ischemia would have 
resolved spontaneously in these patients. 
Still, in all 4 studies recurrent ischemia of ~ 
30 minutes was required, suggesting that an 
intervention was warranted. FLUther studies 
are needed on bOUl &1fety and efficacy, com-
paring them with eiU,er placebo or other 
strategies such as rescue PTCA. TIle value of 
a prolonged dose of the same agent or a 
second dose of a different agent when U,e 
primary thrombolytic agent was lUlSUC-
cessful remains to be investigated. Most 
importantly, studies are needed fOCUSSUlg on 
the prevention of recurrent occlusion. 
Resclle corollary nngioplasty 
Coronary angiography with rescue 
PICA" in patients with ongoing or recur-
rent occlusion has been under debate for 
about a decade now but only 2 rando-
mized trials have been organized.3J3,:19 The 
strong polarization between proponents 
and opponents, the deficiency of 24 hour 
catheterization facilities, and the lack of 
reliable non-invasive patency assessment 
methods have made it difficult to organize 
a large enough multi-center trial that can 
give a definite answer." Table 4 lists argu-
ments in favor and against a strategy of 
rescue PTCA. 
Belenkie and co-workers randomized 28 
patients with an angiographically deter-
mined failure of tllrombolytic therapy." Of 
the 16 patients treated with rescue angio-
plasty only 1 patient died during hospitali-
zation, notably 1 of the 3 patients in whom 
PTCA failed to restore patency. Of the 12 
conservatively treated patients 4 died (p = 
0.13, NS). Ellis and co-workers randomi-
zed 151 anterior myocardial infarction 
patients with an angiographically occlu-
ded infarct related artelY following throm-
bolytic Iherapy to rescue PTCA (n = 78) 01' 
a conservative strategy (n = 73) 1.5 to 8 h.rs 
following onset of symptoms.J9 The pre-
specified primary endpoint of resting 
ejection fraction afler 30 days did not show 
any improvement following rescue PICA: 
40 ± 11 % after rescue PTCA versus 39 ± 
12% following the conservative strategy. 
Secondary endpoints were 30 day morta-
lity or congestive heart failure (class ill-IV) 
at 30 days. A trend toward clinical im-
provement follOWing rescue PTCA was 
noted: death in 5% and 10% (p = 0.18); 
congestive heart failure in 1 % and 7% (p = 
0.11); and death or congestive heart failure 
in 6% and 17% (p = 0.05) following reSClle 
PICA versus conservative treahnent res-
pectively. Furthermore, exercise ejection 
fraction did show significant improvement 
following rescue PTCA: 43 ± 15% follow-
ing rescue PTCA versus 38 ± 13% follo-
wing conservative treahnent (p = 0.04). 
No definitive answers regarding the 
value of rescue PICA can be given based 
on current evidence. With the data avail-
able a conservative strategy seems warran-
ted. Rescue PTCA should be reserved for 
patients in whom the clinicat hemodyna-
Inic status deteriorates following standard 
conservative treatment. A sufficiently 
large randomized trial of rescue PTCA 
versus conservative treatment with non-
invasive ST monitoring and or biochemical 
patency assessment for the primary triage 
seems warranted. Furthennore, compari-
son with rescue thrombolytic therapy 
should be made if efficacy and safety of 
that strategy have been established. 
IV: ST MONITORING IN CLINICAL TRIALS 
Mortality following acute myocardial 
infarction occurs relatively infrequent and 
studies with a mortality endpoint therefo-
re require large study populations. Infarct 
size, left ventricular function, and angio-
graphic patency of the infarct related 
artery have therefore been used as alterna-
tive endpoints, Since angiography is not 
available in every hospital there is an 
increased interest in simple noninvasive 
patency assessments.57,58 Early opening of 
the infarct related artery is directly related 
to limitation of infarct size, preservation of 
left ventricular function, and a better clini-
cal outcome.H-51 Previous studies have 
shown the unfavorable results of recurrent 
occlusion.4,7,52,53 TIle documentation and 
timing of reperfusion and the assessment 
of re-occlusion with continuously updated 
ST-segment recovelY analysis might there-
fore serve as important endpoints in trials 
comparing drug regimens aimed at early 
stable reperfusion. 
The GUSTO-l ST-segment monitoring 
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substudy was the first large scale attempt 
to compare speed and stability of reperfu-
sion as assessed with continuously up-
dated ST-segment recovery analysis in 4 
different thrombolytic regimens: 1) strep-
tokinase with subcutaneous heparin; 2) 
streptokinase \vith intravenous heparin; 3) 
accelerated rt-PA with intravenous hepa-
rin; and 4) streptokinase and rt-PA with 
intravenous heparin,7,59 In this study 3 
different devices were used: continuous 
vector electrocardiography, continuous 12-
lead monitoring, and 3 channel Holter 
recording,W In contrast with the angio-
graphic substudy in which the accelerated 
rt-PA regimen showed higher early paten-
cy rates,46 no significant difference was 
found in time to first 50% ST recovery, TIle 
ability to detect differences in time to 50% 
ST recovery in this study may have been 
hampered by the uncontrolled and vari-
able time to initiation of ST-segment moni-
toring and by differences among devices, 
such as algorithms used for detection and 
evaluation of ST shift.60 TIlese concerns are 
supported by a multiple regression model 
in which time to onset of ST monitoring 
was the most significant predictor of time 
to 50% recovery, followed closely by the 
type of device used. Furthermore ... techni-
cal requirements such as onset of monito-
ring within 1 hour following initiation of 
thrombolytic therapy, no interruption of 
monitoring prior to 50% ST recovery, or a 
peak amplitude ~ 200 flV where not met in 
over 40% of the patients who undelwent 
ST monitoring. The greater than expected 
number of patients excluded from analysis 
has reduced the power to detect differen-
ces. 
TIle second a priori assumption in the 
GUSTO-l ST-segment monitoring substu-
dy was that patients treated with strepto-
kinase would show greater stability of ST 
recovery.' The results showed that ST-
segment re-elevation reflecting recurrent 
Table 3 
author Barbash" White" Simoons36 Mendia37 
N 52 31 26 11 
N control group 1447 618 
initial TIX rt-PA 100-120 mg or SK 1.5 million U or rt-PA 100 mg rt-PA 100 mg 
SK 1.5 million U rt-PA 100 mg 
2ndTIX rt-P A 100-120 mg SK 1.5 million U or rt-PA50 mg « 24hrs) rt-PA 100 mg or 
rt-PA 100 mg rt-PA 100 mg (> 24 hrs) SK 1.5 million U 
time to 2nd TIX ~ 1 hr (-8 days) 5 days (1-716) ~ 5 hrs (-77) 105 days (1-28) 
ST I after 2nd TIX 44 (85%) 26 (100%) 11 (100%) 
angio-patency 18/29 (62%) * 16/22 (73%)** 14/26 (54%) *** 10/10 (100%)**** 
after 2nd TIX 
bleeding compl. 19% 13% 23% 
after 2nd TIX 
bleeding compl. 6% 19% 
in control group 
transfusion 4% 3% 12% 
after 2nd TIX 
transfusion 3% 
in control group 
1CH 0 1 0 
after 2nd TIX 
ICH 2 
in control group 
Table 3: Efficacy and safety of repeated administration of recombinant tissue-type plasrrrinogen activator as reported :in 4 studies.34-37 In the first study 
patients received either intravenous heparin, subcutaneous heparin, or placebo, depending on the main trial in which they where enrolled. 
In the second study 19 patients received intravenous heparin. In the third study patients were randomized between intravenous heparin 
or placebo. Patients in the fourth study were treated vvith subcutaneous or intravenous heparin. All patients received aspirin, and 12 patients 
in the second study also received dipyridamole 400 mg daily. The control groups in the first and thlrd study consisted of patients not 
selected for repeat administration of thrombolytic therapy. TTX = thrombolytic treatmenti rt-PA : recombinant tissue-type plasminogen 
activator; SK = streptokinase; time to 2nd dose of thrombolytic therapy is reported as median and (one sided) range; ST! = 5T recovery 
following elevation, signifying reperfusion following the recurrent occlusion; angio-patency = angiographically documented patency 
following recurrent occlusion; 1st TIX = the initial thrombolytic treatment; 2nd TTX = retreatment with recombinant tissue-type 
plasminogen activator; ICH = number of patients with intracranial hemorrhage; - = not reported. 
••• _ ..
Angiography was performed only when a second recurrent occlusion was suspected due to recurrent chest pain and ST elevation. 
Twenty-tI.'lo patients undenvent late angiography. Reasons not to perform late angiography were early dead in 3, emergency CABG in 1, and known 
coronary anatomy due to early angiography in 5. 
Angiography was performed a median of 64 hours following the second dose of alteplase (range 2 to 120 hours) . 
Angiography was performed ~ 72 hours.after the acute ischemic symptoms. 
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Table 4 
PRO rescue PICA 
1. increased early infarct related artery 
patency rates 
2. patency, early or late, is associated ,vith 
improved short and long term survival 
3. relatively late reperfusion may lead to 
improved infarct healing, increased 
electrical stability 
4. late reperfusion may provide a source 
for caHateral flow in multi-vessel di-
sease 
CONTRA rescue PTCA 
1. no proven benefit due to lack of ran-
domized trials 
2. spontaneolls late reperfusion may occur 
(catch-up patency) 
3. complications related to emergency an-
giography and PTCA may outbalance 
benefits 
4. recurrent occlusion following PTCA 
may reduce the salutary effect of a pa-
tent infarct related artery 
5. may require referral to specialized cen-
ters 
6. involves costly, impractical procedures 
Arguments pro and contra rescue angioplasty (PTeA) for failed or recurrent occlusion of the infarct 
related artery following thrombolytic treahnent. 
occlusion occurred equally in each treat-
ment group. This finding does support the 
similar re-infarction and re-occlusion rates 
seen in the main trial and the angiographic 
substudy."" Results regarding time to 
first 50% recovery and stability of 5T reco-
very for the 4 treatment arms were inde-
pendent of the device used. 
V: 5T MONITORING TO DETERMINE PRoc,-
NOSIS 
Besides the possibility to tailor thrombo-
lytic and adjuvant therapy to the patient's 
individual response, continuous real-time 
5T-segment monitoring might be helpful 
in determining the prognosis of individual 
patients. Barbash and co-workers showed 
in a series of 286 patients that a reduction 
in the summated ST elevation of i! 50% 
from the admission ECG 1 hour after 
Ireahnent onset with alteplase (rt-PA) was 
associated with a significantly smaller 
infarct size (release of creatine kinase), 
better preservation of left ventricular 
function, lower morbidity, and itnproved 
short and long term survival (Table 5/ 
Figure 3)." It is noteworthy that the sum-
mated ST elevation at admission had no 
independent predictive value for clinical 
outcome when presence or absence of ST 
recovery was taken into account. The 
association between ST recovery and out-
come was less pronounced in patients with 
inferior infarction as compared with pa-
tients with anterior infarction as the for-
mer already had a smaller enzymatic 
infarct size, with a better clinical outcome 
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Table 5 
rapid ST YES NO 
recovery (n = 189) (n = 97) 
24 ius. total CK 5248 IV 10553IU P < 0.0001 
release (SO 4265) (SO 7762) 
discharge 55% 44% P < 0.0001 
LVEF (SO 12) (SO 14) 
60-day 3 (1.6%) 10 (10.3%) P = 0.0015 
mortality 
CHF 8 (4.2%) 18 (18.6%) p < 0.001 
The effect of rapid ST-segment recovery following h'eatment with rt-PA (~ 50% reduction in 
summated ST deviation within 1 hour following treatment onset) on: 1) total Creatine Kinase (CK) 
release in 24 hours as an area under Ule curve of several samples; 2) left ventricular ejection fradion 
(LVEF) prior to discharge assessed with radionuclide gated blood pool scan; 3) 60 day mortality; and 
4) presence of congestive heart failure (CHF) during hospitalization (CHF at admission excluded 
patients for this study). SD = standard deviation. Dnta reported by Barbaslt et al..61 
Figure 3 
14 
12 
o Rapid 8T resolution 
• Persistent ST erevalion 
2345678 
Time (months) 
Cumulative mortality (%) of patients with rapid resolution of ST elevation and without. Reprinted 
by permission o/fhe British Hearl ]ollma!, Barbaslt GI, Roth A, Hod H, Miller HI. Ratlt 5, Har-Zavah Y, 
Madan M, Sefigsolm U, BattIer A, KapUt/sky E, Rabinowitz B, Laniado 5; volume 64: pp 241-7, 1990. 
Copyright 1990. All rights reserved. 
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and ejection fraction. Other factors that 
influenced left ventricular function were a 
history of prior infarction, presence of 3 
vessel disease, age, and sex, while only a 
history of prior infarction was also a pre~ 
dictar of mortality. Saran and co-workers 
also found that rapid ST recovelY was 
associated with preservation of left ventri-
cular function.62 
Preliminary data showed that patients 
without ST fe-elevation indicating recur-
rent occlusion > 3 hours after onset of 
thrombolytic therapy have a lower morbi-
dity and mortality than patients with 
unstable or failed reperfusion after 3 
hours.63 Prognostic importance of para-
meters derived from continuous monito-
ring such as presence and timing of rapid 
ST recovery, maximum amplitude and 
extent of the infarct zone, time to reperfu-
sian and early or late stability of reperfusi-
on need to be explored in large patient 
groups and should be compared and 
combined with other noninvasive clinical 
information (e.g. age, history of angina, 
history of prior infarction, enzymatic 
infarct size, left ventricular function, treat-
ment delay, reperfusion therapy given, 
presence of congestive heart failure, elec-
trocardiographic 01' enzymatic infarct 
size)51,64 such that risk stratification and 
thus medical care following reperfusion 
therapy can be individualized as well. 
Ideally the duration of hospital stay can be 
shortened or lengthened based on indivi-
dual risk assessments. A very low risk of 
complications could for instance lead to a 
shorter stay at the coronary care unit, 
followed by an earlier discharge."'" On 
the other hand, high risk patients would 
require longer observation in the coronary 
care unit. Models predicting long term 
prognosis could also include outcomes of 
early ambulatory ST monitoring following 
discharge from the coronary care unit67.613 
or exercise treadmill electrocardiography 
prior 01' following hospital discharge.6HI 
VI: CONTINUOUS ST MONITORING DEVICES 
Arrhythlllia IIIOllitOrillg systellls 
Electrocardiographic monitoring systems 
used to detect cardiac arrhythmias in real 
time are available in most coronary care 
units, intensive care units, medium care or 
step down units (telemetry), elnergency 
rooms, catheterization laboratories, and 
surgical suites. However, many of these 
devices are not suitable for ST-monitoring, 
although the displayed elech'ocardio-grap-
hic signal may show ST abnormalities. 
Often distortions of the low frequency 
content of the signal due to inadequate 
filtering techniques and 'baseline wander 
correction' may result in misleading mor-
phologies of the ST-segment." Further-
more, in most systems only one lead is 
displayed on the central monitoring sta-
tion although many systems currently 
record 2 or 3 leads simultaneously. Lead 
orientation is focussed on arrhytlunia 
detection rather than ischemia detection 
which results in decreased sensitivity for 
ST episodes occurring in other areas than 
the lead monitored.7:·Ps Also, fatigue of the 
medical staff, partly due to the display of 
multiple patient tracings simultaneously 
results in under-reporting of ST-episodes?6 
Thus, these systems can only be used 
reliably for ST monitoring if: 1) filtering 
teclmiques result in an adequate Jaw fre-
quency response; 2) lead orientation allows 
detection of both ischemia and arrhyUunias; 
and 3) proper ischemia detection algoritluns 
are integrated, including storage of C01'n-
plexes and measurements for comparison in 
full disclosure format and trending of tl,e 
ST deviation over time. 
Holter recorders 
The major disadvantage of Holter recor-
ders applied in continuous ST monitoring 
is the retrospective off-line analysis not 
allowing real-time triage at the bedside. 
Holter ST monitoring should therefore be 
restricted to use in comparative trials and 
research.12,77 Furthermore, the number of 
leads monitored is restricted. A 3 lead 
system with a (pseudo-) orthogonal orien-
tation such as an anterior lead V2, apical 
lead V5, and an inferior lead a VF or III 
should be preferred so that sufficient inju-
ry current is recorded for ST-segment 
recovery analysis.72,74,75,78,79 It is also impor-
tant to realize that ST-segment amplitudes 
measured on the bipolar Holter recordings 
are not fully cornparable with ones mea-
sured on the unipolar precordial leads of 
ti,e 12-lead ECG."' An advantage of Holter 
ST monitoring is that it records all beats 
without front-end selection or classificati-
on, making it appropriate for the parallel 
analysis of ST-segment recovery and 
arrhythmias in full disclosure.sl,82 Further-
more, many clinics already have Holter-
recorders for the purpose of arrhythrnia 
monitoring, and often their system is also 
suitable for ST-segment monitoring with 
an adequate frequency response and with 
an adequate analysis system. Familiarity 
with the device and financial considerati-
ons will lower the threshold for these 
hospitals to participate in multi-center 
trials. 
Computer aided contillll0llS 11lultilead electro-
cardiography 
Computer aided continuous multilead 
electrocardiographic devices were deve-
loped to provide real-time information on 
the dynamic ECG changes at the bedside 
with optional alarms warning the clinician 
when such changes occur. Two different 
approaches for real-time computer aided 
ECG monitoring have specifically been 
developed for ST-segment monitoring and 
are conunercially available. The first one is 
based on the continuous sampling and 
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averaging of the 12-lead ECG. This thesis 
describes parts of the development and 
application of one of these devices, known 
as the snoo, developed in close coopera-
tion with and marketed by Mortara Instru-
ment (Milwaukee, WI, USA). Other manu-
fachtrers have developed continuous 
multi-lead monitoring units based on 
conventional electrocardiographic leads as 
well.s3 
The second approach to real-time com-
puter aided ECG monitoring is the conti-
nuous monitoring of the vector electrocar-
diogram, developed by Hodges, Seder-
holm, GrOturn, Del1borg and co-wor-
kers.84.85 This device, known as the MIDA 
1000 was developed in close cooperation 
with and marketed by Ortivus Medical 
AB, Taby, Sweden. The 3 orthogonal vec-
torcardiographic leads X, Y and Z are 
computed from the Frank lead system and 
averaged to form mean vectorcardio-
graphic complexes. In acute myocardial 
infarction studies the 2 most closely stu-
died derived parameters are the QRS 
vector difference and the ST-vector magIu-
tude. TI,e QRS vector difference is espe-
cially sensitive to changes in the QRS 
morphology and duration, making it a 
parameter reflecting infarct evolution and 
conduction changes. TIle ST vector magni-
tude is the result of ti,e ST-segInent deflec-
tion in the 3 orthogonal leads and thereby 
reflects the presence or absence of ST 
deviation as a result of ischemia, similar to 
the recording of the ST deviation in the 12-
lead device. Dellborg and co-workers re-
ported on the performance of evaluation of 
the QRS vector difference and ST vector 
magnihtde changes for noninvasive paten-
cy assessment (fable 2)." Only a marginal 
benefit from monitoring the QRS vector 
changes in addition to ST changes was 
found, namely for patients with only mi-
nor changes in the ST trend. So far no fully 
quantitative patency assessment algorithm 
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allowing real-time analysis has been deve-
loped lIsing continuous vectorcardiograp-
hic parameters. TIlliS, for bedside triage 
one has to rely on visual inspection of the 
h'encllines of Ulese 2 parameters over time. 
The vectorcardiographic format is only 
understood well by skilled medical per-
sonnel, although others generally intuiti-
vely will recognize parallels with the 
standard 12-lead ECG, Its major advantage 
is that spatial parameters of ST recovery 
are easy to represent in a single parameter. 
VII: OTHER NONINV ASlVE PATENCY ASSESS-
MENT METHODS 
Arrhythlllia monitorillg 
It has been noted as early as in 1935 that 
arrhythmias may accompany occlusion 
and reperfusion of coronary arteries.56 
Accelerated idioventricular rhythm (AlVR) 
occurs most frequently during reperfu-
sion.s7 early occurring AIVR seems to be 
the most reliable of the "reperfusion 
arrhytlunias" .87.92 Table 6 lists 6 studies 
focussing on the performance of early 
AlVR as a predictor of infarct related 
artery patency, With current knowledge it 
can be considered a limitation of these 
studies that presence of AIVR was not 
correlated with other continuous simulta-
neous regisb'ation of reperfusion behavior 
such as multiple angiograms at the mo-
ment of arrhythmia Of continuous multi-
lead ST-segment recovery analysis.81 ,82 The 
possibility of a transient reperfusion cau-
sing the arrhythmia could have been mis-
sed in the patient groups labeled occluded 
by a single angiographic assessment. Re-
ported sensitivity and specificity varied 
widely per study, No clear relation was 
observed between the type of reperfusion 
therapy (intravenous versus intra corona-
ry) or the administration of intravenous 
lidocaine and the performance of AIVR as 
a patency predictor. As can be seen in 
Figure 4, sensitivity and specificity stron-
gly related to the reported incidence of 
AIVR, which in itself varied widely per 
study (5% to 71%), Incidence of AIVR 
clearly depended on the monitoring dura-
tion following onset of tllrombolytic thera-
py: the shorter the monitoring time, the 
lower fue incidence and thus the lower the 
sensitivity and the higher the specificity 
for reperfusion. Differences in incidence 
may also be explained by differences in 
AIVR definition, while other potential 
causes could not be reconstructed from 
reported data, Combined analysis of these 
studies as shown in Table 7 support the 
assumption that especially AIVR early 
following thrombolytic therapy might 
herald reperfusion with high specificity 
but with low sensitivity due to its infre-
quent incidence of 35%. The negative 
predictive value of 43% indicates that 
AlVR cannot be used as a single noninva-
sive marker of infarct related artery paten-
cy. Furthermore, a direct temporal rela-
tionship between ST recovery as a marker 
of reperfusion and the occurrence of repel'-
fusion arrhythmias was not found in one 
study," 
Bioc/lemicai assays 
Presence or absence of infarct related 
artery reperfusion can be detected by 
rapid assays of myocardial proteins in 
plasma, such as the enzyme Creatine 
K ' (CK) 91,93-96 tl d' 'f" lllase , le car lOspecl IC 1S0-
f 94-100 I b' 94--9698 d I orm CK-MB, myog 0 m, 'an t le 
cardiac specific antigen Troponin T.9S,101 
An early rise in plasma levels of any of 
these proteins indicates reperfusion. When 
reperfusion occurs, the rate of release of 
these substances abruptly increases, prob-
ably as a consequence of the increase of 
blood flow through the necrotic area 
("wash-out phenomenon"). Acceleration in 
breakdown of compromised myocytic 
membranes at the moment of reperfusion 
Table 6 
author N ttx TIM! Sens. Spec. Incid. Lidocaine monitoring comments 
2-3 duration 
GoldbergB7 21 Ie 81% 59% 100% 48% all duringttx definitoion of AIVR nor reported 
Miller" 31 IC 55% 82% 43% 71% all 12 hours 
Gorgels89 87 IC 80% 37% 94% 31% 49% on demand during ttx observation duration not reported 
N 
Gore90 56 IC 45% 8% 97% 5% all 90 min. definiton of AIVR not reported 
Hohnloser91 82 N 77% 40% 95% 32% not reported 90 min. 
Gressin92 40 N 73% 76% 82% 60% 32% on demand 6 hours 
Reported perfonnance of early AIVR (accelerated idiovenfricular rhythm) as a predictor of infarct related artery patency in 6 studies.87-92 N = the population 
size; ttx = the type of thrombolytic therapy involved; TIM! 2w3 = the percentage of patients with a reperfused .infarct related artery at coronary 
angiography; Sens. = sensitivity, the ability to detect an angiographically reperfused infarct related artery; Spec. = specificity, the ability to correctly predict 
an angiographically occluded infarct related artery; Incid. = the incidence of AIVR; Lidocalne = the percentage of patients receiving intravenous lidocaine; 
Ie = intra-coronary thrombolytic therapy; IV -= intravenous thrombolytic therapy; VT = ventricular tachycardia. 
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Figure 4 1-l1li-- sensitivity -.I.- specificityl 
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Reported sensitivity and specificity of early AIVR (accelerated idioventricular rh~lhm) as a predictor 
of infarct related artery patency related to the incidence of AIVR in 6 studies:'i7.n 
Table 7 
Combined analysis of AIVR (N = 317) 
pre-test probability of patency 
incidence of AIVR 
sensitivity 
specificity 
positive predictive value 
negative predictive value 
accuracy 
70% 
35% 
45% 
97% 
97% 
43% 
61% 
The cornbined analysiS using the results of 6 studies assessing performance of occurrence of early 
AIVR as a noninvasive predictor of infarct related artery patency.II].n See also Table 6. 
may also contribute to the increased re-
lease ("reperfusion injury"). TIle increased 
early release following reperfusion call be 
distinguished from failed reperfusion by 
an earlier peak plasma level and/or a 
higher rate of appearance into the blood-
stream. 
The ratio of the Creatine Kinase (CK) 
subforms CK-MB2/CK-MBl may also be 
used for noninvasive patency assess-
ment.102 Following reperfusion the unmo-
dified sub form MB2 is released into the 
bloodstream at an increased rate. Enzy-
matic conversion into the MBI subform 
occurs in the blood. With the sudden incre-
ase of MB2 typical of reperfused infarction, 
the accumulation of MBZ in plaslua ex-
ceeds the conversion to MUl, resulting in 
an increased MB2/MBI ratio. In contrast, 
nonreperfused infarction is characterized 
by a more gradual release of MB2 with a 
relative constant conversion into MBl, 
resulting in a lower MB2/MBl ratio. 
Patency assessments based on differen-
ces in the rate of appearance in plasma 
between patients with and without reper-
fusion should be preferred above detenni-
nation of the tune from treatment to peak 
plasma levels, since waiting for the peaks 
to occur \Vitil serial plasma determinations 
delays the clinical triage."'" Simple assays 
that can be performed 24 hours a day 
preferably by the coronary care unit per-
sOlIDel, with raEid results, are essential for 
clinical utility. 2.95 Table 8 lists published 
assays that have been tested in humans 
and can be used in the early assessment of 
. f 959798102 II 1ll arct related artery patency. . .. A 
assessment methods seel'n to have ade-
quate sensitivity and specificity. Except for 
the Troponin-T and CK MB2/MBI ratio 
based assessments, all assays can be per-
formed relatively easily and qUickly with 
current techniques and can therefore be 
used for early triage. More simplified and 
more rapid tests are awaited. It should be 
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appreciated however that myoglobin and 
CK are non-cardiospecific proteins, giving 
(false positive) increased levels following 
muscle lraurna, resuscitation, renal impair-
ment, vigorous exercise and other condi-
tions. Serial enzyme assays may indicate 
the presence of cyclic reperfusion, as is 
demonstrated in Figure 5. 12 Recurrent 
occlusion will only be detected when 
subsequent reperfusion results in a second 
rise of released enzymes, or when the first 
rise in the enzyme curve is aborted sud-
denly. Application of serial enzyme assays 
for dynamic patency mOlutoring requires 
further development. 
Comparillg alld combillillg ST mOllitorillg, 
arrhythmia monitoring, a1ld biochemical as-
says 
Continuously updated ST-segment recove-
'y analysis has the advantage of detecting 
both (failure of) reperfusion and recurrent 
occlusion. Biochem-ical assays currently 
provide a static assessment only. No di-
stinction is made between stable versus 
unstable repel' fusion and detection of 
recurrent occlusions depends on other 
assessments. Arrhythmia monitoring is not 
useful as a single indicator of reperfusion 
due to the infrequent occurrence of AIVR. 
Furthermore, it does not indicate recurrent 
occlusion. 
As discussed previously there are two 
situations in which ST-monitoring is not 
applicable. Firstly, it has not yet been 
validated in patients with delayed ventri-
cular conduction, but that comprises a 
small part of the population of acute myo-
cardial infarction patients.13,I6,I7 More 
restricting is the requirement that initial ST 
deviation reflective of coronary occlusion 
should be present when ST monitoring is 
initiated. Accuracy of patency assessment 
by continuous ST-segment recove,y analy-
sis strongly depends on monitored peak 
ST deviation.Is,Is When ST monitoring is 
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Table 8 
assay N time Sens. Spec. test 
CK 20 min. 
Zabel" 63 90 min. 87% 71% 
CK·MB 15 min. 
Garabedian 97 29 90 min. 83% 100% 
Ellis" 42 120 min. 85% 100% 
Zabel" 63 90 min. 85% 71% 
CKMB2/MBl 45 min. 
Puleo102 39 15·120 min. 90% 89% 
Myoglobill 30 min. 
Zabel" 63 90 min. 94% 88% 
Tropollill' T elaborate 
Zabel" 63 90 min. 80% 65% 
Biochemical assays measuring the rate of appearance of macro-molecules for early patency 
assessment,95,97.9i\)1)1 N :::: the population size; time:::: the interval between the pre- and the post-
treatment serum sample; Sens. :::: sensitivity, the ability to detect an angiographically reperfused 
infarct related arterYi Spec. :::: specificity, the ability to correctly predict an angiographicaUy occlude 
d infarct related artery; test = the "turn around" time needed fOf test measurements. 
Figure 5 
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Serial assessment of serum. creatine kinase (CPK) and myoglobin simultaneous with continuous 
vectorcardiographic registration of the ST-segment vector magnitude (ST-VM), The early rise of 
myoglobin is more rapid than that of creatine kinase and both cqincide with rapid ST-VM recovery. 
A second small rise of myoglobin paraUeled a re-elevation of the ST-segment, secondary to a 
reocdusion of the infarct related artery, Angio = angiography; ITCA = percutaneous transluminal 
coronary angioplasty; TIM! = thrombolysis in myocardial infarction flow grade. Repriflfed by permission 
of flte American /oumal of Cardiology, Klootwijk P, Cobbaert C, Fioretti P, Killt PP, Simoolls ML; volume 
72: PP 75G-84G, 1993. Cop!lright 1993. All rights reserved. 
not applicable either biochemical essays or 
arrhythmia monitoring would be a logical 
alternative. The integration of arrhythmia 
detection algorithms into an ST moni-
toring environment seems logical. Parallel 
application of ST monitoring, a 2-point 
biochemical assay, and/or arrhythmia 
monitoring might increase patency predic-
tion accuracy,91 would provide a back-up 
assessment in case of failure of one of the 
methods/7 or might even give additional 
separate infonnation. J03 
VIII: OTl-IER APPLICA nONS OF ST -SEGMENT 
MONITORING 
TIle application of ischemia monitoring in 
acute myocardial infarction has been the 
focus of this thesis. OU,er possible applica-
tions include monitoring post coronary 
angioplasty (PTCA), detection of (silent) 
ischemia in unstable angina, chest pain 
evaluation, pre-hospital monitoring, and 
peri-operative monitoring. 
ST mOllitorillg post corollary allgioplasty 
Ischemic episodes following coronary 
angioplasty (PTCA) are silent in approxi-
mately 50% of the patients and may beco-
lHe symptomatic after a prolonged silent 
episode.1m,lOs Continuous multi-lead ST 
lnonitoring may be an early warning of 
(pending) coronary occlusion at the site of 
coronary angioplasty. The multi-lead ST 
deviation pattern recorded during the 
angioplasty induced coronary occlusion 
provides a patient and site specific "finger-
print" that will be reproduced whenever 
reocclusion occurs at the same site.78,IO-H07 
On the other hand, ST elevation in a diffe-
rent pattern most likely signifies occlusion 
a t a different site, while ST depression 
usually reflects subendocardial ischemia, 
either in the perfusion area of the dilated 
vessel, Of in a remote area. The importance 
of multi-lead monitoring was demonstra-
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ted in a series of 524 patients who under-
went elective or emergency coronary 
angioplasty.l()l Figure 6 shows the occur-
rence of a combined clinical endpoint of 
untoward clinical events (acute myocar-
dial infarction, urgent coronary artery 
bypass surgery, or death during hospitali-
zation) related to U,e ST deviation pattern. 
In a smaller series of 200 patients moni-
tored following elective PTCA 90% of 
patients with ST elevation had enzyme 
evidence of acute myocardial infarction 
versus 3% of patients with ST depression 
oniy.IOS In this series episodes of ST eleva-
tion were eventually accompanied by 
angina in 90% of cases, whereas only 41 % 
of ST depression episodes were accompa-
nied by angina. Amongst patients with ST 
elevation, detectable ST changes preceded 
angina by a mean of 45 min. (range 5 -
150). Thus, multilead monitoring does 
provide an early warning of vessel occlu-
sion following PTCA, allOWing early medi-
calor mechanical intelVention, potentially 
preventing acute myocardial infarction or 
limiting infarct size. 
ST monitoring illllnstable allgilla pectoris 
Patients suffering unstable angina pectoris 
have a high risk of developing acute myo-
cardial infarction, probably due to the 
same pathophysiological substrate of 
plaque disruption, leading to platelet 
activation, enhanced reactivity of the 
coronary smooth muscle, and eventually a 
shift of the coagulation balance toward 
thrombosis.9,108--1l1 Unstable angina pectoris 
patients also have an increased risk of 
sudden death and life-threatening 
arrhythmias and frequently require urgent 
revascularization for persistence of symp-
toms under maximal medical treahnent. 11o-
113 Unfortunately ischemia is most often 
silent: 80 to 95% of episodes occurring in 
more than half of the unstable angina 
patients. I12•116 Table 9 summarizes results 
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Figure 6 
432 patients (82%) 
no ST episodes 
endpoint In 3 (1%) 
62 patients (57%) 
ST depression only 
endpoint In 1 (2%) 
14 patients (35%) 
different pattern 
endpoint in 2 (14%) 
524 PTCA 
patients 
92 patients (18%) 
STepisodes 
endpoint In 26 (28%) 
RR 41 (13.132) 
p<O.0001 
RR 33 (5.230) 
p<0.0001 
RR 6 (2-23) 
p<O.0001 
40 patients (43%) 
ST elevation 
endpoint In 25 (63%) 
26 patients (65%) 
fingerprint pattern 
endpoint In 23 (88%) 
Occurrence of a combined clinical endpoint of untoward clinical events (acute myocardial infarction, 
urgent coronary artery bypass surgery, Of death during hospitalization) related to ST deviation 
patterns recorded with continuous ST-segment monitoring following percutaneous transluminal 
coronary angioplasty (PICA) in 524 patients. Fingerprint pattern =: ST deviation pattern on multilead 
monitoring similar to the pattern occurring during the original coronary occlusion (PTCA). Data 
reported lly Krucoff et al.,wl 
Table 9 
study N typeUAP TIE silent TIE outcome with TIE no TIE P 
measure 
Gottlieb 112 70 CPatrest 37 (53%) 90% 1 month 
with"ST AMI 6/37 1/33 0.005 
CABG/PTCA 10/37 3/33 0.02 
total 16/37 4/33 0.02 
2 years 
AMI or death 10/37 1/33 <0.01 
Langer1l3 136 CPatrest 89 (66%) 92% in hospital 
crescendo death or AMI 14/89 2/46 <0.001 
AP CABG/PTCA 29/89 7/46 <0.01 
CP>20min. total 43/89 9/46 < 0.005 
Results of 2 studies investigating the occurrence and prognostic value of (silent) transient ischemic episodes (TIE) during bed rest in the coronary care 
Ulut for unslable angina pectoris (lIAP)."'-'" ,,5T = 5T change ~ 1mm. at qualifying ECG; AMI = acute myocardial infarction; CABG = emergency coronary 
artery bypass grafting; PTCA = emergency percutaneous transluminal coronary angioplasty. 
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of two investigations into the occurrence 
and prognostic significance of (silent) 
ischemia as recorded during acute coro-
f t bl . t' 112,113 nary care Of UOS a e angma pee ons. 
The presence of transient ischemic epi-
sodes (TIE) strongly predicted an unfavor-
able outcome, most of them occurring 
early in the hospital course. Gottlieb and 
co-workers showed in a multivariate ana-
lysis that presence of (silent) TIE was the 
strongest predictor of an unfavorable 
outcome (p < 0.002), followed by chest 
pain during the first 2 days (p < 0.02). 
None of the other 13 tested demographic, 
clinical, electrocardiographic, or angio-
graphic variables were significant in addi-
tion to these 2 variables,l12 Langer and co-
workers prospectively confirmed that 
patients with a total duration of both silent 
and symptomatic TIE (,total ischemic 
burden') ~ 60 minutes per 24 hours had a 
worse prognosis than patients with a 
shorter total ischemic burden,lI3 Similar 
results regarding clinical outcome fol-
lowing unstable angina pectoris have been 
found for the presence of (silent) ischemia 
detected with pre-discharge ambulatory 
Holter ST-segment monitoring."4, il5 
Real-time multilead ST-segment moni-
toring may thus detect (silent) ischemia, 
identifying patients at high risk of sustai-
ning a major cardiovascular event, and 
might be useful in guiding medical thera-
py and selection of high risk patients for 
angiographic evaluation. The use of mul-
tiple leads increases sensitivity for ische-
mia and enables the differentiation be-
tween transmural ischemia (ST elevation) 
and subendocardial ischemia (ST depres-
sion) and may thus be an early warning of 
an evolving acute myocardial infarction, 
thereby allowing early institution of 
thrombolytic therapy .3,13,75,84,116,117 Sh'ategies 
using real-time ST monitoring information 
in patient management rem.ain to be tested 
however, 
ST mOllilorillg for c!zesl paill evalualioll 
Patients without prior history of coronary 
disease who present at the emergency 
department with symptoms potentially 
due to unstable ischemic syndromes are 
generally evaluated by history and phy-
sical examination. Further exmninations 
include the 12-lead ECG, chest X-ray, and 
laboratory tests.IlI•11S When the ECG is 
non-diagnostic for ischemia and the other 
examinations are also non-indicative of 
cardiac disease the risk of complications is 
low and patients are discharged or admit-
ted to a non-intensive setting such as a 
step-down unit or a general cardiology 
ward. Typically, subsequent ECGs and 
serum biochemical markers of cardiac 
necrosis are taken every 8 to 12 hours over 
the next 1 to 2 days. Evaluation may be 
shortened using continuous ST monitoring 
and the addition of exercise electrocardi-
ography and (stress) echocardiography 
when indicated, to identify patients with a 
low risk of acute cardiac disease. Recently 
Gibbler and co-workers described their 
experience with continuous 12-lead elec-
h'ocardiographic monitoring (STlOO, Mor-
tara Instrument, Milwaukee) in patients 
presenting to the emergency deparhnent 
with chest pain. l1S Visual inspection of the 
ST trend over time as well as individual 
EeGs was performed at regular intervals, 
looking for ST changes as well as Q-wave 
formation, R-wave amplitude loss, and T 
wave morphology changes. Out of the 384 
patients evaluated according an intensive 
9 hour protocol, 86 were eventually admit-
ted to the cardiology deparhnent. On 
discharge 18 patients (21%) had diagnoses 
of cardiac disease after evaluation for 
acute myocardial ischemia and acute 
myocardial infarction. Continuous 12-1ead 
ECG recordings detected ischemic changes 
in 7 out of 18, thus having a sensitivity of 
39% (95% confidence interval 16 to 61 %). 
Continuolls 12-lead ECG monitoring lead 
to a false positive prediction of acute ische-
mia in 10 of 366 patients eventually clasM 
sified as having symptoms of non~cardiac 
origin, thus had a specificity of 9rh. (95(-10 
confidence interval 96% to 99%). The im-
portance of the continuous 12-1ead ECG 
recordings relative to the biochernical 
assays or the echocardiographic evaluation 
was not reported. While continuous ECC 
rnonitoring may detect all forms of ische-
ll1ia, biochemical assflys detect necrosis 
only. Previously it was shown that serial 
analysis of 12-lead ECGs taken at 3 to 4 
hour intervals had a sensitivity of 39(10 for 
detecting acute myocardial infarction 
while sensitivity of serial CK-MB determi-
nations was 68(10.119 Specificity of the 2 
methods were 88% and 95% respectively. 
It was not reported whether these assess-
ment methods identified the sarne patients 
or whether they were cornplimentary. 
ST lIIollitorillg ill tI,e pre-hospital phase 
Continuous 12-lead ECG recordings may 
be helpful in pre-hospital monitoring of 
patients suspected of having an acute 
myocardial infarction or other ischemic 
syndromes. Recent reports have advocated 
the pre-hospital adm.inistration of throm-
bolytic therapy to reduce the time between 
f d I2U·124 onset 0 symptoms an treatment. In 
these studies the decision whether or not 
to h'eat a patient in the field was made on 
presence of symptoms, absence of contra-
indications, and a conventional 12-lead 
electrocardiogram. In one study the decisi-
on was supported by an automated analy-
sis of the 12-lead ECG by a portable elec-
trocardiograph (Sicard P, Siemens Elema 
E.ll., Salna, Sweden) which has the capabi-
lity of automated serial ECG recording.12u 
When major ST elevation was present 
thrombolytic therapy was initiated, other-
wise the patient was re-evaluated at the 
hospital. Continuous registration of ECGs 
can be initiated in the pre-hospital phase 
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to evaluate patients with equivocal electro-
cardiographic evidence of transmural 
ischemia. Especially when transient occlu-
sion of the coronary artery is present the 
diagnosis of acute myocardial infarction 
might be missed by one or a few static 12-
lead ECCs. J,J,J2s It is not known whether 
pre-hospital thrombolytic treatment is to 
be recommended in these patients, but the 
added information of continuous electro-
cardiographic rnonitoring will facilitate the 
decision rnaking process once the patient 
has arrived in the emergency room. Of 
course the added value of continuolls ECG 
registration as compared to a single ECG 
in the pre-hospital phase is greater when 
transport time of patients is longer, for 
instance when patients are transported 
from rural areas. Furthermore, accuracy of 
STMsegment recovery analysis for the pur-
pose of noninvasive patency assessment 
depends on the continuous electrocardio-
graphic registration initiated as early in 
the course of the evolving myocardial 
infarction as possible. The documentation 
of the dynamic ST changes in the early 
phase of acute myocardial infarction and 
the detection of the true peak amplitude 
will enhance accuracy of the noninvasive 
patency assessment.6, II, 12, IS, 18 
Peri~opemtive ST monitori1lg 
Acute myocardial infarction and congesti-
ve heart failure are major contributors to 
peri-operative morbidity and morta-
lity .126,127 TIle entire period from the induc-
tion of anesthesia to recuperization is 
stressful, characterized by complex and 
rapidly changing responses that ma), be 
poorly tolerated by patients with coronary 
disease or a compromised left ventricular 
function. Factors that are liable for these 
rapid changes include depression of myo-
cardial contractility and cardiac output by 
anesthetics, as well as fluctuations in arte-
rial pressure, ventricular filling pressllres, 
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blood volume, activity of the autonomic 
nervous system and body temperature. 
The absolute risk of cardiac adverse events 
depends on the type and duration of the 
operation, the type of anesthesia applied, 
and whether it is performed electively or 
under emergency conditions. 111ere is a 
general increase in mortality of 25 to 50% 
in patients ,vith underlying cardiovascular 
disorders relative to patients with a nor-
mal cardiac function,l27 Among the nOI1-
cardiac surgical procedures, the highest 
cardiovascular complication rates are seen 
in peripheral vascular surgery, especially 
in abdominal aortic aneurysm surgery, 
since such patients often have substantial 
t d · ll126-129 Th . coronalY ar ery lsease as we . elf 
peripheral vascular disease may have led 
to a more sedate lifestyle in which exertion 
related symptoms of cardiac disease are 
not provoked. As a result, the extent of 
cardiac disease will be underestimated 
during history taking. TI,e symptoms of 
peripheral vascular disease may also re-
strict the value of exercise electrocardio-
graphy to identify the patients WiU, severe 
coronary artery disease. 
Determining the risk factors for adverse 
peri~operative cardiac outcomes would 
allow the development of preventive 
strategies and a more efficient allocation of 
health care resources. Patients at high risk 
of adverse outcomes can be identified by a 
history of recent acute myocardial infarc-
tion or presence of congestive heart failure, 
while other pre-operative predictors re-
main controversial. 126,127 Specialized car-
diac testing before surgery, such as dobu-
talnine stress echocardiography,I30,131 di-
pyridamole-thallimn scintigraphy,l21l and 
ambulatory electrocardiographic (Holter) 
monitoring,126 may also identify patients 
with increased risk. It has been shown by 
Mangano and co-workers that continuous 
ischemia monitoring may be helpful prior 
to, during, and especially after surgery in 
men with a high risk of or known coronary 
artery disease undergoing non-cardiac 
surgeryI26 Of the 474 men included in the 
study, 83 or 18% had post-operative car-
diac events during hospitalization: 15 had 
an ischemic event (cardiac death, myocar-
dial infarction, unstable angina); 30 had 
congestive heart failtu'e; and 38 had ventri-
cular tachycardia. Post-operative myocar-
dial ischemia was seen in 41 % of the pa-
tients monitored with a 2-chatmel Holter 
recorder and was associated with a 2.8-
fold increase in the odds of all cardiac 
outcomes (95% confidence interval 1.6 to 
4.9; P < 0.0002) and a 9.2-fold increase in 
the odds of an ischemic event (95% con-
fidence interval 2.0 to 42.0; p < 0.004). 
Many variables were univariate!y associa-
ted with adverse cardiac outconle, inclu-
ding a history of previous myocardial 
infarction, arrhythmias, congestive heart 
failure, claudication, 01' definite coronary 
artery disease, treated diabetes mellitus, 
use of digoxin, a serum creatinine ~ 177 
J-lmol! liter, vascular surgery, risk scores, 
as well as ischemia on Holter rnonitorjng 
prior to, during or after surgery. Multivari-
ate analysis identified ischemia detected 
with Holter monitoring after surgery to be 
the only variable independently associated 
with ischemic events. Only ischemia on 
pre-operative Holter rnonitoring and the 
use of digoxin for congestive heart failure 
were predictors of ventricular tachycardia. 
Variables associated with congestive heart 
failure included a history of arrhythmia, 
medication treated diabetes mellitus, 
duration of anesthesia and surgely, vascu-
lar surgery, and the type of anesthetics 
used. This was the only outcorne variable 
for which ischemia on Holter monitoring 
was no independent predictor. TIle Holter 
recordings revealed transient episodes of 
myocardial ischemia in 12 of 14 patients 
with adverse ischemic events, preceding 
any clinical evidence of these adverse 
outcomes by at least 4 hours. 
Pasternack and co-workers evaluated 
the value of peri-operative ischemia moni-
toring in 385 patients undergoing peri-
pheral vascular surgery.132 TIley showed a 
sh'ong correlation between the total dura-
tion of ischemic events detected with a one 
channel (CMS) real-time ambulatory ECG 
recorder (QMED Monitor One Star, QMED 
Inc., Clark, N.J., US.A) and peri-operative 
myocardial infarction as well as late car-
diac complications up to 2 years after 
operation. In multivariate analysis only 
age and the presence of peri-operative 
ischemic episodes during more than 1 % of 
the monitoring time were independent 
predictors of peri-operative myocardial 
infarction as well as late cardiac events. 
Similarly, Landesberg and co-workers 
reported that long-duration (> 2 hours) 
postoperative ST-depression as recorded 
with a 3-channel Holter recorder was the 
only factor significantly associated with 
cardiac morbidity in 151 patients under-
going l11ajor vascular surgery.129 Long 
dtuation ischemia preceded 85% of the 13 
cardiac events (6 acute myocardial infarc-
tions, 2 unstable angina, and 5 congestive 
heart failure). 
It can be concluded that ischemia moni-
toring is a valuable predictor of adverse 
cardiac outcomes following major non-
cardiac surgery, especially in patients at 
risk of or with proven coronary artery 
disease. Therapeutic trials in which care is 
guided by real-time ischemia lllOnitoring 
are warranted to determine whether pre-
vention or treahnent of peri-operative 
ischemia can reduce cardiac morbidity or 
mortality. 
IX: AREAS FOR FUrURE RESEARCH 
The snoo device has been developed as a 
mobile ST rnonitor and is therefore limited 
in its display capabilities. The option to 
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link the device to a central monitoring 
network in which several beds can be 
monitored simultaneollsly, with real-time 
display of the wave-forms as well as 
trends of ST deviation over time and other 
analysis tools, has now overcome these 
restTictions. TI,e possibility of real-time ST 
monitoring should be integrated in or be 
compatible with monitoring devices in 
other environments, including rnonito-
ring/defibrillator devices used during 
patient transport, emergency room and 
catheterization laboratory monitoring 
equipment, coronary care and intensive 
care unit monitoring systems and anes-
thesia monitoring equipment. To facilitate 
the analysis and comparison of electrocar-
diographic data over prolonged episodes 
under different circumstances a standard 
for data compression and the minimum 
amollnt of electrocardiographic and other 
information transferred should be set so 
that data call be transferred, appended, 
and compared regardless of the device 
they were recorded with. The similarities 
and differences in lead systems, signal 
processing and averaging, and data reduc-
tion and their influence on comparability 
of ST-segment monitoring data recorded 
with either Holter recorders, continuous 
vectorcardiography, or continuous 12-lead 
electrocardiography need to be addres-
sed.w.w 
The algorithm involved in the auto-
mated patency assessment should undergo 
further testing in patients suffering acute 
myocardial infarction, preferably inclu-
ding comparisons with simultaneous 
angiography. Optimum thresholds for the 
slope, recovery threshold, and minimum 
amplitude should be sought, potentially 
with infarction area specific algorithms to 
compensate for the reduced lower ampli-
tudes encountered in inferior and especial-
ly posterior and lateral infarctions.18,20 
So far the patency assessment algo-
118 
rithms have not been validated in patients 
with conduction delays. Of special concern 
is the accuracy of the algorithm in patients 
with a left bundle branch block, in whom 
the repolarization phase is markedly dis-
torted and the ST segment may display 
varying slopes depending on heart rate. 
The only study addressing the possibility 
of self referencing for detection of coro-
nary occlusion during left bundle branch 
block used coronary angioplasty as a 
model in which only modest increases 
(median of 4 ± 3 beats/min) in heart rate 
were found during balloon induced coro-
nary occlusion,I:H Whether self-referencing 
is able to compensate for the more dyna-
Inic heart rate changes observed during 
acute myocardial infarction remains to be 
investigated. 
Combinations with arrhythmia monito-
ring and biochenlical essays need to be 
explored. This may lead to improved 
accuracy, methods may provide a back-up 
assessment in case of failure or inapplica-
bility of one of them, or might even give 
additional separate infonnation.77,91"o3 
More quantitative approaches in addi-
tion to detection of patency of the infarct 
artery or the determination of speed and 
stability of reperfusion need to be sought. 
Continuous monitoring might improve 
definition of the maximum amount of 
ischelnia in patients with cyclic reperfu-
sian in whom a single or few static ECGs 
were taken during periods of actual ST 
recovery. The detection of extent of the 
ischemic area reflected in the number of 
leads with ST deviation could be improved 
similarly. TI,e integration of the dynamics 
in severity and extent of ischemia over 
time as a time-severity index might help to 
clarify the response to treatment as a rela-
tionship among infarct related artery 
patency, the amount of myocardium sal-
vaged, and clinical outcome. Relevance of 
this information should be related to alld 
compared with other preferably noninva-
sive information. To develop such models 
will require a thorough process of statis-
tical modeling or neural network develop-
ment that includes other routinely avail-
able noninvasive descriptors to yield a 
practical probabalistic, patient specific 
prediction of infarct outcome.77 
TI,e physiology and clinical relevance of 
the different reperfusion patterns pre-
viously described by DelJborg and co-
workers need to be investigated. Rapid 
resolution of 5T elevation seems to signify 
reperfusion and persistent ST elevation 
failure to achieve reperfusion. Little is 
known about the clinical importance of 
cyclic reperfusion: recent publications 
have suggested that this phenomenon is 
associated ,vith larger infarctions.4,7 It is 
not known whether this is a causal 
relationship or whether this is largely due 
to the fact that cyclic reperfusion is rnore 
obvious when infarction generates higher 
5T-segment arnplitudes. The relevance of 
an increased 5T elevation prior to 5T reco-
very ("late peak pattern")' is also un-
known. Some authors have suggested that 
the late elevation is related with larger 
infarctions or less myocardial salvage, 
possibly due to reperfusion injury.I3-t-137 
Another explanation however is that the 
late peak pattern represents a variation of 
the cyclic reperfusion pattern in a patient 
in whom 5T monitoring was initiated after 
one or multiple previous 5T elevation and 
recovery episodes.6 Knowing what these 
patterns actually represent might enable 
better guidance of Ulerapy. TI,e physiologic 
reasons for discrepancies behveen continu-
ously updated 5T-segment recovery analy-
sis and angiographic patency assessment 
need to be explored.13 While this may be 
partly due to threshold and tinling pro-
blems, other explanations may be found, 
Development of collateral flow rnay result 
in ST-recovery while the infarct related 
Occlusion at a microvascular level may 
explain persistent ST elevation while the 
infarct related ar-tery is patent. The functio-
nal sufficiency of TIM! 2 flow remains 
debated.51 ,138,139 In th.ese patients the presen-
ce or absence of ST recovery may be of 
prognostic importance. 
Most importantly, it needs to be asses-
sed whether continuous ST-segment moni-
toring is helpful in patient triage in vari-
ous unstable coronary syndromes. Its 
value depends on the accuracy of the in-
formation provided as well as on whether 
alternative therapeutic strategies indeed 
show to be beneficial. Illis is particularly 
true for rescue strategies for failed reper-
fusion through the infarct related artery, 
h'eahnent strategies for (silent) ischemia in 
unstable angina pectoris, coronary occlu-
sion follOWing PICA, and treahnent of 
ischemia during peri-operative monitoring 
in major (vascular) surgery. Studies ad-
dressing these issues are needed. 
X: CONCLUSION 
Continuously updated ST-segment re-
covery analysis is a useful noninvasive 
patency assessment technique, allowing 
the identification of failed or unstable 
reperfusion and recurrent occlusion with 
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SUMMARY 
Chapter 1 
An introduction to the history of electro~ 
cardiography and the physiology of ST 
elevation as a marker of transmural ische-
mia due to infarct related artery occlusion 
is presented. Continuous digital multi-lead 
ST segment monitoring and its major 
applications are briefly described. 
Chapter 2 
A total of 44 angiographic observations in 
22 patients were compared with noninva-
sive patency assessments by continuously 
updated ST-segment recovery analysis 
using continuous 12-1ead ST monitoring. 
Sensitivity of the noninvasive method for 
an occluded infarct related artelY was 90% 
and specificity was 92%. Of the 22 pa-
tients, 11 (50%) had ST evidence of cyclic 
reperfusion prior to angiography. In 5 
patients (31%) cyclic reperfusion was 
recorded before treahnent onset. Since 
static patency assessments cannot describe 
this behavior, 3 additional parameters 
describing the speed, stability, and dura-
tion ofST-recovery are proposed. 
Chapter 3 
Inter- and intra- observer variation for 3 
readers was assessed for continuously 
updated ST-segment recovery analysis. A 
high level of concordance was found in 
and between readers for patency assess-
ments 90 minutes after onset of thrombo-
lytic treatment, with Kappa values of 1.0 
for intra-observer variation and 0.79 to 
0.93 for inter-observer variation. Patency 
assessments 6 hours after onset of throm-
bolytic therapy showed a slight reduction 
in Kappa values, although concordance 
overall remained high. Similar resuits 
were found for the number of ST recovery 
and/or re-elevation events, and for conti-
nuous assessments comparing each mi-
nute of the recording. Sources of variabi-
lity included differences in interpretation 
of low ST amplitude ECGs with relatively 
high noise content, anterior ST-segment 
depression, and gaps in the ST recording, 
as well as operator fatigue. Thus, conti-
nuously updated ST-segment recovery 
analysis can be ensued to a high level of 
intra- and inter-observer consistency. 
Clmpter 4 
Essential principles of the continuously 
updated ST-segment recovery analysis 
described in Chapter 2 were modified into 
an automated patency assessment pro-
gram and incorporated into the ST moni-
tor itself. The algorithms and definitions of 
measurement EeGs, as well as the opera-
tor interactions required, are described. 
Chapter 5 
The automated patency assessment me-
thod described in Chapter 4 detected all 35 
angioplasty balloon inflations causing> 
200 f1V peak ST elevation. In addition ailS 
inflations with < 200 f1V peak ST elevation 
preceded by an inflation causing> 200 f1V 
were detected. Occlusion was detected a 
median of 40 seconds after inflation, feper-
fusion a median of 17 seconds after defla-
tion. The requirement of > 200 f1V ST 
elevation measured in at least 1 EeG prior 
to or at the moment of assessment intro-
duced a bias favoring detection of LAD 
occlusions over RCA occlusions, and both 
over LCX occlusions. 
Clmpter 6 
Patterns of ST deviation were related to 
the angiographically determined infarct 
related artery. Of the patients with the 
right coronary artery as the infarct related 
artery, 87% had lead III as the most eleva-
ted lead. Leads V2-V4 were the peak lead 
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in 98% of the patients with occlusion of the 
left anterior descending artery. Location of 
the peak lead was inferiorly and apically 
in patients with a left circumflex artery 
occlusion. Combining leads III, V2, and V5 
would record at least 1 lead with> 200 flV 
ST eleva tion in 321 au t of 361 01' 89% of the 
patients. A 3 lead system with inferior, 
anterior, and apical lead orientations 
should be adequate to record at least one 
lead with sufficient ST deviation. Twelve-
lead 01' vectorcardiographic ST-monitoring 
systems will increase sensitivity for ST 
deviation especially in smaller infarcts and 
will facilitate comparison of the ST devia-
tion pattern during recurrent ST elevation 
with the primary ST elevation episode to 
assess whether it indeed signifies recurrent 
occlusion of the infarct related artery. 
Chapter 7 
Continuously updated ST-segment re-
covery analysis in conjunction with fre-
quent electrocardiographic acquisition 
allows accurate, noninvasive assessment of 
the perfusion status of the infarct area over 
time. It gives more information than 
"snap-shot" assessments made with coro-
nary angiography. It may be helpful in 
selecting patients with failed or unstable 
reperfusion for trials testing more aggres-
sive secondary revascularization strate-
gies. More knowledge is needed about the 
clinical and physiological meaning of ST-
segment evidence of extent, severity, and 
duration of ischelnia, and the stability of 
reperfusion. Continuously updated ST-
segment recovery analysis might than be 
used as an important noninvasive end-
point in acute myocardial infarction trials. 
Chapter 8 
Continuous 12-lead ECG recordings were 
reviewed in 40 patients in whom a perfu-
sion balloon catheter (PBC) was used to 
stabilize an intimal dissection following a 
routine angioplasty procedure with a 
conventional balloon PTCA. Comparing 
PBC with PTCA median single lead peak 
ST deviation were 132 versus 321 pV (p = 
0.0001), median extent of leads with new 
ST elevation were 0 versus 3 leads (p = 
0.0001), and the total sUllunated absolute 
ST deviation over all 12 leads over the 
entire balloon inflation duration were 1083 
versus 1173 pVmin (NS). D,US, despite the 
fivefold longer PBC balloon inflations, 
severity and extent of ST elevation were 
significantly reduced, but ischemia was 
not entirely eliminated. 
Chapter 9 
Accuracy of patency prediction was asses-
sed in 82 acute myocardial infarction pa-
tients for the continuously updated ST-
segment recovery analysis and 5 methods 
using static electrocardiograms. Accuracy 
(95% confidence interval) was 85% (77-
93%) for the continuous method .. and 68% 
(57-78%), 78% (69-87%), 83% (74-91%), 
82% (73-90%), and 80% (71-89%) for the 
static methods. At the moment of angio-
graphy a median of 2 hours following 
onset of thrombolytic treatment the most 
accurate static method and the continuous 
method agreed in 90% of patency asses-
sments. Agreement was reduced to 83% 
when patency assessments were perfor-
med earlier at 90 minutes following treat-
ment onset, and to 77% at 60 minutes. 
Early disagreement was mainly seen when 
the continuous ST recording showed ST 
recovery from a delayed peak ST elevation 
after the pre-treahnent static ECG or when 
dynamic ST changes suggesting cyclic 
reperfusion occurred. Such findings occur 
in approxitnately 50% of patients treated 
with thrombolytic therapy. Thus, the 
continuous method is as accurate as the 
static methods when compared to angio-
graphy 2 hours following treatment onset. 
The continuous updating of reference 
points appears to provide important addi-
tional information early following throm-
bolytic therapy, when ST behavior is more 
dynamic. 
Chapter 10 
Intermittent reperfusion has consistently 
been reported to occur in approximately 
37% of acute myocardial infarction pa-
tients treated with thrombolytic therapy 
and seems to be related to unfavorable 
outcomes. A reliable, noninvasive assess-
ment technique able to detect both failed 
and unstable reperfusion would therefore 
be useful. For this reason continuously 
updated ST-segment recovery analysis has 
been developed. It has been shown to be a 
practical noninvasive patency assessment 
technique with acceptable accuracy. 
Possible treahnent options that could be 
chosen depending on the reperfusion 
behavior as evidenced by continuously 
updated ST-segment recovery analysis are 
discussed, including: discontinuation of 
thrombolytic therapy when reperfusion 
has OCCUlTed; addition of anti-coagulants 
or new platelet inhibitors when intermit-
tent reperfusion occurs; repeat admini-
stration of thrombolytics for failed or 
recurrent occlusion; and urgent angiograp-
hy with PTCA for failed or recurrent oc-
clusion. Many of these options are under 
debate or have not yet been investigated, 
partly because a practical (continuous) 
noninvasive patency assessment method 
was not available. 
The use of ST monitoring in clinical 
trials comparing drug regimens aimed at 
early stable reperfusion is discussed. Main 
outcomes of the GUSTO-l ST-segment 
monitoring substudy, the first large scale 
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attempt to compare speed and stability of 
reperfusion as assessed with continuously 
updated ST-segment recovery analYSis in 
4 different thrombolytic regimens, are 
presented. 
ST monitoring may help determine the 
prognosis of individual acute myocardial 
infarction patients. A very low risk of 
complications could for instance result in 
a shorter stay at the coronary care unit, 
followed by an earlier discharge. 
Other noninvasive patency assessment 
methods are described and compared with 
continuously updated ST-segment re-
covery analysis. Accelerated idioventri-
cular rhythm (AIVR) is a specific but in-
frequently occurring marker of reperfu-
sian. It does not indicate recurrent occlu-
sion. AIVR is therefore not useful as a 
single marker of failed or unstable reper-
fusion. Several biochemical assays have 
been developed for early detection of 
failed reperfusion. They currently provide 
a static assessment only, no distinction is 
made between stable versus unstable 
reperfusion and detection of recurrent 
occlusion depends on other assessments. 
Parallel application of ST monitoring, a 2-
point biochemical assay, and/ or 
arrhytlunia monitoring might increase 
patency assessment accuracy, would pro-
vide back-up assessment in case of failure 
of one of the methods, or might even give 
additional separate infonnation. 
ST monitoring may also be useful in 
other circumstances such as: post angio-
plasty, tmstable angina pectoris, chest pain 
evaluation, pre-hospital monitoring, and 
peri-operatively. Application of ST moni-
toring in these syndromes requires further 
development. 
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SAMENVATTING 
HODfns/llk 1 
De Engelse fysioloog Augustus Desire 
Waller (1856 - 1922) maakte met een capil-
laire electrometer de eerste registraties van 
de electrlsche activiteit van he! menselijke 
hart gemeten vanaf de borstwand. De 
Leidse hoogleraar in de fysiologie Willem 
Einthoven (1860 - 1927) was ontevreden 
met de kwaliteit van de registraties met dit 
ongevoelige instrument en ontwikkelde 
daarom eell meer gevoelige snaar-galva-
nometer. Hij introduceerde de term elec-
trocardiogram (EKG, ECG), noemde de 
achtereenvolgende uitslagen P, Q R, S en 
T, en introduceerde de standaardafleidin-
gen I, II en III. Voor het ontwikkelen van 
de techniek en het ontdekken van de 
mechanismen achter het ECG ontving hij 
in 1924 de Nobel-prijs voor geneeskunde. 
Fred H. Smith toonde in 1918 aan dat 
ST-segment eleva tie het gevolg was van 
afsluiting van een van de kransslagaderen. 
ST elevatie is het gevolg van verschil in 
rust- en activerings- potentialen tussen de 
transmurale ischaemische zone en het niet 
ischaem.ische deel van de hartspier. Onge-
veer 75% van de patienten met een acuut 
myocard infarct hebben ST eleva tie op hun 
ECG door afsluiting van een van de krans-
slagaderen, meestal door een thrombus. 
Zonder reperfusie door de infarct-gerela-
teerde kransslagader vermindert de ST 
eleva tie geleidelijk in de navolgende uren 
tot dagen door het afsterven van de ischae-
tnische myocard cellen. Als er echter re-
perfusie plaats vindt, dan treedt er een 
versnelde normalisering van het ST-seg-
ment op. Continue ECG registratie voor 
het vervolgen van de ST elevatie ("ST 
bewaking") kan dan oak op niet-invasieve 
wijze een adequaat inzicht geven in het 
weI of niet succesvol zijn van therapieen 
gericht op reperfusie. 
Het "Ischemia Monitoring Laboratory" 
van de Duke University Medical Center in 
Durham, Verenigde Staten, heelt in sa-
menwerking Inet de firma Mortara Instru-
ment in Milwaukee een apparaat ontwik-
keld voor continue digitale 12-afleidingen 
electrocardiografie (STlOO). Dit appamat is 
gericht op de onmiddelijke ST-segment 
bewaking en analyse aan het bed, zodat de 
behandeling van het acute myocard infarct 
gestuurd kan worden op basis van kennis 
over het weI of niet succesvol zijn van de 
reeds ingestelde behandeling. Dil proef-
schrift is het gevolg van mijn activiteiten 
als een "research fellow" aan de Duke 
University, waar ik mij bezig hield met de 
ontwikkeling en toetsing van apparatuur, 
pl'Ogranunatuur, alsmede klinlsche toepas-
singen voor ST bewaking. 
HDDfdstuk 2 
In 22 patienten werden 44 angiografische 
bepalingen gedaan van de infarct-gerela-
teerde kransslagader doorbloeding en 
deze verge Ie ken met gelijktijdige non-
invasieve bepalingen, gedaan met de 
continu bijgestelde ST -segment normalise-
ring bepalings-methode. Hierbij werd 
gebruik gemaakt van continue digitale 12-
afleidingen ECG registratie met de STlOO 
electrocardiograaf. De non-invasieve met-
hode had een sensitiviteit voor een afge-
sloten kransslagadel' van 90% en een speci-
ficiteit van 92%. Van de 22 patienten toon-
den er 11 tekenen van intermitterende 
reperfusie in hun continue ST registratie 
voordat angiografie plaats had gevonden. 
Vijf patienten toonden intermitterende 
reperfusie voordat thrombolyse was aan-
gevangen. Statische bepalingen van de 
kransslagader doorbloeding kunnen dit 
gedrag niet registreren, daarom werden 3 
nieuwe parameters voorgesteld tel' be-
schrijving van de snelheid, stablliteit en 
duur van ST normalisatie. 
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Hoofdstuk 3 
Voor de continu bijgestelde ST-segment 
normalisering bepalings-methode werden 
de inter- en intra- waarnemers varia tie 
bepaald tussen 3 waarnemers. De (onco1'-
dan ties tussen waarnemers en binnen eell 
waarnemer voor non-invasieve bepalingen 
van kransslagader doorbloeding 90 minu-
ten na aanvang van thrombolyse waren 
hoog, met Kappa waarden van to VQor 
intra-waan1emer variatie en tussen 0,79 tot 
0,93 voor inter-waarnemer varia tie. De-
zelfde bepalingen voor 6 UUf na begin van 
behandeling Heten een geringe afname in 
Kappa's ziell, hoewel de concordantie over 
het geheel genomen hoog bleef. Vergelijk-
bare uitkomsten werden" gezien voor bepa-
Hngen van het aantal malen clat ST norma-
lisa tie en re-elevatie optrad en voor de 
continue bepalingen waarin iedere Ininuut 
van iedere apname met elkaar werd verge-
leken. Oorzaken van variabiliteit waren: 
de interpretatie van ECG's met een hoog 
"ruis" gehaltei voonvand ST depressiei 
onderbrekingen in de ST registra tie; alsme-
de vennoeidheid van de waarnemer. 
Geconcludeerd wordt dat continu bijge-
stelde ST-segment nonnaliserings bepalin-
gen gedaan kUImen worden met een hoge 
mate van concordantie tussen waarnemers 
en birulen een waarnemer. 
Hoofdstllk 4 
Principes van de continu bijgestelde ST-
segrnent normalisering bepalings-metho-
de, zoals beschreven in hoofdstuk 2, wer-
den gemodificeerd, zodat deze non-inva-
sieve methode kan functioneren als een 
geautomatiseerde procedure. De geauto-
matiseerde methode diende uitgevoerd te 
kUlUlen worden binnen de continue digita-
Ie 12-afleidingen electrocardiograaf. De 
gebruikte algoritlunes en de definities voor 
de selectie van ECG's welke gemeten en 
vergeleken worden, alsmede de interacties 
welke nodig zijn om de geautomatiseerde 
procedure te laten verlopen, worden hier 
beschreven. 
Hoofdslllk 5 
De geautomatiseerde procedure vaal' non-
invasieve bepaling van de kransslagader 
doorbloedingwerd getest tijdens percuta-
ne transluminale coronair angioplastie 
(PTCA). AUe ballon inflaties die door 
afsluiting van de kransslagader een ST 
elevatie ~ 200 pV veroorzaakten werden 
herkend. Verder werden aUe ballon infla-
ties met een ST eleva tie < 200 flV herkend 
die vooraf waren gegaan door een ballon 
inflatie met ~ 200 flV piek ST elevatie. De 
kransslagader afsluiting werd na een 
mediane duur van 40 seconden herkend, 
reperfusie na defJatie van de ballon na een 
mediane duur van 17 seconden. De in de 
algoritmes ingestelde voanvaarde dat er 
minimaal een ECG vaor het moment van 
bepaling moet zijn die ~ 200 fI V ST eleva-
tie vertoont, veroorzaakt een selectie ten 
gunste van herkeruung van LAD afsluitin-
gen ten opzichte van RCA afsluitingen. 
Beiden worden beter herkend dan LCX 
afsluitingen. 
HoofdsllIk 6 
Patronen van ST deviatie op het 12-aflei-
dingen ECG werden vergeleken met de 
angiografisch bepaalde infarct-gerelateer-
de kransslagader (RCA, LAD, LCX) in 361 
patienten. Van de patienten met een RCA 
afsluiting hadden 87% de meeste ST eleva-
tie in afleiding III. De meeste ST eleva tie 
werd gezien in afleidingen V2-V4 in 98% 
van de patienten met een LAD afsluiting. 
De meeste ST eleva tie bevond zich in een 
van de ondelWands- of apicale- afleidin-
gen in patienten met een LCX afsluiting. 
Een combinatie van afleidingen III, V2 en 
V5 zou ten minste een afleiding met ~ 200 
flV ST elevatie hebben in 321 van de 361 
patienten (89%). Een ECG afleidingen 
systeem met orienta ties naa1' de onder-
wandl voonvand en apex zal daarom 
adequaat zijn voor de detectie van ST 
eleva tie in veel van de patienten geselec-
teerd voor thrombolyse. Vectorcardiografi-
sche of twaalf afleidingen ECG systemen 
kunnen de sensitiviteit voor ST eleva tie 
verhagen, met name bij kleinere infarcten. 
Beide systemen zijn oak geschikter voor 
vergelijking van ST re-elevatie patronen 
Inet de oorspronkelijke ST patronen, zodat 
bepaald kan worden of het inderdaad om 
een hernieuwde afsluiting van de infarct 
gerelateerde kransslagader gaat. 
Hoofdstllk 7 
Continu bijgestelde ST-segment normaHse-
rings bepalingen met behulp van frequent 
genomen ECG's zijn in staat om met bruik-
bare precisie non-invasieve achtereenvol-
gende bepalingen van de kransslagader 
doorbloeding te doen. Door deze achter-
eenvolgende bepalingen is het mogelijk 
een betere indruk te krijgen over de snel-
heid en stabiliteit van reperfusie. Hierdoor 
is het mogelijk patienten te herkennen bij 
wie geen of intermitterende reperfusie is 
opgetreden na thrombolyse, hetgeen niet 
mogelijk is met enkelvoudige angiografie. 
Deze patienten met onvoldoende resultaat 
van initiele thrombolyse kunnen dan 
geselecteerd worden voor vergelijkend 
onderzoek met meer agressieve strategieen 
gericht op stabiele reperhlsie. Meer kennis 
is nodig omh'ent de klinische en fysiologi-
sche betekenis van omvang, ernst, alsmede 
de duur van ischaemie, en de stabiliteit 
van reperfusie. De continu bijgestelde ST-
segment normalisering bepalings methode 
kan dan gebruikt worden als een belang-
rijk non-invasief eindpunt in acuut myo-
card infarct onderzoek. 
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Hoofdstllk 8 
Continue 12-afleidingen ECG registraties 
van 40 patienten bij wie een perfllsie bal-
Ion catheter (PBC) was gebruikt ter stabili-
sering van een intima dissectie na stan-
daard procedures met een conventionele 
PICA balion. PBC inflaties veroorzaakten 
een mediane ST deviatie van 132 pV ten 
opzichte van 321 pV bij conventionele 
PTCA (p = 0,0001). Het mediane aantal 
afleidingen met ST elevatie was 0 ten 
opzichte van 3 afleidingen (p = 0,0001), en 
de totale ST deviatie over 12 afleidingen 
gesommeerd over de gehele hallan inflatie 
was 1083 ten opzichte van 1173 flVmin 
(NS), respectievelijk. Hieruit blijkt dat 
ondanks vijfvoudig langere PBC inflaties 
de ernst en omvang van ST afwijkingen 
significant waren verminderd, maar is-
chaenlie niet totaal verdwenen was. 
Hoofdstllk 9 
Een vergelijking van de nauwkeurigheid 
waarmee non-invasieve bepalingen van 
kransslagader doorbloeding gedaan klln-
nen worden met de continue bepalings 
methode en 5 statische ECG methoden 
werd uitgevoerd in 82 patienten met een 
acuut myocard infarct. Nauwkeurigheid 
(95% betrouwbaarheids interval) op het 
moment van angiografie was 85% (77-
93%) voor de continue methode en 68% 
(57-78%), 78% (69-87%), 83% (74-91%), 
82% (73-90%), and 80% (71-89%) voor de 
statische ECG methoden. Op het moment 
van angiografie, 2 uur na aanvang van 
thrombolyse, was er overeenkomst in 
bepaling tussen de continue methode en 
de beste van de statische methode in 90% 
van de patienten. Bij eerdere bepalingen 90 
minuten na aanvang van thrombolyse was 
dit gereduceerd tot 83% en tot 77% bij 
bepalingen 60 na minuten. Een verschil in 
bepalingen werd met name gezien na het 
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optreden van een verlate piek in de ST 
eleva tie en bij intermitterende ST eleva tie. 
Deze 2 pa tronen werden gezien in onge-
veer 50% van de patienten. 
Geconcludeerd werd dat de continue 
methode even nauwkeurig is als de stati-
sche ECG methoden bij vergelijking met 
angiografie 2 Ullf na aanvang van throm-
bolyse. De continue methode Iijkt belan-
grijke meerwaarde te hebben vroeg na 
aanvang van thrombolys€, wanneer het 
beloop van de ST eleva tie meer dyna-
misch is. 
Hoofdsilik 10 
Intennitterencle reperfusie treedt op in 
37% van de patienten die thrombolyse 
ondergaan voor een acuut myocard in-
farct. Dit verschijnsellijkt te resulteren in 
ongunstige uitkomsten na het aClIut myo-
card infarct. Daarom is een betrouwbare 
non-invasieve techniek nodig die in staat 
is patienten te herkennen waarbij geen of 
intermitterende reperfusie is opgetreden. 
Voor dit doel is de continu bijgestelde ST-
segment normalisering bepalings-methode 
ontwikkeld, waarvan aangetoond is dat 
het een praktische methode is met bruik-
bare precisie. 
Afhankelijk van het reperfusie gedrag 
na thrombolyse, welke herkend wordt met 
de continu bijgestelde ST normaliserings-
methode, kan gekozen worden voor ver-
schillende aanvullende of andere behande-
lingen. De volgende opties worden be-
sproken: het stoppen van toediening van 
thrombolytica bij het optreden van reper-
fusie; de toevoeging van anti-coagulantia 
of nieuwe plaaljesremmers bij intermltte-
rende reperfusie; herhaalde toediening 
van thrombolytica indien er geen reperfu-
sie optreedt, of bij re-occlusie; spoed angi-
ografie en PTCA voor persisterende occlu-
sie of re-occlusie. Veel van deze opties zijn 
nog tel' discussie of zijn nog niet onder-
zochl, mede door een gebrek aan prakti-
sehe non-invasieve bepalingen. 
De toepassing van continue ST bewa-
king in klinisehe studies wordt in dit 
proefsehrift beschreven. Vooral onderzoe-
ken naar strategieen gericht op vroege en 
stabiele reperfusie kwmen van deze toe-
passing gebruik maken. De belangrijkste 
resuitaten van de GUSTO-l ST-segment 
bewakings studie worden gepresenteerd. 
Dit is de eerste stu die waarin 4 verschillen-
de thrombolyse regimes worden vergele-
ken in de snelheid en stabiliteit van reper-
fusie. 
ST-segment bewaklng kan gebruikt 
worden voor het bepalen van de prognose 
na het acute myocard infarct. Laag fisko 
patienten kunnen eerder van de ceu naar 
de afdeling worden overgeplaatst, met 
daarop volgend een vroeger ontslag. 
Andere non-invasieve bepalingen van 
reperfusie worden beschreven en vergele-
ken met ST-segment bewaking. Versneld 
idioventriculair ritme (AIVR) is een speci-
fieke maar weinig optredende marker van 
reperfusie. Bovendien kan A1VR intermit-
terende reperfusie ruet herkennen. Daar-
om is AIVR ruet geschikt als een alleen-
staande non-invasieve bepalingsmethode. 
Verschillende biochemische bepalingen 
zijn ontwikkeld voor de non-invasieve 
bepaling van reperfusie. Ook deze metho-
den zijn statisch van karakter: er wordt 
geen onderseheid gemaakt tussen inter-
mitterende en stabiele reperfusie. Boven-
dien kunnen ze geen re-occlusie her ken-
nen. Het gelijktijdig vervolgen van het ST-
segment, het bewaken van het hartribne 
en het doen van biochemisehe bepalingen 
kan de precisie van non-invasieve reperfu-
sie detectie verhogen, een alternatief bie-
den als een van de methoden niet toege-
past kan worden, of mogelijk aanvullende 
informatie opleveren. 
Tenslotte worden andere toepassingen 
van ST -segment bewaking en registratie 
beschreven. Oil kan bruikbaar zijn in de 
bewaking na PTCA, tijdens onstabiele 
angina pectoris, voor de bewaking tijdens 
transport van patienten naar het zieken-
llllis, en voor de peri-operatieve bewaking 
137 
van patienten met kransslagader vernau-
wing. Toepassingen van ST bewaking 
tijdens deze omstandigheden dienen ver-
der ontwikkeld te worden. 
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